close
Medical supplies

Woodbridge Police donate ballistic vests and medical supplies to Ukraine

Photo by Liz Hardaway


Constable Brian Pedalino, left, Yuriy Faryna, center, and Constable Joseph Kubik stand with body armor and medical supplies donated by the Woodbridge Police Department to help Ukraine.

Woodbridge Police Department/Contributing Photo

WOODBRIDGE — Members of the Woodbridge Police Department have donated numerous ballistic vests and medical supplies to Ukrainians as they continue to fight the Russian invasion, the police department said Friday.

Several weeks ago, Officer Joseph Kubik reached out to his Ukrainian friend and Woodbridge resident Yuriy Faryna about how to help the Ukrainian people.

Faryna, who was born in Ukraine and moved to the United States in 2001, has many family members and friends who still live in the now war-torn country. Faryna told Kubik that the Ukrainians urgently needed ballistic vests and medical supplies.


“The Woodbridge Police Department would like to show its support for the Ukrainian community,” the police department said Friday. “We hope our small gesture will encourage others to show their support for the Ukrainian people.”

Less than two weeks ago, several Connecticut police departments donated more than 200 previously worn ballistic vests and dozens of helmets to the Ukrainian American Coordinating Council, according to a previous report. Police in Hamden and New Haven have made similar donations in previous weeks.

Ukrainians still need additional equipment, in particular level 4 ballistic vests and helmets, police said. Any residents wishing to donate any of these items should contact Kubik at [email protected] or Officer Brian Pedalino at [email protected]

read more
Medical products

Laser manufacturing of high precision medical products

By Matthew Nipper, Spectrum Plastics Group, Director of Engineering

Laser micromachining is one of the highest precision processes used in the manufacturing of medical devices. In fact, lasers are often the only option capable of producing certain delicate features, especially in thin or sensitive materials. Lasers can quickly cut micron-sized features to sub-micron tolerances without defects, thereby reducing or eliminating secondary finishing processes, shortening cycle times and accelerating time to market. Because of these advantages, lasers are quickly becoming the preferred method for micro-machining miniaturized and/or complex parts and products for medical devices, in virtually any shape or pattern.

Innovative product designs that require microscopic features are often best produced using laser machining, for example, catheters, medical balloons, and devices for neurovascular, cardiovascular, and diagnostic procedures. Features produced in polymers can be as small as 10 microns in width, with tolerances as tight as 1-2 microns.

Polymers are the material of choice for many medical devices. These materials are mechanically robust, bioinert and have excellent insulating properties. Polymers can be engineered to exhibit specific mechanical and chemical characteristics, to improve biocompatibility and performance, and can be extruded, injection molded or additively manufactured. Virtually any thermoplastic or thermoset polymer material can be laser processed with high precision, including polycarbonate, polyurethanes, ABS, FEP, polyamides, polyimides, PEEK, PTFE, PMMA, polyester , nylon, PE and acrylics.

laser methods

As products become smaller and more complex, engineers must use their technical skills, materials knowledge, and experience to design processes that can create tiny, high-precision features that enhance product functionality, which can ultimately improving or saving the lives of patients.

Here are examples of commonly used high-precision laser methods:

laser removal

Lasers can be programmed to remove or “vaporize” material from surfaces with sub-micron precision. Ablation selectively removes substrate or coating layers from the surface of fabricated parts, with little or no negative thermal or structural impacts on the surrounding material.

Laser cut

Laser cutting is ideal for manufacturing/industrial applications that require a powerful, highly precise cutting tool that creates sharp features on a microscopic scale. As products become smaller, with more functionality, complexity and tight tolerances, laser cutting is often the only method that can produce the high precision features these devices require.

Laser drilling

Many manufactured parts today require microscopic features that can only be created with laser drilling. This highly adaptable, versatile and reliable microfabrication process is used in a wide range of industries. Laser fabrication and post-laser processing can be customized to meet unique drilling needs, optimizing applications such as micro-holes, hole arrays, blind holes and specialty portals. Micron-scale holes can be laser drilled in a variety of patterns with the utmost precision, with no burrs or residual material to clog the holes.

wire stripping

Wire stripping removes sections of insulation or shielding from wires and cables to provide electrical contact points for termination. Conventional stripping methods make physical contact with the conductor, which can damage the wire and slow processing speed. Laser wire stripping is much faster, offers excellent accuracy and process control, and eliminates wire contact, allowing the processing of gauges as small as 46 AWG (0.0015 inches in diameter).

Ultra-fast lasers

Ultra-fast lasers are in high demand due to their speed, accuracy, and lack of thermal or structural damage to the material being processed. With an average pulse width of 150 femtoseconds (150 quadrillionths of 1 second), there is virtually no heat transfer beyond the dimensions of the cut, making it a “cold” process. Therefore, secondary processing is usually not required to remove burrs from cutters or improve edge quality, saving time and money.

Components and laser technology

Precision laser processing can be used for extruded medical tubing, catheters and drug delivery products, medical balloons, injection molding and flexible films. For example:

  • Extruded medical tube. Lasers are high-precision machining instruments that cut micron-scale features in extruded tubing that enable specific medical applications, such as intravascular delivery of drugs or stents. Extruded medical tubing is a commonly used component in medical devices. It is made from a variety of materials and in a wide range of shapes and sizes. Important chemical and mechanical properties include heat and chemical resistance, lubricity, flexibility, kink resistance, and drug eluting capabilities.
  • Catheter technologies. The lasers, which offer high speeds, incredible precision and the ability to process without thermally altering the surrounding material, are ideal for removing material by ablation or drilling a variety of micron-sized features in tubing. catheter and other materials. As medical catheters become smaller and more complex, lasers are often the only manufacturing technology capable of providing the precision needed.
  • Medical balloons. Lasers play a vital role in creating detailed, high-precision medicine ball features that no other method can replicate, including; texturing, grooving and section thinning. With the latest laser technologies, tools, and materials, medicine balloons can be fabricated with microscale features, from a wide variety of materials, for neurovascular, cardiovascular, gastrointestinal, urology, and catheterization procedures. increasingly innovative.
  • Injection molding. For injection molded products, lasers can be used to create micron-sized features in molds, process molded ophthalmic implants, and improve osseointegration of injection molded bioresorbable implants. Because ultra-fast lasers cause no thermal damage, they are ideal for treating sensitive implantable and bioresorbable materials.
  • Flexible films. Laser processing can be used for a variety of film applications. For example, lasers can be used to create surface micro-texture patterns on thin films increasing adhesion in delicate bonding applications. Lasers are also ideal for drilling small features, such as dense arrays of holes in filters or spargers. These are often made from thermoplastic materials, which are very heat sensitive.

Spectrum laser processing

As a full-service laser solutions provider, Spectrum can manufacture high-precision parts to exact specifications in the most efficient and cost-effective manner. Spectrum excels at turning even seemingly impossible designs into high-value products that exceed customer expectations.

Not only is Spectrum a contract manufacturer of high precision laser products, but we also supply ready made laser die tubes and laser cut marking tapes online at online store.spectrumplastics.com, which can be used to speed up the development phase of your next project. For more information on Spectrum’s services and laser processing capabilities, visit www.spectrumplastics.com or call 404-564-8560.

Content sponsored by Spectrum Plastics Group

read more
Prescription drugs

Hunter legislation to protect low-cost prescription drugs

SPRING FIELD – A measure led by State Sen. Mattie Hunter (D-Chicago) to protect access to low-cost prescription drugs passed the Senate on Wednesday.

“Prescription drugs are a health need for many people, and therefore should be more affordable and easier to access,” Hunter said. “We have to make sure people don’t go broke trying to stay healthy.”

House Bill 4595 protects access to low-cost “340B” prescription drugs for uninsured, low-income patients by prohibiting drug benefit managers and third-party payers from using certain contractual provisions in contracts that they conclude with health care providers benefiting from a safety net.

The federal 340B drug pricing program allows entities to stretch limited federal resources as much as possible, reach more eligible patients, and provide more comprehensive services.

“People living with different diseases and disorders need access to medicine, and we need to make it easier for them to access it,” Hunter said. “The Drug Pricing Program was created to reduce drug costs, and this measure stays true to that.

Similar laws have been passed in 16 other states.

House Bill 4595 passed the Senate on Wednesday and is subject to House approval.

read more
Medical supplies

Southeast Asia Disposable Medical Supplies Market Will Soar

NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) — Traditionally, the disposable medical supplies industry has focused on usability, compliance and quality to meet health and safety standards. However, in addition to the increase in demand, environmental concerns are on the rise. As a result, the industry is seeing a renewed interest in low cost and environmentally friendly products.

With recorded sales worth US$6 billion in 2021, the Southeast Asia Disposable Medical Supplies Market is expected to witness a high growth rate in the coming years owing to the growing preference for low-cost disposable medical supplies amid the COVID-19 pandemic.

Maintaining health and hygiene has become the top priority for the prevention of communicable diseases. Disposable supplies come in aseptic packaging which limits the risk of cross-contamination and can help stop the spread of infections, save money and manage hospital resources. Growing awareness of personal hygiene and safety has accelerated the demand for disposable medical supplies.

One of the most promising opportunities for improving care and reducing costs is moving care delivery to the home. Key players are launching and adapting models to move primary, acute and palliative care to homes. Home care can avoid the need for more expensive treatments in hospitals and other institutional settings for vulnerable patients. Disposable medical supplies provide support not only for care of acute and chronic medical conditions, but also for disease prevention and lifestyle choices.

Many key manufacturers are leveraging their capacity for innovation and ingenuity to open up a world of possibilities for healthcare professionals and patients to deliver affordable services and improve patient outcomes.

Request for copy of report: https://www.persistencemarketresearch.com/samples/33019

Key insights from market research

  • Hypodermics and Radiology holds nearly 17.8% market share by value in the disposable medical supplies market in Southeast Asia.
  • With a market share of 26.2% in 2021, cardiovascular procedures dominate the application segment.
  • Hospitals hold nearly half of Southeast Asia’s overall market share for disposable medical supplies.
  • Indonesia is the No. 1 country in Southeast Asia for disposable medical supplies and accounted for 1/4 market share in 2021.

“Increased prevalence of hospital-acquired infections and rising health and hygiene awareness will drive demand for disposable medical supplies in Southeast Asia,” says an analyst at Persistence Market Research.

Get a customized report as needed: https://www.persistencemarketresearch.com/samples/33019

Market competition

Major manufacturers of disposable medical supplies are focusing on partnerships with emerging companies to expand into the Southeast Asian market and reach a wider customer base to meet growing demand.

Moreover, major market players have embraced expansion as a business growth strategy.

  • For example, in September 2021, Lankenau Heart Institute, part of Main Line Health, signed a long-term strategic partnership agreement with Philips, using integrated solutions related to cardiovascular diseases.

Get full access to the report: https://www.persistencemarketresearch.com/samples/33019

What does the report cover?

Persistence Market Research offers a unique perspective and actionable insights into the Southeast Asia disposable medical supplies market in its latest study, presenting a historical demand assessment from 2017 to 2021 and projections for 2022 to 2032.

The research study is based on the product (sterilization consumables, wound care products, dialysis products, infusion products, hypodermic and radiology products, intubation and respiratory supplies, surgical procedure kits and trays, supplies blood management and diagnostics and general disposables), application (cardiovascular, cerebrovascular, dental, laparoscopy, gynecology, urology, orthopedics and others) and end user (hospitals, outpatient surgery centers, clinics, diagnostic centers, long-term care centers and nursing homes) in Southeast Asian countries.

Related reports:

About Persistence Market Research:

Persistence Market Research (PMR), as a third-party research organization, operates through a proprietary fusion of market research and data analytics to help businesses soar high, regardless of the turbulence encountered due to the financial/natural crises.

Overview:

Persistence Market Research is always ahead of its time. In other words, he presents market solutions by putting himself in the shoes of the companies/customers long before they themselves have a boost in the market. The proactive approach followed by the experts of Persistence Market Research helps companies/clients to get their hands on technical-commercial information in advance, so that the subsequent action plan can be simplified on their part.

Contact

Rajendra Singh

Persistence Market Research
USA Sales Office:
305 Broadway, 7th Floor
New York, NY 10007
+1-646-568-7751
United States
United States – Canada Toll Free: 800-961-0353
Email: [email protected]

Visit our website: https://www.persistencemarketresearch.com

read more
Generic drugs

Drug price reforms put generic drugs at risk – Pratt Tribune

By Merrill Matthews Resident Scholar at the Institute for Policy Innovation in Dallas, Texas Twitter @MerrillMatthews.

In Washington DC, Senate Democrats and White House officials are hastily assembling a revised version of the Build Back Better Act, after Senator Joe Manchin announced he could not support the version passed by the House.

Early reports indicate that any updated bill will still allow Medicare to set drug prices, which proponents say will result in cheaper drugs for American patients.

They are wrong. Ironically, price controls will reduce patient access to low-cost generic drugs, at least in the long term. In effect, the Build Back Better Act would undermine a landmark Reagan-era law that allowed thousands of generics to reach patients.

Passed in 1984, the Hatch-Waxman Act created a legal framework that allows generic drug manufacturers to manufacture and sell lower-cost versions of brand name drugs. Any American who has ever saved money buying a generic drug has the law to thank.

Hatch-Waxman gave new drugs a five-year period of exclusivity, during which the company that invented the drug has the market for itself. Generic manufacturers can use this time to develop and test their versions of the drug. After that time, generic competitors can launch their own versions at a lower price.

The objective of these reforms was twofold: to increase access to generic medicines at low prices while encouraging companies that invent original medicines to continue to invest in innovation. In both cases, the law has proven to be extremely effective.

While generics made up less than 20% of prescriptions filled before Hatch-Waxman, they now make up 90%. This has made it easier for patients to purchase their medications, as generics typically cost 80-85% less than brand name drugs.

The Hatch-Waxman Act also had a significant impact on pharmaceutical innovation. Since then, America has become the undisputed leader in the development of new drugs.

The bipartisan group of lawmakers that passed the law went to great lengths to strike the right balance between promoting innovation and affordability. Now, however, the Democrats’ drug pricing proposal would destroy the law’s incentive system.

For there to be a thriving market for generic drugs, there must first be a thriving market for brand name drugs. The US has both, but not if the US Senate passes the House’s flawed drug pricing provisions.

Democrats say their proposal allows the government to “negotiate” the prices of targeted drugs with brand-name drug companies. But pharmaceutical companies either accept the price from the government or lose almost all of the revenue from the sale of a drug. Since manufacturers won’t know what the government’s “negotiated” price will be until the drug is developed, many potentially life-saving new drugs will never be explored.

For nearly four decades, Hatch-Waxman has fostered a competitive market for low-cost generic drugs, while helping medical science reach new heights. The Democrats’ drug pricing plan would undermine that achievement.

Because there can’t be a cheap generic version of a brand name drug that was never invented.

read more
Generic drugs

Global Generic Drugs Market Report 2022: Market Reached High

Dublin, March 30, 2022 (GLOBE NEWSWIRE) — The report “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2022-2027” has been added to from ResearchAndMarkets.com offer.

The global generic drugs market reached a value of US$320 billion in 2021. Going forward, the market is expected to reach US$482.5 billion by 2027 growing at a CAGR of 7% in 2022-2027 .

Keeping in mind the uncertainties of COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic. This information is included in the report as a major market contributor.

A generic drug is a drug that contains the same active ingredient and has an equivalent therapeutic effect as the brand name drug. It is also identical in terms of safety, quality, dosage, strength, route of administration, intended use, effect, form, quality, and side effects.

These drugs can only be produced after the brand name drug’s patent expires. Compared to branded drugs, the production of generics is much cheaper because it does not require repeated clinical (human) and animal studies to demonstrate the effectiveness and safety of the drug. Due to a reduction in the initial cost of research, generics are generally sold at a significantly lower price in the market.

Market trends:

Due to the aging of the population and the increasing incidence of chronic diseases, governments in developed countries have made efforts to reduce health care costs by encouraging the production of generics. While, in developing countries, affordability and accessibility are some of the major issues facing the healthcare sector.

To address these issues, governments and other regulatory bodies have encouraged manufacturers to introduce effective generic drugs. However, despite the rapid expiration of patents on branded drugs, there has been a shortage of generics. This situation is currently being corrected by various initiatives taken by hospitals, institutions and other organizations around the world.

For example, in 2018, a coalition of seven hospitals and three philanthropic organizations in the United States announced that they would tackle drug shortages and the high cost of essential drugs by launching a generic drug company, named Civica Rx. . The company produces 14 FDA-approved drugs available on the market since the start of 2019.

Apart from this, in 2018, the United States Food and Drug Administration (USFDA) created policies to make the market entry and generic approval process more efficient. It has published guidance documents for the development of hard-to-copy drug classes and specific complex drugs.

Key Market Segmentation:

  • Central nervous system diseases are currently the leading therapeutic area, accounting for the majority of the total market.
  • Currently, oral medications are the most preferred product, due to the convenience attached to their administration, which requires little or no medical assistance.
  • Currently, the majority of generics are distributed through retail pharmacies, as most generic drugs are over-the-counter drugs that can be purchased without a prescription.
  • On a regional basis, the United States accounts for the largest market, accounting for the largest market share. This growth is driven by numerous US government initiatives aimed at improving manufacturing and access to generic drugs in the country.

Competitive Landscape:

The market is fragmented in nature with the presence of various small and large manufacturers.

Some of the major players operating in the market include

  • Teva Pharmaceuticals Industries Ltd.
  • Mylan AG
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Fresenius SE & Co.
  • Lupine Limited
  • Endo Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Aspen Pharmacare Holdings Limited.

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive Summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakdown by Country
5.5 Market Breakdown by Therapeutic Area
5.6 Market Breakdown by Drug Delivery
5.7 Market Breakdown by Distribution Channel
5.8 Market Forecast
5.9 SWOT analysis
5.10 Value chain analysis
5.11 Porter’s Five Forces Analysis
5.12 Regulation in the generic industry
5.13 Key Market Drivers and Success Factors

6 Performance of key countries
6.1 United States
6.2 China
6.3 Brazil
6.4 Germany
6.5France
6.6 India
6.7 United Kingdom
6.8 Japan
6.9 Canada
6.10 Italy

7 Market Breakdown by Therapeutic Area
7.1 Central nervous system
7.2 Cardiovascular
7.3 Dermatology
7.4 Genitourinary/Hormonal
7.5 Respiratory
7.6 Rheumatology
7.7 Diabetes
7.8 Oncology

8 Market Breakdown by Drug Delivery
8.1 Oral
8.2 Injectables
8.3 Dermal/Topical
8.4 Inhalers

9 Market Breakdown by Distribution Channel
9.1 Retail pharmacies
9.2 Hospital pharmacies

10 Competitive Landscape
10.1 Market structure
10.2 Market Breakdown by Major Players
10.3 Key Player Profiles

11 Generic drug manufacturing process
11.1 Product Overview
11.2 Detailed process flow (tablets)
11.3 Detailed process flow (injectable)
11.4 Various types of unit operations involved
11.5 Mass balance and raw material requirements

12 Project details, requirements and costs involved
12.1 Land Requirements and Expenditures
12.2 Construction Requirements and Expenses
12.3 Plant machinery
12.4 Images of machines
12.5 Raw Material Requirements and Expenditures
12.6 Packaging Requirements and Expenses
12.7 Transportation Requirements and Expenses
12.8 Utility Requirements and Expenses
12.9 Labor Requirements and Expenditures
12.10 Other capital investments

13 Loans and Financial Assistance

14 Economics of the project
14.1 Capital cost of the project
14.2 Technical and economic parameters
14.3 Product Pricing and Margins at Different Levels of the Supply Chain
14.4 Taxation and depreciation
14.5 Revenue projections
14.6 Expenditure Projections
14.7 Financial Analysis
14.8 Profit Analysis

For more information about this report visit https://www.researchandmarkets.com/r/hp8ne7

  • Global Generic Drugs Market


        
read more
Medical supplies

Disposable Medical Supplies Market Report: Sizing and Growth, Dynamics, Competitive Landscape, SWOT Analysis and Forecast to 2031

the disposable medical supplies market is expected to grow gradually over the next 10 years. Video calling has penetrated the healthcare vertical, resulting in effective long-distance monitoring. Virtual doctor visits are followed by outstanding telemedicine, which results in cost effectiveness as well as various options to choose from (concerning doctors). This would be how the healthcare vertical would unfold in the coming period.

According to the WHO, 15% of hospitalized patients suffer from nosocomial viral, bacterial and fungal infections. To prevent and reduce the prevalence of nosocomial infections, several measures, such as the use of sterile and disposable products, pre-packaged medical kits, sterile medical devices and disposable gloves, among other disposable medical supplies, are taken. Healthcare workers use a number of disposable medical supplies and protective equipment, such as surgical drapes, surgical gowns, surgical gloves, eye protection equipment, face masks, etc., during the execution of operations.

Get a sample copy of this [email protected] https://www.persistencemarketresearch.com/samples/3242

Company Profiles:

  • Cardinal Health, Inc.
  • Covidien plc.
  • 3M Healthcare Ltd.
  • Halyard Health, Inc.
  • Molnlycke Health Care AB
  • Medline Industries Inc
  • Sempermed USA, Inc.
  • Ansell Healthcare LLC
  • Nipro Corp.
  • McKesson Corporation
  • Others.

Methodology [email protected] https://www.persistencemarketresearch.com/methodology/3242

Disposable Medical Supplies Market: Key Dynamics Impacting Growth

The increased awareness of nosocomial infections and the crucial role played by disposable medical supplies are the two factors preventing the rapid spread of these infections. The European Center for Disease Prevention and Control (ECDC) has reported that one in 18 patients in European hospitals suffers from a hospital-acquired infection (HAI). On average, approximately 3.2 million patients per year suffer from IAS. Disposable medical supplies are used in the treatment of numerous infectious diseases, which is expected to drive the growth of the disposable medical supplies market over the forecast period.

An increasing number of surgeries performed globally is another significant factor expected to drive the disposable medical supplies market. Likewise, the rising focus of governments of various countries on regularizing the healthcare profession by implementing strict guidelines will further enhance the disposable medical supplies market revenue. Various hygiene awareness programs in various regions promote the use of disposable medical supplies, such as gloves, gowns and sheets.

The continuous innovations of disposable medical supply manufacturers, the lucrative marketing strategies employed by companies, and the development of disposable medical supplies with better protection quality, such as disposable gowns, sheets, gloves, feeding tubes and others, etc are expected to further boost the Disposable Medical Supplies Market.

Some disposable medical supply products, such as procedure kits and trays, reduce workload and allow for a simple and efficient workflow. The global disposable medical supplies market is expected to be driven by the growing number of end users, rising healthcare expenditure per capita, and increasing number of surgeries.

The rapid growth in the healthcare industry is the major driver of growth in the global disposable medical supplies market. Rising demand for disposable gloves and growth in the healthcare sector will in turn propel the growth of the disposable medical supplies market. According to a latest report published on NCBI, of the total surgical gowns consumed in the United States, more than 80% are disposable. The use of disposable surgical gowns is also increasing in the emerging regions of APAC and MEA due to increased hospital budget and improved living standard of people in these regions.

However, pricing pressure and saturation of the disposable medical supplies market are the two factors that will limit the growth of the disposable medical supplies market over the forecast period.

Access the full [email protected] https://www.persistencemarketresearch.com/checkout/3242

Disposable Medical Supplies Market: Segment Insights

The disposable medical supplies market is segmented on the basis of product type and end users. Based on product type, the disposable medical supplies market is segmented into surgical drapes, feeding tubes, gloves, gowns, and procedure kits and tray. On the basis of end users, the disposable medical supplies market is segmented into Tier 1 hospitals (>500 beds), Tier 2 hospitals (250-500 beds) and Tier 3 hospitals (

In terms of revenue, the Gloves product type segment, in the Disposable Medical Supplies Market, is expected to hold a major share during the forecast period. By end-users, the tier 3 (

Access related reports-

Interventional pulmonology market:

According to analysis by Persistence Market Research, the interventional pulmonology market should present a CAGR over 4% over the forecast period (2021 – 2031).

Tinnitus Masker Market:

Tinnitus is the noise of a ringing in the ear and it is an annoying sensation of hearing a sound when the external sound does not exist. Tinnitus Masker Market: Analysis of global industry trends 2013 to 2017 and forecast 2018 – 2026

Disposable Circular Staplers Market:

Disposable Circular Staplers Market: Analysis of global industry trends from 2013 to 2017 and forecast from 2018 to 2028. A disposable circular stapler is designed to stitch and make cuts at the same time during surgery.

About Us: Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York, NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]

read more
Prescription drugs

Kewanee police arrest woman for selling prescription drugs to minor

The Kewanee Police Department conducted an investigation on March 22 that led to the arrest of Kathy Chanton-Khemphomma, 30, of Davenport, Iowa, for drug-related charges.

A KPD press release said it was determined the suspect had once sold prescription pills to a teenager earlier in the day.

The teenager’s father then contacted law enforcement after discovering the identity of the person who sold his child drugs. The father arranged to meet the suspect to buy more pills. After the suspect arrived at the scene, the father contacted law enforcement to confront the suspect. Kewanee police arrived at the scene and conducted an investigation. Officers took statements from the father and the suspect, and also reviewed text messages and phone call logs.

“It was determined that there was probable cause that Chanton-Khemphomma had illegally sold prescription pills to the minor and was attempting to sell more pills,” the statement read.

Chanton-Khemphomma was arrested and transported to the Kewanee Police Department. She was eventually rushed to Henry County Jail on the preliminary charges of Delivering a Controlled Substance (Class 3 Felony) and Contributing to the Delinquency of a Minor (Class 4 Felony). Class 3 felony carries a potential sentence of 2 to 5 years in the Illinois Department of Corrections. His bail was originally set at $100,000.

A preliminary hearing was held on March 28 where probable cause was found and a pre-trial conference was scheduled.

This article originally appeared on Star Courier: Kewanee police arrest woman for selling prescription drugs to minors

read more
Medical products

Counterfeit medical products increased by 47% between 2020 and 2021, report says

Fueled by the COVID-19 pandemic, incidents of substandard and falsified (SF) medical products increased nearly 47% between 2020 and 2021, according to a report by the Association of Authentication Solution Providers ( ASPA), a non-profit organization that deals with anti-counterfeiting awareness.

The report said the incidents found were mostly related to medical products related to COVID-19, including vaccines, drugs, COVID test kits, antibiotics, face masks and disinfectants. During the peak of COVID-19, incidents of SF medical products were seen in 23 out of 29 states and 7 union territories of India.

“Criminals have seen the pandemic crisis as an opportunity to sell more and more substandard and falsified medical products, taking advantage of the vulnerability of people in need. The huge negative impact of the huge increase in circulation counterfeit medicines and essential medical products on the The fight against the COVID-19 pandemic has gone almost unnoticed.It is unfortunate that criminals manufacture ineffective or harmful products in packages that appear identical to the genuine products, which makes them difficult to detect,” said Nakul Pasricha, ASPA President.

“The circulation and use of these SF medical products violates the right to health and slows down the pace of providing the quality health services that people deserve. It is high time to act firmly to stem this threat. If preventive measures are taken now, we will be in a better position to provide effective healthcare to patients,” Pasricha added.

Despite the guidelines, the circulation of SF medical products has been an under/under-treated problem in India. The government has recently taken the decision to make QR codes on Active Pharmaceutical Ingredients (APIs) mandatory. APIs are the main raw materials used in the manufacture of medicines – capsules, tablets, syrups and others.

National authentication and traceability projects have seen an international trend in recent years, with China, Brazil, Turkey, the United States and the EU being the pioneers in this field. It has helped these countries reduce the parallel market in various industries, improve tax collection, and significantly reduce business losses from counterfeit products and illegal trade. India should also implement these measures in other sectors to join the league of advanced digital economies, observes the report.

Despite the Union government’s efforts to deliver real coronavirus vaccines through transparent procurement and procurement systems and the technology-backed CoWin administration platform, the global monitoring and surveillance system The World Health Organization (WHO) control for substandard and counterfeit medical products in August 2021 had also identified fake versions of the COVID-19 Covishield vaccine in India and Uganda. The apex global public health agency also this month reported the circulation of a fake drug Remdisvir used for the management of COVID-19.

Also read: CBI has made ‘substantial progress’ in investigation of NSE collocation cases: FM Sitharaman

Also Read: PE/VC Investors Raise a Record $41.3 Billion Through Exits in 2021

read more
Medical supplies

Medical Supplies Vending Machines Market Size | Incredible Possibilities and Growth Analysis and Forecast to 2028 | ZOOMGU, The Wittern Group, Benleigh, VendTek

Medical Supplies Vending Machine Market 2022 the research provides detailed industry insights including classifications, applications and industry chain structure. Global medical supply vending machine industry analysis is provided for the international markets including development trendscompetitive landscape analysis and key regions state of development. Development policies and plans are discussed as well as manufacturing process and cost structures are also analyzed. This report also indicates import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report also gives 360 degree viewew of the industries competitive landscape. SWOT analysis has been used to understand the Thus, helping companies understand the threats and challenges facing businesses. The medical supply vending machine market is showing steady growth and CAGR is expected to improve over the forecast period.

Get a sample PDF copy of this report for FREE!
https://www.qurateresearch.com/report/sample/MnE/global-medical-supplies-vending-machine-market/QBI-BIS-MnE-1122405

Manufacturer’s detail
ZOOMGU
The Witern group
Benleigh
SellTek
Technology
Hunan Xingyuan Technology Co., Ltd.
Hunan TCN Vending Machine Co.,Ltd.
Wholesale Equipment VendTek, Inc.
Betson
Guangzhou Taiyun Tech Co., Ltd.

Segmentation of product types
electronic type
mechanical type

Application segmentation
Hospital
Pharmacy
Clinical

The Medical Supplies Vending Machines market report includes comprehensive information about the major market competitors including various organizations, companies, associations, suppliers and manufacturers competition for production, sourcing, sales, revenue generation and after-sales performance expectations. The bargaining power of many sellers and buyers has also been included in the research report.

Free report data (in the form of an Excel data sheet) will also be provided upon request with a new purchase.

Medical Supplies Vending Machine Market Regional Coverage (Regional Production, Demand & Forecast by Countries etc.):

  • North America (S., Canada, Mexico)
  • Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
  • Asia Pacific (China, India, Japan, Southeast Asia, etc.)
  • South America (Brazil, Argentina, etc.)
  • Middle East and Africa (Saudi Arabia, South Africa, etc.)

For an inquiry OR a question? Ask our expert here
https://www.qurateresearch.com/report/enquiry/MnE/global-medical-supplies-vending-machine-market/QBI-BIS-MnE-1122405

The study analyzes the following key business aspects:

  • Analysis of the strategies of the main players: Market players can use this analysis to gain a competitive edge over their competitors in the Medical Supplies Vending Machines market.
  • Study on the main market trends: This section of the report offers a more in-depth analysis of the recent and future trends in the Medical Supplies Vending Machines market.
  • Market forecast: Buyers of the report will have access to accurate and validated estimates of the total market size in terms of value and volume. The report also provides consumption, production, sales, and other forecasts for the Medical Supplies Vending Machines market.
  • Regional Growth Analysis: All major regions and countries have been covered in the report. The regional analysis will help market players to tap into unexplored regional markets, prepare specific strategies for target regions, and compare the growth of all regional markets.
  • Segmental analysis: The report provides accurate and reliable forecasts of the market share of important segments of the Medical Supplies Vending Machines market. Market players can use this analysis to make strategic investments in key growth pockets of the Medical Supplies Vending Machines market.

Overview of the chapters analyzing the global Medical Supplies Vending Machines Market in detail:

  • Chapter 1 details information on the introduction of medical supply vending machines, Product scopemarket overview, Market risks, driving forces of the market, etc.
  • Chapter 2 analyze the top manufacturers Medical Supplies Vending Machine Market by Sales, income etc for the forecast period 2022 to 2028
  • chapter 3 analyze on the competition landscape among the top manufacturers based on sales, turnover, market share etc for the period 2022 to 2028.
  • Chapter 4 defines the global medical supply vending machine market by Regions and their market sharing, sales, revenue etc for the period 2022 to 2028.
  • Chapters 5 to 9 analyze Medical Supply Vending Machine regions with Medical Supply Vending Machine countries based on the market sharing, revenue, sales and
  • Chapter 10 and 11 contain knowledge about the basis of the market types and application, sales market share, growth rates etc for the forecast period 2022 to 2028.
  • Chapter 12 focuses on the market forecast for 2022 to 2028 for the medical supply vending machine market in regions, type and application, sales and revenue.
  • Chapter 13 to 15 contain transitional details associated with sales channels, suppliers, traders, resellers, search results and conclusion, etc. for the medical supply vending machine market.

You can buy this report at [email protected]
https://www.qurateresearch.com/report/buy/MnE/global-medical-supplies-vending-machine-market/QBI-BIS-MnE-1122405

Contact us:
The Web: www.qurateresearch.com

E-mail: [email protected]

Telephone: USA – +13393375221, IN – +919881074592

read more
Prescription drugs

Prescription Drugs Market Outlook Update Future Trends, Scope, Top Players from 2016 to 2028

The Global prescription drug market The report emphasizes on a detailed understanding of some crucial factors such as size, share, sales, forecasted trends, supply, production, demand, industry, and CAGR to provide a comprehensive perspective of the overall market. Further, the report also highlights challenges impeding market growth and expansion strategies utilized by leading companies in the “Prescription Drugs Market”.

Global Prescription Drugs Market research report analyzes leading players in key regions such as North America, South America, Middle East & Africa, Asia-Pacific. Provides insights and expert analysis on important market trends and consumer behaviors, as well as insights into key market data and brands. It also provides all the easily digestible information.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=107215

The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures on the Prescription Drugs market and its important drivers such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

Key Players Covered in Prescription Drugs Markets:

  • Pfizer
  • Gilead Sciences
  • Johnson & Johnson
  • rock
  • AbbVie
  • Sanofi
  • Amgen
  • Novartis
  • Merck & Co. (MSD)
  • GlaxoSmithKline (GSK)
  • Bayer
  • Takeda
  • Astra Zeneca
  • Takeda
  • Novo Nordisk
  • Suits you
  • Bristol Myers Squibb
  • Boehringer Ingelheim
  • Allergan
  • Eli Lily

    Prescription Drugs Market Split By Type:

  • brand name drugs
  • General medicine

    Prescription Drugs Market Split By Application:

  • Hospital
  • Clinical
  • Other

    The Prescription Drugs Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=107215

    Scope of the Prescription Drugs Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Prescription Drugs report provides information on the market area, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and the growth rate for each region, country and sub-region during the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Aims and objectives of prescription drug market research

    • Understanding the Prescription Drug opportunities and advancements determines the market highlights, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prescription Drugs market and the dynamics of the Prescription Drugs in the market.
    • Categorize prescription drug segments with increasing growth potential and assess the futuristic segment market.
    • To analyze the most important trends related to the different segments that help decrypt and convince the Prescription Drugs market.
    • Check region-specific growth and development in the Prescription Drugs Market.
    • Understand the major stakeholders of the Prescription Drugs market and the competitive image value of the Prescription Drugs market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prescription Drugs Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical prescription drug distribution data from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=107215

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prescription Drugs Market Segmentation by Types

    4 Prescription Drugs Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Major Countries Prescription Drugs Market Product Commodity

    7 North America Prescription Drugs Landscape Analysis

    8 Europe Prescription Drugs Landscape Analysis

    9 Asia-Pacific Prescription Drugs Landscape Analysis

    10 Latin America, Middle East and Africa Prescription Drugs Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Driven by Ukrainian student, Florida Southern collects medical supplies

    LAKELAND — A cardboard box covered in sky-blue paper sat in a hallway Friday morning outside the Florida Southern College bookstore. The open box on top bore a handcrafted message in dark blue letters on a yellow background: “Stand With Ukraine.”

    The box, one of the few on campus for supply drives, reflects the college’s gesture of support not only for a nation six time zones away, but also for one of its own students.

    Maria Rezhylo, a junior from Ukraine, came up with the idea of ​​gathering medical supplies to ship to her home country, where her parents and many of her family members are enduring the anxiety and dislocation surrounding the Russian military invasion that started on February 24.

    “It’s something really small and insignificant for us, but for the people there, it can literally save someone else’s life,” said Rezhylo, 23, known to his family and friends. her friends under the name Masha. “And it would also give that person (donor) an idea that they are directly doing good to someone else overseas. I think it’s a really amazing idea.

    “She knows the risk; she can be killed’:Lakeland woman refuses to leave Ukrainian village amid Russian invasion

    ‘A clear right and a clear wrong’:Polk natives living in Europe help Ukrainians

    Grocer’s program:Publix launches relief program for those affected by the Russian invasion of Ukraine. Here’s how to donate

    While most Americans probably think the Russian-Ukrainian conflict only started in February, Rezhylo is quick to explain that Ukraine’s eastern neighbor has been threatening the country for years. She spent her early childhood in the city of Donetsk in eastern Ukraine, but her family’s life changed dramatically in 2014 with the Russian invasion of the Donbass region.

    Rezhylo went to live with an aunt in kyiv for about a year before her parents joined her in the capital. Most of his relatives also moved west, but some sided with the Russians and stayed in Donetsk, and Rezhylo moved away from them. This included her paternal grandmother, whom she did not see for seven years until the woman died last year.

    Rezhylo said his father was a senior transport official in Donetsk and his mother worked as a midwife, but the two had to start over in Kyiv with minimal savings.

    “It was traumatic, to some extent, because when we moved to Kyiv, it was really difficult for my parents to navigate the whole process because they stayed in Donetsk for a while during a very intense war,” said said Rezhylo. “The living conditions were, like, awful, awful, awful; I don’t want to give details about it. My parents started from scratch and eventually found better jobs. Life kind of got back together and we were living really, really well for the past, like, three, four years.

    Rezhylo, a swimmer, has long aspired to compete for a varsity team in the United States. (She taught herself to speak English mostly by watching influencers and swimming channels on YouTube.) She received a student visa and enrolled in 2019 at a university in the northeast before transferring in South Florida last fall.

    During the tense months leading up to Russia’s invasion of Ukraine, Rezhylo said she grew increasingly anxious. As of Friday, her parents still had electricity and an internet connection, and she is able to communicate with them on a daily basis.

    In contact with parents

    “I think I’m really lucky in that aspect because I have friends who live here (in the United States) and they’re from Ukraine, and some of their family members live in Mariupol, which is the ‘one of the hottest places right now in Ukraine, and they can’t communicate with their families,” she said. “A friend of mine, she told me that she spoke to her mother on Monday last, and that was it. And they just found a service (Internet) to say, for example, “We are alive”. That was it.”

    On Friday, the Russian attack had killed more than 1,000 Ukrainian civilians, including about 90 children, according to the United Nations.

    Rezhylo said his father, who is 53, volunteers with a group of civilian guards in his neighborhood, carrying a gun and wearing a bulletproof vest while on patrol. Her mother, 51, volunteers at a bakery that produces bread and other goods for needy locals and soldiers.

    The couple have been spending every night since February 24 in a bomb shelter, Rezhylo said.

    The student said she avoids asking her parents for many details about the situation in Kyiv.

    Rezhylo

    “I think it’s, like, a mutual thing where we don’t say negative things to each other,” she said. “We kind of realize that it won’t do us any good to say anything bad to each other. Because even though I’m worried about them, they’re also worried about me here, because I’m the only child, I’m alone here.

    Rezhylo, who specializes in sports management and psychology, said she suffers from anxiety and has trouble sleeping, and when she sleeps she sometimes endures nightmares. On Thursday, she did not feel able to attend classes. But she said she wouldn’t tell her parents, not wanting to add to their worries.

    Rezhylo, a Division II All-American at a previous school, said FSC swim coaches and her teammates provided crucial emotional support. The team is currently undergoing off-season training and head coach Andy Robins said he has allowed Rezhylo to adjust his schedule as needed.

    “She’s really easy to support because she’s generally in a good mood,” Robins said. “She will interact with anyone. When you have a team of 45-50 athletes, sometimes there are people who never interact with others, but she seems really good with everyone.

    Not all of her classmates know she’s from Ukraine, but Rezhylo said her swimming teammates do.

    “The swimming team, at all levels, it was really amazing,” she said. “A lot of people, whenever they saw me on campus, they just came over to hug me without asking rhetorical questions, like, ‘Oh, how are you?’ Because it’s obviously a tough time for me, so people were very empathetic about it.

    Search for donations

    As the situation in Ukraine worsened, Rezhylo yearned to do something to help his home country. But she didn’t want to ask the students for cash donations.

    An uncle told her about Ukraine Express, a company that ships items from the United States to Ukraine, and she got the idea to collect supplies to deliver to a non-profit organization in her country. Rezhylo said she pitched the idea to South Florida President Anne Kerr and Dean of Students Mike Crawford, and they responded enthusiastically.

    She then met with leaders of the Student Government Association, who embraced the concept and began decorating collection boxes that were placed near the bookstore, library and other locations on Wednesday. The SGA sent an email to students informing them of the campaign, which is scheduled to last two weeks.

    Rezhylo and the Student Government Association are looking for non-perishable medical supplies, such as tourniquets, bandages, antiseptics, hemostatic drugs, and over-the-counter pain relievers. SGA will send the supplies to a Ukraine Express office in Delaware, and from there they will be transported to Ukraine.

    Florida Southern also accepts monetary donations through its website and will use the money to purchase more supplies, said Natalie McGinniss, administrative vice president of the Student Government Association.

    “It’s really exciting to be able to stand with Ukraine during this heartbreaking tragedy, knowing that we are making a huge difference in the lives of these people,” said McGinniss. “With students on campus, we’ve been contacted by locals, and I already have boxes full of different supplies, which is amazing considering it’s only been three days since we started this campaign.”

    As Rezhylo worries about her loved ones in Ukraine, she said she hopes the United States and other countries will step up their military aid to the country. She would like to see allies impose a no-fly zone over Ukraine, a step President Joe Biden and NATO leaders have resisted because it would mean a direct military confrontation with Russia.

    But Rezhylo said she was grateful to see the global expressions of solidarity with her native country.

    “I think that’s great and really reassuring,” she said. “The support all over the world – it’s just, like, crazy, amazing, and people are just able to recognize what we’re fighting for, and that’s really our freedom.”

    Gary White can be reached at [email protected] or 863-802-7518. Follow on Twitter @garywhite13.

    read more
    Prescription drugs

    Animal Prescription Drugs Market Size, Trends, Growth Analysis and Forecast 2022 to 2028

    The Animal Prescription Drugs Market 2022 published by Gravitas Market Insights is expected to grow at a steady rate and register a significant CAGR during the forecast period. The presence of prominent players in the ecosystem has been responsible for a diverse and competitive market. Initiatives based on innovation and development of digital transformation across several industries are expected to lead the global animal prescription drug market over the forecast period.

    The final deliverable report will add the analysis of the impact of COVID-19 on this industry. The report gives an in-depth historical analysis of the global Animal Prescription Drugs market from 2016 to 2021 and provides an overall market forecast from 2022 to 2028 by sub-segments and regions. The report obscures revenue, historical growth, and future perceptions in the Animal Prescription Drugs market.

    Get Sample Report of Animal Prescription Drugs Market – 2022 to 2028

    Major market players have been summarized to better understand the global businesses. Our Animal Prescription Drugs Market research reports provide comprehensive information on several of the major manufacturers operating in the regions of the world. We render company profiles which include a detailed company overview, business performance, business information, key strategies executed over the years.

    This report also presents the market competition landscape and subsequent comprehensive analysis of the major manufacturers in this market such as:

    Elanco Animal Health, Ceva Sant Animale, Msd Animal Health, Zoetis, Virbac, Dechra, Vetoquinol, Animalcare Group, Ourofino Saude Animal, Boehringer Ingelheim

    Carry on…

    The COVID19 pandemic has taken a toll on the global economy, it has caused a general lockdown, which has significantly affected various businesses. Our industry specialists work non-stop to timely distinguish, accumulate and transmit the Animal Prescription Drugs Market investigation owing to the phenomenal choices in the impact of COVID-19 on numerous organizations. The full form of this report will include the general effect of the pandemic and the anticipated change on the company’s point of view, taking into account monetary, political, innovative and social boundaries.

    Click here to see the post-COVID-19 impact on this market:

    The report talks in detail about the following segments:

    Animal Prescription Drugs Market – By Application:

    • Pet
    • Livestock

    Animal Prescription Drugs Market – By TYPES:

    • oral-type
    • Smear type
    • Type of injection
    • Type of spray

    Regionally, the global animal prescription drugs market is segmented as follows:

    • North America (United States, Canada, Mexico)
    • Europe (UK, Germany, France, Italy, Spain, Russia and the rest of Europe)
    • Asia-Pacific (China, India, Japan, Korea, Australia, Southeast Asia, Rest of Asia-Pacific)
    • The continent of South America (Brazil, Argentina, Colombia, Rest of South America)
    • Africa and Middle East (GCC, South Africa, Rest of Middle East and Africa)

    Premium Report Special Discount Offer:

    The global Animal Prescription Drugs Market research report offers business communication insights through numerous factors and some of the many highlights of the report are:

    • Broad parent market assessment
    • Growth of substantial aspects of the market
    • Analysis of market segments in all sectors
    • Historical, current and forecast market assessment
    • Strategic approach of the main market players
    • Productive strategies to help companies strengthen their place in the market

    Contents:

    Section 1: Executive Summary
    1.1. 360° Overview of Animal Prescription Drugs Market, Year 2016-2028
    1.2. Business Model Trends
    1.3. Growth trends
    1.4. End User/Volume Trends
    1.5. Regional trends
    Section 2: Market Dynamics – Industry Overview of Prescription Animal Drugs Market
    2.1. Growth engines
    2.2. Opportunities
    2.3. Industry Challenges
    2.4. SWOT analysis
    2.5. Porter’s analysis
    2.6. Global Industry Landscape, Year 2016 – 2028
    2.7. Industry segmentation
    2.8. Landscape of technology and invention
    2.9. Regional landscape
    2.10. Competitive environment
    Section 3: Global Prescription Animal Drugs Market, By Carrier Type
    Section 4: Global Animal Prescription Drugs Market, by Volume
    Section 5: Global Prescription Animal Drugs Market, Regional Analysis
    Section 6: Company Profile – Animal Prescription Drugs Market

    Do you have a question ? Request a sample report from our industry experts! :

    Contact:
    Sharon Smith
    Gravitas market overview
    USA: +1 888 298 9289
    E-mail: [email protected]

    read more
    Medical products

    Hot Extrusion Medical Products Market Trend, Impact of COVID-19, Current Industry Figures with Demand by Countries and Future Growth 2026

    The latest economic intelligence report on Hot Extrusion Medical Products Market elaborates on the factors responsible for the growth of the industry such as key growth enablers, restraints, and opportunities. Moreover, it expands past years data and current business scenario to infer the performance of the industry over the period 2020-2025.

    To calculate the size of the industry on a global level, an exhaustive analysis of how this business sphere operates on a regional and national level is incorporated into the report. Going further, the research literature scrutinizes the dominant players and assesses the strategies adopted by them to stay in the competitive arena. Additionally, the current and projected impact of the Covid-19 pandemic was taken into consideration with a focus on revenue generation prospects and methodologies to deal with the changing landscape.

    Main highlights of the table of contents:

    Request a sample copy of this report @ https://www.runningafrica.com/request-sample/2952

    Product land

    • Product range: Films, taste masking, drug eluting devices and others
    • Forecasts of the growth rate of each product type over the forecast period.
    • Returns earned and market share held by each product category.

    Scope

    • Application spectrum: Research laboratory, contract manufacturing organization and pharmaceutical companies
    • Estimates of product demand and market share for each type of application.
    • Annual growth rate of each application segment over the forecasted schedule.

    Regional outlook

    • Geographic bifurcation: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.
    • Figures relating to total sales and net income accumulated by each regional market.
    • Annual growth rate of each region over the forecast period.

    Competitive landscape

    • Main contenders: AbbVie Formex BASF Pharma Omipa Biogrund Lubrizol
    • Assessment of the market concentration ratio.
    • Portfolio of products and services of listed companies.
    • Manufacturing units of key players in operating regions.
    • Financial attributes such as pricing model, sales, profit margins, and market share for each company.
    • Updates on the latest mergers, acquisitions and expansion proposals.

    To summarize, the report authors have inspected the Hot Melt Extrusion Medical Devices market through several segmentations followed by in-depth discussion on industry supply and sales channel including upstream basics and downstream to help companies effectively deploy their products and solutions to market. .

    The Hot Extrusion Medical Products market report is summarized as follows:

    Industry with market definition, key elements such as market restraints, drivers, potential opportunities, challenges, Medical Hot Melt Extrusion Products market trends, etc.

    Hot Extrusion Medical Products Market Segmentation Based on Product, Application, Geographic Region and Competitive Market Share

    Hot Extrusion Medical Products Market Size, Approximations, Forecast for the said Period

    Hot Melt Extrusion Medical Products Market Distribution Channel Assessment

    Competitive analysis of crucial Hot Melt Extrusion Medical Products Market manufacturers, trends, company profiles, strategies, etc.

    Factors responsible for the growth of the hot extrusion medical products market

    The in-depth geographic market assessment of the leading hot melt extrusion medical products market

    Customization request on this report @ https://www.runningafrica.com/request-for-customization/2952

    read more
    Medical supplies

    Remedy’s Rx collects medical supplies for Ukraine

    Content of the article

    Jocelyne Bousquet, director of Remedy’s Rx in the Espanola mall, says the incentive to collect medical supplies for the people of Ukraine came in early March, through their pharmacist Ken Burns, through her mother and dad. a friend of the family.

    Content of the article

    Ukrainians are asking for medical supplies as part of what they need to survive an unjust war inflicted on them by Russia. As hospitals, homes, churches, schools and shelters are bombarded, the need for medical supplies will become more urgent.

    On March 5, Bousquet posted an announcement on Remedy’s Rx Facebook page, asking people to donate over-the-counter medications such as ibuprofen, acetaminophen, cough and cold products, and pain medications. allergies. First aid products such as bandages, gels, gauze pads and ointments are needed as well as petroleum jelly and baby supplies such as pacifiers. The only restriction is that there can be no liquid medications. Collected medical supplies will be delivered in person by the family friend in early April.

    Bousquet says watching what was happening in Ukraine was horrible and she wanted to help in any way she could. “We try to do our small part, do what we can.”

    The response from the community has also been phenomenal, with people donating amounts of $300 and $250, and even small children bringing their candy money and donating it for medical supplies. As of March 15, she estimated that nearly $1,000 in drugs had already been raised.

    Kathy Carre, author of Victoria’s Children’s Tales, was one of the people who walked into the store with her grandchildren, and the youngsters expressed a desire to show they care about what is happening in Ukraine . She says they don’t watch the news, but they are aware of what is going on.

    Content of the article

    Eli, 10, and Avery, 12, originally intended to buy crisps and other treats, but ended up spending the money on medicine.

    Eli went so far as to draw a card with “Hang In There” written in Ukrainian, to send as well. The design also includes sunflower, national flower of Ukraine, Ukrainian flag and hands with thumbs up.

    Another little girl, six-year-old Dani McKechnie, designed a Ukrainian flag for the Ukrainian people. She also contributed $24.25 of her own money for drugs.

    Bousquet said she would contact local schools to see if other children would like to create cards and drawings to place with the mailing to let the people of Ukraine know that Canadians, including school children, support them.

    This isn’t the only fundraising effort that Remedy’s Rx is currently involved with. They are also selling $5 raffle tickets to support a new van for Community Living Espanola. The van is $45,000 and tickets are available in store to support this very worthwhile community effort. There are three prizes to be drawn and the draw day is May 20.

    Photo providedEli Carre, 10, showed his support for the people of Ukraine by drawing a card with “Hang In There” written in Ukrainian along with some of the country’s national symbols.
    read more
    Prescription drugs

    When should prescription drugs for heart disease be used?

    This article is part of Health Divide: Heart Disease Risk Factors, a destination in our Health Divide series.

    Julie Bang / Alright


    Verywell Health: When should you consider prescription drug intervention to help prevent heart disease?

    Dr Velarde: When honest efforts to incorporate lifestyle changes have not yielded the desired results, medication can and should be considered.

    It starts with setting specific goals for specific risk markers (eg, blood pressure measurement) and performing basic lifestyle interventions for them. If after three to six months of lifestyle changes you haven’t reached your target or goal, it’s time to intervene with medication.

    However, it is essential that patients know that there is no fixed period for lifestyle changes. They should not be given up because you start taking medication. Lifestyle changes must be made for life, whether or not the patient is taking medication.

    Unfortunately, this message is not always heard by patients. They may think that once they take medication, they can unleash their food choices or their commitment to exercise. This is not the case. The goal is to first give an honest effort to lifestyle changes, then if goals have not been met, begin a prescribed drug regimen.

    This is particularly the case for blood pressure. For example, we know that nearly half of the US adult population (47% or 116 million) has high blood pressure, and about two-thirds of them need more than two medications to control it. So what’s the point of taking a pill or two if there isn’t a good basis for life first? Patients often fail to do what is necessary – the basic effort of their lifestyle – to control their blood pressure with medication.

    In many cases, basic lifestyle commitments are broken or abandoned. The reasons for this are complex but constitute obstacles that we must identify and overcome. Medication adherence also often involves cost, access to care, and lack of awareness of the impact of risk factors if left untreated. But failing to make the necessary basic lifestyle changes is an extremely important first step.

    read more
    Generic drugs

    The generic drug market will reach $482.5 billion worldwide by 2027

    The latest research report from the IMARC group, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

    A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing. the The global generic drug market reached a value of US$320 billion in 2021. Looking ahead, IMARC Group expects the market to reach US$482.5 billion by 2027 growing at a CAGR of 7% during the period 2022-2027.

    Get a free sample copy of the report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

    Overview of the impact of COVID-19:

    We regularly monitor the direct effect of COVID-19[feminine sur le marché, ainsi que l’influence indirecte des industries associées. Ces observations seront intégrées dans le rapport.

    Attribut important et faits saillants du rapport :

    • Analyse détaillée de la part de marché mondiale
    • Segmentation du marché par domaine thérapeutique, délivrance de médicaments et canal de distribution.
    • Taille historique, actuelle et projetée du marché en termes de volume et de valeur
    • Dernières tendances et développements de l’industrie
    • Paysage concurrentiel pour le marché des médicaments génériques
    • Stratégies des principaux acteurs et offres de produits

    Le marché mondial est principalement tiré par la prévalence croissante de maladies chroniques telles que les maladies cardiovasculaires, le diabète, la maladie d’Alzheimer et la maladie de Parkinson. De plus, la croissance significative de l’industrie pharmaceutique a stimulé la croissance du marché à travers le monde. En dehors de cela, l’augmentation des dépenses du gouvernement ainsi que des entreprises privées pour fabriquer des médicaments génériques pouvant améliorer le système de santé a créé une perspective positive pour le marché. De plus, la croissance de la population gériatrique a influencé positivement la croissance du marché. De plus, l’expiration prochaine du brevet de nombreux médicaments de marque devrait conduire le marché vers la croissance.

    Liste des fabricants de médicaments génériques :

    • Teva Pharmaceuticals Industries Ltd.
    • Mylan SA
    • Novartis SA
    • Pfizer inc.
    • Sun Pharmaceutical Industries Ltd.
    • Fresenius SE & Co.
    • Lupin Limitée
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma Limitée
    • Aspen Pharmacare Holdings Limitée

    Savez-vous plus d’informations, contactez notre analyste au– https://www.imarcgroup.com/generic-drug-manufacturing-plant

    Segmentation clé du marché :

    Répartition par domaine thérapeutique :

    • Système nerveux central
    • Cardiovasculaire
    • Dermatologie
    • Génito-urinaire/Hormonal
    • Respiratoire
    • Rhumatologie
    • Diabète
    • Oncologie
    • Les autres

    Rupture par administration de médicaments :

    • Oral
    • Injectables
    • Cutané/Topique
    • Inhalateurs

    Répartition par canal de distribution :

    • Pharmacies de détail
    • Pharmacies hospitalières

    Répartition par région :

    • Amérique du Nord (États-Unis, Canada)
    • Asie-Pacifique (Chine, Japon, Inde, Australie, Indonésie, Corée, Autres)
    • Europe (Allemagne, France, Royaume-Uni, Italie, Espagne, Autres)
    • Amérique latine (Brésil, Mexique, Autres)
    • Moyen-Orient et Afrique (Emirats Arabes Unis, Arabie Saoudite, Qatar, Irak, Autres)

    Table des matières du rapport d’étude de marché sur les médicaments génériques :

    • Préface
    • Portée et méthodologie
    • Résumé
    • introduction
    • Marché mondial des médicaments génériques
    • Analyse SWOT
    • Analyse de la chaîne de valeur
    • Analyse des prix
    • Paysage concurrentiel

    Parcourir plus de rapports de recherche par groupe IMARC :

    Contactez-nous:

    Groupe IMARC

    30 N Gould St, Ste R

    Sheridan, WY (Wyoming) 82801 États-Unis

    E-mail: [email protected]

    Phone. :(D) +91 120 433 0800

    Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

    read more
    Medical supplies

    Colorado Springs medical student collects supplies to support Ukraine | Content reserved for subscribers

    The ground floor of Bre Stafford’s home in northeast Colorado Springs is littered with boxes, filled with her belongings, as she prepares to move to another residence.

    The basement of the house, which she shares with three roommates, is full of boxes and parcels of a completely different kind. Stafford, a third-year medical student at the University of Colorado’s Anschutz Medical Campus, has been on a mission for the past few weeks, collecting an array of medical supplies for a humanitarian expedition to Ukraine.

    Ukrainians in Colorado fear for their homeland

    Stafford began his refueling campaign in early March after a series of conversations with his best friend Joanna Rak, a former classmate who is currently attending medical school in Krakow, Poland. The central European country has taken in hundreds of thousands of Ukrainian refugees, and Rak sees them roaming the streets every day – mostly women and children, forced to flee their homes, sometimes equipped with only what little they could. carry.

    “The stories I hear are pretty heartbreaking,” Stafford said. “A lot of (refugees) aren’t even sure if their family members are alive.”

    After talking on the phone with a Ukrainian refugee whom Rak had helped with food and shelter, Stafford felt a sense of kinship with the young woman and with the Ukrainian people.

    “I heard the (refugee’s) story,” she said. “A few weeks ago, she was living her life, just like (Americans), and now her whole world has been turned upside down. It made me feel visceral.

    Colorado Springs high school mobilizes around Ukrainian exchange students

    Eager to help as much as she could, Stafford began networking with her medical school classmates and faculty members, learning where she could pick up medical supplies to ship overseas. She also contacted a non-profit organization called Nova Ukraine, which has support teams on the ground in Ukraine and neighboring countries.

    “They were super on board with the idea,” she said of the nonprofit. “They plan to help out with a cargo plane once I get enough (of supplies).”

    Stafford’s basement is currently stocked with a wide variety of supplies. There are crutches, bandages, antiseptics, suture kits and gloves collected from area clinics. There is trauma equipment like chest drains and intubation kits. A generous cash donation went towards other necessities including ibuprofen, feminine products and diapers.

    “You wouldn’t believe the things they need there,” Stafford said. “It’s just a bit of what they need.”

    Insulin, thyroid medication and burn supplies are also needed, but have been hard to come by, she said.

    Stafford and his colleagues would like to send the cargo plane as full of supplies as possible. But the urgency of a war situation dictates that he act quickly. There are people in and around Ukraine who need these supplies now, she said.

    “We want to gather as much as we can,” she says, “but at the same time, we don’t want to wait too long. People need these supplies and we want to send them soon. »

    Rally in Colorado Springs shows support for Ukraine: ‘We are strong together’

    Next on Stafford’s to-do list is to arrange transportation for the materials she has collected. Nova Ukraine will pick up its supplies — along with other collections from other medical students in Denver and Fort Collins — from a central location in Denver. But she needs a truck to take her there.

    “There’s no way I could fit all of this in my little car,” she said.

    Leading a humanitarian supply campaign while responding to demands from a third-year medical student was hectic and at times exhausting, Stafford said. But she was buoyed by an outpouring of support from classmates, faculty members and even strangers. She regularly receives emails and social media posts from people who want to help.

    “There are horrible things happening in the world,” she said. “But there are also good people who want to help.”

    read more
    Medical products

    Swabs Market Size and Forecast

    New Jersey, United States,- The latest research report provides a comprehensive assessment of the swab market for the forecast year 2022-2029, which is beneficial for businesses regardless of their size and revenue. This survey report covers key market insights and industry approach related to COVID-19 (Omicron) in the coming years. The Swab market report provides data and information on investment structure development, technological enhancements, market trends and developments, abilities, and in-depth information about major Swab market players. The market strategies followed globally with respect to the current and future scenario of the industry have also been detailed in the study.

    The report begins with a brief introduction and overview of the Swabs market, current market landscape, market trends, major market players, product type, application, and region. It also covers the impact of COVID-19 (Omicron) on Swabs Market trends, future forecasts, growth opportunities, end-user industries, and market players. It also provides historical data, current market scenarios and future information on the Swab Market. This study provides a comprehensive understanding of the market value with product price, demand, gross margin, and supply of the Swabs market. The Competitive Perspective section of the report provides a clear insight into the market share analysis of key industry players.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23805

    Key Players Mentioned in the Swabs Market Research Report:

    Puritan Medical Products, Sarstedt, MWE, SARSTEDT AG & Co, Lab M Limited., Clean Cross Co. Ltd., GPC medical ltd., Citotest Labware Manufacturing Co., Ltd. and Q-TIPS, ELMEX.

    Swabs market is segmented by Product and Type. All of these segments were examined individually. The detailed study helps to evaluate the factors affecting the Swabs market. Experts analyzed the nature of development, investments in research and development, changing consumption patterns and the growing number of applications. In addition, analysts have also assessed the development of the economy around the Swab market, which is likely to impact its price.

    Swabs Market Segmentation:

    Swabs Market, By Application

    • Pharmaceutical
    • Microbiological
    • Laboratory
    • Others

    Swab market, by well

    • Aluminum
    • Polypropylene
    • Others

    Swabs Market, By Test Type

    • DNA test
    • Urine test
    • Saliva test
    • Others

    The regional analysis section of the report allows players to focus on high growth regions and countries that could help them expand their presence in the swabs market. Besides expanding their presence in the swabs market, regional analysis helps players increase their sales while gaining a better understanding of customer behavior in specific regions and countries. The report provides CAGR, revenue, production, consumption and other important statistics and figures in global and regional markets. It shows how different types, applications, and regional segments of the Swabs market are progressing in terms of growth.

    Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23805

    Scope of Swabs Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    It becomes easy to determine the pulse of the market with this detailed analysis of the swabs market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

    Answers to key questions in the report:

    1. Who are the top five Swab market players?

    2. How will the swab market evolve over the next five years?

    3. Which product and application will occupy the lion’s share of the Swab market?

    4. What are the Swab Market drivers and restraints?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Swab market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/swab-market/

    Visualize the swab market using verified market intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    About Us: Verified Market Research®

    Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

    Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

    At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

    Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

    Contact us:

    Mr. Edwyne Fernandes

    Verified Market Research®

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    E-mail: [email protected]

    Website:- https://www.verifiedmarketresearch.com/

    read more
    Prescription drugs

    Pharmacists blame government for prescription drug abuse

    Ugandan pharmacists have blamed the government for its alleged failure to recruit them into the civil service, which they claim is the increase in the abuse of drugs, especially prescription drugs by patients.

    Mr. Musa Ssemanda, the Treasurer of the Pharmacists Society of Uganda (PSU) noted on Monday that with no more than 1,500 pharmacists in Uganda, the country still has a small number of such drug experts.

    “Pharmacists play a vital role in helping people get the best results from their medications. They prepare and issue prescriptions, ensure medications and doses are correct, prevent harmful drug interactions, and counsel patients on the safe and appropriate use of their medications,” said Dr. Ssemanda.

    “But despite their small numbers, very few have been recruited from the public sector, with most of the few who have been recruited working in regional referral hospitals while others are in self-employment and in private practice,” he added.

    With Uganda’s population of around 45 million, PSU records indicate that there are currently 1,500 licensed and registered pharmacists in the country.

    This implies 1 pharmacist for every 30,000 Ugandans, compared to the ratio of 1 for 2,000 recommended by the World Health Organization (WHO).

    To make matters worse, over 90% of these pharmacists practice in the central region, which leaves the rest of the regions lacking.

    “We call on the government/Ministry of Health to expedite the process of recruiting pharmacists for all public hospitals and health facilities,” Dr Ssemanda said.

    Dr. Ssemanda noted that the practice of patients buying or receiving over-the-counter prescription drugs from pharmacies, pharmacies and public health facilities has not only resulted in death but also increased spending on drug options. treatment for both patients and the government side. who pays for treatment in public health facilities.

    “Pharmacists should have the ability to dispense drugs because while drugs have many benefits, they come with risks. There may be an overdose or an underdose that contributes to antimicrobial resistance.

    Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that make drugs used to treat the infections they cause ineffective.

    Prescription drugs are drugs classified by the National Drug Authority (NDA) to be sold at retail only with a written prescription from a properly qualified physician or surgeon and may only be dispensed under the supervision of a pharmacist approved.

    Some of the prescription drugs include codeine which is used as an analgesic and commonly used for the treatment of headaches, pethidine (pain reliever) and azithromycin which is an antibiotic drug used for the treatment of a number of ailments. bacterial infections. This includes middle ear infections, strep throat, and pneumonia.

    The PSU appeal comes at a time when health experts in Uganda are warning that the country is seeing worrying increases in deaths and healthcare costs due to drug-resistant infections, which are being blamed on the use inappropriate use of antibiotics combined with the challenge of insufficient access to drugs.

    Asked why the Ministry of Civil Service was not recruiting pharmacists, the Permanent Secretary of the Ministry of Civil Service, Ms Catherine B. Musingwiire, referred the matter to the Health Services Commission.

    “I can’t answer that. Ask the Health Services Commission who their immediate recruiter is,” Ms Musingwiire said.

    But Professor Pius Okong, chairman of the Health Services Commission, said the commission was not responsible for the problem, explaining that the commission only recruits to fill vacancies advertised by the Department of Health.

    “We are not recruiting only because there are workers on the market. There must be pharmacist vacancies for us to recruit,” Prof Okong said.

    He explained that in lower health units like Health III and II, there are no positions for pharmacists, adding that drugs in health units at this level are dispensed by drug dispensers or attendants. to medications.

    read more
    Generic drugs

    South Korean pharmaceutical companies to supply generic Covid-19 drugs to low- and middle-income countries

    Celltrion and Dongbang FTL will develop and produce generic drugs and supply them to 95 low- and middle-income countries under the license agreement.

    South Korea will supply generic drugs for Covid-19 therapy to low- and middle-income countries with two pharmaceutical companies, Celltrion and Dongbanf FTL, having obtained the license for its production. Celltrion and Dongbang FTL will develop and produce generic drugs and supply them to 95 low- and middle-income countries under the license agreement. Celltrion plans to complete development and begin commercialization of the drug, after which the finished drug will be manufactured at its pharmaceutical plant in Cheongju.

    Celltrion recently signed a contract with the UN Medicine Patent Pool (MPP) for the generic production of Pfizer’s oral Covid-19 treatment.

    This follows Pfizer’s decision to expand accessibility of its Covid-19 drug in low- and middle-income countries through the MPP. The license was only granted to 35 companies in 12 countries.

    Korean companies Dongbang, Celltrion and Hanmi Pharmaceutical FTL are able to produce and supply generic drugs after obtaining a license for oral Covid-19 treatment from MSD.

    Starting by producing the AstraZeneca vaccine and also the Novavax vaccine, SK Bioscience has become the hub for Asian vaccine production.

    Currently producing and supplying Moderna’s Covid-19 vaccines, Samsung Biologics also produces Covid-19 antibody treatments from Lilly, GSK and AstraZeneca. Developed by India’s Zydus Cadila, Hanmi Pharmaceutical will also produce a COVID-19 plasmid DNA vaccine “Zycov-D”, on consignment.

    read more
    Generic drugs

    South Korea to provide generic drugs for COVID-19 treatments worldwide



    NNA |
    Update:
    March 21, 2022 9:17 a.m. STI

    Seoul [South Korea], March 21 (ANI/Global Economic): South Korea has emerged as a global production hub for supplying generic drugs for Covid-19 treatments to middle- and low-income countries. From vaccines to oral treatments, Korea has been recognized for the production and supply of drugs against Covid-19.
    Celltrion announced on the 18th that it had signed a license agreement with the UN Medicine Patent Pool (MPP) for the generic production of Pfizer’s oral Covid-19 treatment.
    The contract follows Pfizer’s decision to expand accessibility to its Covid-19 pills in low- and middle-income countries through the MPP. The license was only granted to 35 companies in 12 countries. In Korea, two pharmaceutical companies, Celltrion and Dongbanf FTL, have obtained the license.
    Under the license agreement, Celltrion and Dongbang FTL will develop and produce generic drugs and supply them to 95 middle- and low-income countries. Celltrion, which is in charge of supplying the finished drugs, plans to complete development as soon as possible and begin commercialization. The finished products will be manufactured by Celltrion Pharmaceutical’s Cheongju plant.
    By obtaining the license, Korean companies are able to produce and supply the two generic drugs for oral treatments of Covid-19. In January, three Korean companies, Celltrion, Dongbang FTL and Hanmi Pharmaceutical, obtained a license for MSD’s oral Covid-19 treatment.
    Korea has also become a global production hub by manufacturing Covid-19 vaccines on consignment.
    Starting with the AstraZeneca vaccine, SK Bioscience produced the Novavax vaccine, becoming the center for vaccine production in Asia.
    Samsung Biologics currently produces and supplies Moderna’s Covid-19 vaccines. It also produces Covid-19 antibody treatments from Lilly, GSK and AstraZeneca. Hanmi Pharmaceutical will produce a COVID-19 plasmid DNA vaccine ‘Zycov-D’, developed by Indian Zydus Cadila, on consignment. (ANI/Global Economy)

    read more
    Medical supplies

    Meest in Clifton NJ ships goods, medical supplies

    CLIFTON — For the first few weeks after Russia invaded Ukraine, the pace at shipping company Meest was frenetic.

    Meest specializes in shipping goods to Ukraine, and demand for medical and other relief supplies has been intense since the fighting began.

    Meest workers say things have slowed down, but recently, in an interview with Vasyl Tehza, who runs operations at the Clifton satellite office, things were still buzzing.

    It’s well past 5 p.m. and Tehza’s cell phone rings almost nonstop. When he answers questions, he is lively but laconic.

    “For the first two weeks after the war started, we worked 21 hours a day,” Tehza said, adding that he sometimes had to show up at 3 a.m. to receive a shipment.

    The story continues after the gallery

    The Clifton office alone shipped more than 1,000 pallets of much-needed goods in those first two weeks, he said.

    Meest is the go-to shipper for getting items to Ukraine, especially since the company and many of its employees have direct ties to the beleaguered country.

    Tehza and his wife left Ukraine eight years ago, and his parents are still there. Although Meest workers are always supportive of humanitarian efforts, the Russian-Ukrainian war is personal to them.

    Immediately after news of the Russian invasion, his office was flooded with orders as people were desperate to help Ukraine and its people.

    Continued:By popular demand, Clifton will build 12 dedicated pickleball courts, open to everyone

    Continued:Bombs, bandits and a frozen border: NJ native recounts harrowing escape from Ukraine

    Items must be unpacked, sorted and prioritized.

    Tehza said dozens of volunteers turned out to help sort the goods. The first priority went to medical supplies. Clothes, with rare exceptions, have taken a back seat.

    “I tell them, keep them and wait a few weeks,” he said. Returning to a box full of medical supplies, he grabbed a pack of catheters. “Do you see that? It saves lives.

    Nataliya Rivna, from Meest, works between piles of boxes in Clifton.  Tuesday, March 15, 2022

    The equipment is shipped by air or sea. Air deliveries take five to seven days and usually land in Poland, as all Ukrainian airports are closed, then transferred to trucks and dispatched to relief groups or a government agency. Items sent by sea take weeks.

    Despite the war, in parts of Ukraine, Meest resumed parcel delivery.

    Among these shipments were firefighting equipment collected and organized by Clifton Fire Department.

    Andriy Rivnyy is shown with Vasyl Tehza, from Meest.  Rivnyy began volunteering with Meest since the start of the war.  Here they place bags of tactical drugs in Rivnyy's vehicle.  He then drove the bag to someone who will fly to Poland.  From there, Meest employees will take the bags through the Ukrainian border.  Tuesday, March 15, 2022

    Items like personal protective equipment donated by Passaic and 21 other fire departments as far away as Norwich, Vermont — in all, 400 sets of turnout gear — were sent out last week, Lt. Mark Drew said of Clifton.

    “We currently have another 400 to 500 sets of personal protective clothing to ship and they will be packed this Sunday,” Drew said.

    Tehza said he greatly appreciates the donations and doesn’t mind the extra work, considering what Ukrainians are going through.

    He foresees a time when people will be settled as refugees, or perhaps able to return home, when there will be a need for items like clothing.

    His company, based in Port Reading, New Jersey, offers deep discounts and welcomes donations to offset costs. Donations are accepted at razomforukraine.org/meest and are tax deductible.

    Matt Fagan is a local reporter for NorthJersey.com. For unlimited access to the most important news from your local community, please subscribe or activate your digital account today.

    E-mail: [email protected]

    Twitter: @fagan_nj

    read more
    Medical supplies

    UK donates medical supplies to Ukraine as Russia expands missile strikes

    Two million medical items have now been donated to Ukraine, the government said after Russia expanded its missile strikes in Lviv in the west of the country on Friday.

    Supplies including painkillers, insulin injections and critical care equipment are expected to arrive in the war-torn region in the coming days, the Department of Health and Social Care (DHSC) said.

    It comes after Prime Minister Boris Johnson said he told Ukrainian President Volodymyr Zelensky the government knows it “must do more” to help the beleaguered country as it resists an invasion from Russia.

    About 10 flights carrying medical supplies have left Stansted, Heathrow and RAF Brize Norton in the past three weeks, the DHSC said.

    And, following an urgent request from Ukraine, a refrigerated truck left for the region on Friday carrying insulin injections and much-needed drugs for surgery, the department said.



    The UK will continue to stand with the people of Ukraine in the face of the appalling Russian invasion

    Health Secretary Sajid Javid

    The two million figure includes all donations to date and is made up of each individual item and each dose of medicine.

    Resuscitators, cannulas and face masks are part of the kit delivered so far.

    Health and Social Care Secretary Sajid Javid said the UK stood ‘neck to neck’ with Ukraine in the face of Russia’s ‘appalling’ attack, which was launched on 24 February.

    Equipment at the NHS National Services Scotland Titan logistics facility in Bellshill, which was visited by First Minister Nicola Sturgeon, who looked on as medical supplies were loaded to be sent to Ukraine (PA)

    (PA wire)

    “We are leading the humanitarian effort to support Ukraine by providing targeted medical support to those in need. In less than three weeks, the UK has donated over two million medical items,” Mr Javid said.

    “Tens of thousands of sick and injured Ukrainians have now received treatment thanks to donations made by the NHS from England, Scotland, Wales and Northern Ireland.”

    Speaking at the Scottish Conservatives’ conference in Aberdeen on Friday, the Prime Minister said he spoke to Mr Zelensky that morning.

    “From my office I said, ‘We stand with you at a time when your people face such horror with such courage,’ he said.

    “’When you fight, not just for your lives and homes – for the cause of democracy and freedom itself – we know we must do more to help.

    “‘I promise you we will.'”

    Prime Minister Boris Johnson (AP)

    (PA wire)

    Fighting in Ukraine reached the center of the southern port city of Mariupol, where many civilians were still trapped on Friday.

    Russia also launched an early morning attack on Lviv, the city’s mayor said, as British intelligence suggested Russian President Vladimir Putin’s invasion had made “minimal progress” this week.

    An update from the Defense Ministry said Ukrainian forces continued to “thwart” Moscow’s attempt to encircle towns like kyiv and Mykolai.

    Shelling around the capital Kyiv also continued as the number of refugees estimated to have fled the war topped 3.4 million.

    read more
    Generic drugs

    Generic Drugs Market – Growth, Trends, Impact of COVID-19 and Forecast (2022)

    ReportLinker

    The generic drug market was valued at USD 364,925. 27 million in 2021, and it is expected to reach 468,787 USD. 86 million by 2027, registering a CAGR of 4.27% during the forecast period 2022-2027.

    New York, March 18, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Generic Drug Market – Growth, Trends, COVID-19 Impact, and Forecast (2022 – 2027)” – https://www. reportlinker.com/p06246254/?utm_source=GNW

    Early in the pandemic, COVID-19 severely affected the generic drug market due to lockdown restrictions and supply chain disruption. Later, there was an increased demand for generic pharmaceuticals as COVID-19 infections provided many opportunities for generic drug manufacturers to manufacture the drugs for the treatment of this infection. For example, according to a US Food and Drug Administration (FDA) report published in November 2021, the FDA has implemented a generic drug program. This initiative has helped generic drug developers develop products by sending written communications and organizing meetings to clarify regulatory expectations early in the development process and during review of applications. To date, the Food and Drug Administration has received 121 requests for product development and pre-submission meetings for abbreviated new drug applications in 2020.

    As the global generic drugs market is huge, it is very likely to continue growing during the forecast period. The reasons attributed to this growth are the increasing prevalence of chronic diseases, the increase in the geriatric population and the increase in healthcare expenditure.

    Many countries in North America and Asia-Pacific are facing the problem of increasing geriatric population which is also expected to increase the demand for generic drugs as older people need more drugs due to comorbidities and other factors. Due to the prevalence of chronic diseases, the government and many pharmaceutical players are increasing their R&D expenditures for the discovery of new molecules and the improvement of current technologies to address more patient issues. For example, according to the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years old) are living with diabetes worldwide and the total number of people with diabetes is expected to reach 643 million by 2030 and 783 million by 2045.

    Hence, based on the aforementioned factors, the market is expected to grow significantly over the forecast period.

    Main market trends

    The injectables segment is expected to account for a major share of the market studied during the forecast period

    Tablets, capsules, pills are not the only way to deliver the drug in the body, injectable is another way to deliver the drug, and this is considered to be the most effective way, because the bioavailability of medication by this route is superior to other routes. Nowadays, new advances are occurring in this injectable segment. This way, the drug takes less time to react. Recent developments in needleless injectors have contributed to its growth. For example, in November 2021, Bespak Europe Limited is working closely with its biopharmaceutical partners to develop a customized device to meet the needs of specific patient groups. Additionally, the prevalence of diabetes, cardiovascular problems, cancer, and several other chronic diseases will help injectables grow further during the forecast period.

    Additionally, increase in generic intravenous product launches is also expected to boost the growth of this segment during the forecast period. For example, in July 2021, the generic Ferumoxytol, an injectable drug used to treat iron deficiency anemia (IDA) was launched in the United States by Sandoz, a global leader in generic and biosimilar medicines. Rising generic injectable product launches in developed countries are further expected to drive the growth of this segment in the near future.

    Asia-Pacific is the fastest growing region in the overall market and a similar situation is expected during the forecast period.

    Asia-Pacific has shown the fastest growing trend in the global generics market due to increased awareness among people related to any disorder, increase in population can also be attributed to increase in demand for generic drugs. Countries like India and China in Asia-Pacific contribute more than other nations.

    According to the Indian Pharmaceutical Industry Report released in November 2021 by the India Brand Equity Foundation, India is the world’s leading supplier of generic pharmaceuticals. The Indian pharmaceutical industry supplies more than half of the global demand for vaccines, 40% of the demand for generics in the United States and 25% of all pharmaceuticals in the United Kingdom. India has many pharmaceutical companies that manufacture many generic drugs, for example, Alkem Laboratories, Sun Pharma, Aurobindo Pharma Limited, among several others. Hence, the global generic drugs market is expected to grow over the forecast period.

    Furthermore, according to information released in September 2021, India is willing to work with East Asian partners on the development of generic pharmaceuticals and medical technologies for the treatment of patients with Covid-19, as well as vaccine development. This will further lead to increased production of generic drugs in collaboration with other East Asian companies, which is expected to propel the growth of the market over the forecast period.

    Additionally, increasing generic drug approvals in China are expected to further boost the growth of this region. For example, in October 2021, the Yangtze River Pharmaceutical Group in China filed the first marketing application for eslicarbazepine acetate, a class 3 generic drug used to treat patients with epilepsy.

    Therefore, due to the factors mentioned above, the Asia-Pacific region is expected to show faster growth during the forecast period.

    Competitive landscape

    The global generic drug market is highly competitive, with many players dominating the market. Market players are adopting strategies such as increasing R&D investments, mergers, acquisitions, and product innovations, to sustain the growing market rivalry. The major market players in this market are Mylan NV, Eli Lilly and Company, GlaxoSmithKline PLC, Pfizer Inc., Sun Pharma, Novartis, and Sanofi, among others.

    Additional benefits:

    The Market Estimate (ME) sheet in Excel format
    3 months of analyst support
    Read the full report: https://www.reportlinker.com/p06246254/?utm_source=GNW

    About Reportlinker
    ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

    __________________________

    CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
    read more
    Generic drugs

    Generic Drugs Market – Growth, Trends, Impact of COVID-19 and

    New York, March 18, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Generic Drug Market – Growth, Trends, COVID-19 Impact, and Forecast (2022 – 2027)” – https://www. reportlinker.com/p06246254/?utm_source=GNW

    Early in the pandemic, COVID-19 severely affected the generic drug market due to lockdown restrictions and supply chain disruption. Later, there was an increased demand for generic pharmaceuticals as COVID-19 infections provided many opportunities for generic drug manufacturers to manufacture the drugs for the treatment of this infection. For example, according to a US Food and Drug Administration (FDA) report published in November 2021, the FDA has implemented a generic drug program. This initiative has helped generic drug developers develop products by sending written communications and organizing meetings to clarify regulatory expectations early in the development process and during review of applications. To date, the Food and Drug Administration has received 121 requests for product development and pre-submission meetings for abbreviated new drug applications in 2020.

    As the global generic drugs market is huge, it is very likely to continue growing during the forecast period. The reasons attributed to this growth are the increasing prevalence of chronic diseases, the increase in the geriatric population and the increase in healthcare expenditure.

    Many countries in North America and Asia-Pacific are facing the problem of increasing geriatric population which is also expected to increase the demand for generic drugs as older people need more drugs due to comorbidities and other factors. Due to the prevalence of chronic diseases, the government and many pharmaceutical players are increasing their R&D expenditures for the discovery of new molecules and the improvement of current technologies to address more patient issues. For example, according to the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years old) are living with diabetes worldwide and the total number of people with diabetes is expected to reach 643 million by 2030 and 783 million by 2045.

    Hence, based on the aforementioned factors, the market is expected to grow significantly over the forecast period.

    Main market trends

    The injectables segment is expected to account for a major share of the market studied during the forecast period

    Tablets, capsules, pills are not the only way to deliver the drug in the body, injectable is another way to deliver the drug, and this is considered to be the most effective way, because the bioavailability of medication by this route is superior to other routes. Nowadays, new advances are occurring in this injectable segment. This way, the drug takes less time to react. Recent developments in needleless injectors have contributed to its growth. For example, in November 2021, Bespak Europe Limited is working closely with its biopharmaceutical partners to develop a customized device to meet the needs of specific patient groups. Additionally, the prevalence of diabetes, cardiovascular problems, cancer, and several other chronic diseases will help injectables grow further during the forecast period.

    Furthermore, increase in generic intravenous product launches is also expected to boost the growth of this segment over the forecast period. For example, in July 2021, the generic Ferumoxytol, an injectable drug used to treat iron deficiency anemia (IDA) was launched in the United States by Sandoz, a global leader in generic and biosimilar medicines. Rising generic injectable product launches in developed countries are further expected to drive the growth of this segment in the near future.

    Asia-Pacific is the fastest growing region in the overall market and a similar situation is expected during the forecast period.

    Asia-Pacific has shown the fastest growing trend in the global generics market due to increased awareness among people related to any disorder, increase in population can also be attributed to increase in demand for generic drugs. Countries like India and China in Asia-Pacific contribute more than other nations.

    According to the Indian Pharmaceutical Industry Report released in November 2021 by the India Brand Equity Foundation, India is the world’s leading supplier of generic pharmaceuticals. The Indian pharmaceutical industry supplies more than half of the global demand for vaccines, 40% of the demand for generics in the United States and 25% of all pharmaceuticals in the United Kingdom. India has many pharmaceutical companies that manufacture many generic drugs, for example, Alkem Laboratories, Sun Pharma, Aurobindo Pharma Limited, among several others. Hence, the global generic drugs market is expected to grow over the forecast period.

    Furthermore, according to information released in September 2021, India is willing to work with East Asian partners on the development of generic pharmaceuticals and medical technologies for the treatment of patients with Covid-19, as well as vaccine development. This will further lead to increased production of generic drugs in collaboration with other East Asian companies, which is expected to propel the growth of the market over the forecast period.

    Additionally, increasing generic drug approvals in China are expected to further boost the growth of this region. For example, in October 2021, the Yangtze River Pharmaceutical Group in China filed the first marketing application for eslicarbazepine acetate, a class 3 generic drug used to treat patients with epilepsy.

    Therefore, due to the factors mentioned above, the Asia-Pacific region is expected to show faster growth during the forecast period.

    Competitive landscape

    The global generic drug market is highly competitive, with many players dominating the market. Market players are adopting strategies such as increasing R&D investments, mergers, acquisitions, and product innovations, to sustain the growing market rivalry. The major market players in this market are Mylan NV, Eli Lilly and Company, GlaxoSmithKline PLC, Pfizer Inc., Sun Pharma, Novartis, and Sanofi, among others.

    Additional benefits:

    The Market Estimate (ME) sheet in Excel format
    3 months of analyst support
    Read the full report: https://www.reportlinker.com/p06246254/?utm_source=GNW

    About Reportlinker
    ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

    __________________________

    
            
    read more
    Medical supplies

    Over $7 million in medical supplies donated to Ukrainian refugees

    Following a request for medical supplies from Moldovan authorities, World Hope International (WHI), Lift Non-Profit Logistics, Globus Relief, Airlink and Flexport.org have teamed up to transport $7 million in humanitarian aid to more than 300,000 Ukrainian refugees.

    Supplies were moved from Utah and flown in via a Boeing 747 from Chicago to Amsterdam where Flexport.org then arranged for trucking partners to transport the cargo to Moldova. Responding to the Moldovan authorities’ request for assistance required multi-faceted project coordination and experience in managing complex supply chains. This relief effort required specialized skills to source the requested supplies and transport them from Utah to Moldova via Chicago and Amsterdam.”

    “In these difficult times, Moldova is helping Ukrainian refugees with needed shelter and assistance,” said Eugen Caras, Moldova’s Ambassador to the United States. “In this context, we greatly appreciate the efforts that our American friends have made to gather an impressive amount of medical supplies. This support will be used and distributed by the Ministry of Health for Ukrainian refugees in Moldova, and we are very grateful for this. .

    “Airlink is thrilled to be part of this coalition of organizations that are using their resources and expertise to provide humanitarian assistance to Moldova for Ukrainian refugees,” said Steven J. Smith, President and CEO of Air link. “There are significant and growing supply chain challenges in the region, so partnership and coordination are essential to ensure that Ukrainian refugees receive the assistance they need.”

    Shaimaa Al Wassiti, President of Globus Relief Humanitarian, added: “Globus Relief is equipped to meet the needs of all forms of medical care. are used in first response medical care.”

    “The events unfolding in Ukraine and the escalation of violence in the region are beyond tragic on so many levels – and are quickly becoming one of the biggest refugee events of our lifetimes,” said John Lyon, CEO from WHI. “As we look for ways to scale up our support, we hope this week’s effort will have a big impact on those receiving these essential supplies.”

    Susy Schöneberg, head of Flexport.org, said, “Humanitarian responses are incredibly complex and require a wide range of coordination from nonprofit organizations. By providing robust air cargo solutions and financial support, we aim to help our nonprofit partners focus on what they do best and respond immediately when disaster strikes.”

    The partnership provided over 220,000 pounds of medical supplies to meet a need specifically requested by Moldova’s Ministry of Health.

    read more
    Medical products

    Scoliosis Management Market 2022-2030, by Top Key Players – Aspen Medical Products, Boston Orthotics & Prosthetics, LA Brace, Charleston Bending Brace, Spinal Technology

    The Scoliosis Management Market report is a perfect basis for people who are looking for comprehensive study and analysis of the Scoliosis Management Market. This report contains study and miscellaneous information which will help you to understand your niche and focus major market channels in the regional and global Scoliosis Management market. To understand the competition and take action based on your key strengths, market size, current and future years demand, supply chain information, business concerns, competitive analysis and prices as well as supplier information will be presented to you. The report also includes information about the major market players, Scoliosis Management applications, its type, trends and overall market share.

    To put your business plan into action based on our detailed report, you will also receive comprehensive and accurate forecasts and projected figures for the future. This will provide an overview of the market and help design solutions to leverage key profitable elements and gain market clarity to develop strategic plans. The data present in the report comes from different publications in our archives as well as many reputable paid databases. Moreover, the data is gathered with the help of dealers, raw material suppliers, and customers to ensure that the end result covers every minute detail regarding the Scoliosis Management market, making it a perfect tool for serious buyers of this study.

    Scoliosis Management Market: Competition Landscape

    The Scoliosis Management Market report includes information on product launches, sustainability, and outlook from key vendors including: (Aspen Medical Products, Boston Orthotics & Prosthetics, LA Brace, Charleston Bending Brace, Spinal Technology, Inc., Optec USA, Inc., Pro-Tech Orthopedics, DJO Global, UNYQ, Lawall Prosthetics and Orthotics, Chaneco, Trulife, Össur, Ortholutions GmbH & Co. KG, Ottobock)

    Click the link for a free sample report @ https://crediblemarkets.com/sample-request/scoliosis-management-market-385291?utm_source=Amruta&utm_medium=SatPR

    Scoliosis Management Market: Segmentation

    By types

    Thoraco-lumbo-sacral orthosis (TLSO)
    Sacral Lumbar Thoracic Cervical Orthosis (CTLSO)
    Lumbosacral orthosis (OSL)
    Scoliosis brace
    Others

    By apps

    Online pharmacies
    Hospitals & Clinics
    Retail pharmacies

    Scoliosis Management Market: Regional Analysis

    The whole regional segmentation has been studied based on recent and future trends, and the market is forecast through the forecast period. The countries covered in the regional analysis of the Global Scoliosis Management Market report are USA, Canada & Mexico North America, Germany, France, UK, Russia , Italy, Spain, Turkey, Netherlands, Switzerland, Belgium and the rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia Pacific (APAC) in Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), and Argentina, Brazil and the rest of South America as part of South America.

    Key benefits of the report:

    • This study presents the analytical representation of the global Scoliosis Management industry together with current trends and future estimations to determine impending pockets of investment.
    • The report presents information related to key drivers, restraints, and opportunities, along with a detailed analysis of the global Scoliosis Management market share.
    • Current market is quantitatively analyzed from 2021 to 2028 to highlight the growth scenario of the global Scoliosis Management market.
    • Porter’s five forces analysis illustrates the power of buyers and suppliers in the marketplace.
    • The report provides a detailed analysis of the Global Scoliosis Management Market based on the competitive intensity and how the competition will shape in the coming years.

    Directly buy this market research report now @ https://crediblemarkets.com/reports/purchase/scoliosis-management-market-385291?license_type=single_user;utm_source=Amruta&utm_medium=SatPR

    Main points covered in the table of contents:

    Market overview: It includes six sections, research scope, key manufacturers covered, market fragments by type, Scoliosis Management market shares by application, study objectives and years considered.

    Market landscape:Here, the global Scoliosis Management market opposition is dissected, by value, revenue, transactions, and pie slice by organization, market rate, fierce circumstances Latest landscape and patterns, consolidation, development, obtaining and parts of the entire industry from top organizations.

    Manufacturer Profiles: Here, the driving players of the global Scoliosis Management market are considered dependent on region of deals, key elements, net benefit, revenue, cost, and creation.

    Market Status and Outlook by Region: In this segment, the report examines net benefit, transactions, revenue, creation, global industry share, CAGR and market size by region. Here, the Global Scoliosis Management Market is thoroughly examined based on regions and countries like North America, Europe, China, India, Japan, and MEA.

    Application or end user: This segment of the exploration study demonstrates how extraordinary end-customer/application sections are added in the global Scoliosis Management market.

    Market forecast: Production side : In this part of the report, the creators focused on the conjecture of creation and creation esteem, the gauge of the main manufacturers and the estimation of the creation and creation esteem by type .

    Research results and conclusion: This is one of the last segments of the report where the findings of the investigators and the end of the exploratory study are given.

    Answers to key questions in the report:

    • What will be the market development pace of the Scoliosis Management market?
    • What are the key factors driving the Global Scoliosis Management Market?
    • Who are the main manufacturers on the market?
    • What are the market openings, market risks and market outline?
    • – What are sales volume, revenue, and price analysis of top manufacturers of Scoliosis Management market?
    • Who are the distributors, traders and dealers of Scoliosis Management Market?
    • What are the Scoliosis Management market opportunities and threats faced by the vendors in the global Scoliosis Management Industries?
    • What are the deals, revenue, and value review by market types and uses?
    • What are the transactions, revenue and value review by business areas?

    About Us

    Credible Markets is a new era market research company with a firm grip on the pulse of global markets. Credible Markets has become a trusted source for business market research needs in a short period of time. We’ve partnered with leading market intelligence publishers and our report pool coverage spans all key industry verticals and thousands of micro-markets. The massive repository allows our clients to choose from recently released reports from a range of publishers who also provide in-depth analysis by region and country. Moreover, pre-booked research reports are among our best offers.

    The collection of market intelligence reports is regularly updated to provide visitors with quick access to the latest market information. We provide round-the-clock support to help you reuse search parameters and benefit from a full range of reserved reports. After all, it’s about helping you make an informed strategic decision on purchasing the right report that meets all your market research demands.

    Contact us

    Credible market analyzes
    99 Wall Street 2124 New York, NY 10005
    E-mail: [email protected]

    read more
    Prescription drugs

    Animal Prescription Drugs Market 2022-2030, by Top Key Players – Ourofino Saude Animal, Elanco Animal Health, Vetoquinol, Virbac, Dechra

    The Animal Prescription Drugs Market report is a perfect basis for people who are looking for comprehensive study and analysis of the Animal Prescription Drugs Market. This report contains study and miscellaneous information which will help you to understand your niche and focus major market channels in the regional and global Animal Prescription Drugs Market. To understand the competition and take action based on your key strengths, market size, current and future years demand, supply chain information, business concerns, competitive analysis and prices as well as supplier information will be presented to you. The report also includes information about the major market players, Animal Prescription Drug applications, its type, trends and overall market share.

    To put your business plan into action based on our detailed report, you will also receive comprehensive and accurate forecasts and projected figures for the future. This will provide an overview of the market and help design solutions to leverage key profitable elements and gain market clarity to develop strategic plans. The data present in the report comes from different publications in our archives as well as many reputable paid databases. Moreover, the data is collated with the help of dealers, raw material suppliers, and clients to ensure that the end result covers every detail regarding the Animal Prescription Drugs market making it a perfect tool for serious buyers of this study.

    Animal Prescription Drugs Market: Competition Landscape

    The Animal Prescription Drugs Market report includes insights into product launches, sustainability, and outlook from key vendors including: (Ourofino Saude Animal, Elanco Animal Health, Vetoquinol, Virbac, Dechra, MSD Animal Health, Boehringer Ingelheim, Zoetis, Ceva Sante Animale, Animalcare Group)

    Click Link to Get Free Sample Copy of Report @ https://crediblemarkets.com/sample-request/animal-prescription-drugs-market-657793?utm_source=Amruta&utm_medium=SatPR

    Animal Prescription Drugs Market: Segmentation

    By types

    oral-type
    Smear type
    Type of injection
    Type of spray

    By requests

    Pet
    Livestock

    Animal Prescription Drugs Market: Regional Analysis

    The whole regional segmentation has been studied based on recent and future trends, and the market is forecast through the forecast period. The countries covered in the regional analysis of the Global Prescription Animal Drugs Market report are US, Canada & Mexico North America, Germany, France, UK, Russia , Italy, Spain, Turkey, the Netherlands, Switzerland, Belgium and the rest of Europe. in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, the rest of the Middle East and Africa (MEA) as part of the Middle East and Africa (MEA), and Argentina, Brazil and the rest of the South America as part of South America.

    Key benefits of the report:

    • This study presents the analytical description of the worldwide Animal Prescription Drugs industry together with the current trends and future estimations to determine the impending pockets of investment.
    • The report presents information related to key drivers, restraints, and opportunities, along with a detailed analysis of the global Animal Prescription Drugs market share.
    • Current market is quantitatively analyzed from 2021 to 2028 to highlight the growth scenario of the global Animal Prescription Drugs market.
    • Porter’s Five Forces analysis illustrates the power of buyers and suppliers in the marketplace.
    • The report provides a detailed analysis of the Global Animal Prescription Drugs Market based on the competitive intensity and how the competition will shape in the coming years.

    Directly Buy This Market Research Report Now @ https://crediblemarkets.com/reports/purchase/animal-prescription-drugs-market-657793?license_type=single_user;utm_source=Amruta&utm_medium=SatPR

    Main points covered in the table of contents:

    Market overview: It includes six sections, research scope, key manufacturers covered, market fragments by type, Animal Prescription Drugs market shares by application, study objectives and years considered.

    Market landscape:Here, opposition in the global Prescription Animal Drugs market is dissected, by value, revenue, transactions, and pie share by organization, market rate, fierce circumstances Most recent landscape and patterns, consolidation, development, obtaining and industry-wide portions of large organizations.

    Manufacturer Profiles: Here, the driving players of the global Animal Prescription Drugs market are considered dependent on region of deals, key elements, net benefit, revenue, cost, and creation.

    Market Status and Outlook by Region: In this segment, the report examines net benefit, transactions, revenue, creation, global industry share, CAGR and market size by region. Here, the global Animal Prescription Drugs Market is thoroughly examined based on regions and countries like North America, Europe, China, India, Japan, and MEA.

    Application or end user: This segment of the exploration study demonstrates how extraordinary sections of end customers/applications are added to the global Animal Prescription Drugs market.

    Market forecast: Production side : In this part of the report, the creators focused on the conjecture of creation and creation esteem, the gauge of the main manufacturers and the estimation of the creation and creation esteem by type .

    Research results and conclusion: This is one of the last segments of the report where the findings of the investigators and the end of the exploratory study are given.

    Answers to key questions in the report:

    • What will be the pace of market development of the Prescription Drugs for Animals market?
    • What are the key factors driving the global Animal Prescription Drugs market?
    • Who are the main manufacturers on the market?
    • What are the market openings, market risks and market outline?
    • What are sales volume, revenue, and price analysis of top manufacturers of Animal Prescription Drugs market?
    • Who are the distributors, traders and dealers of Animal Prescription Drugs market?
    • What are the Animal Prescription Drugs market opportunities and threats faced by the vendors in the global Animal Prescription Drugs Industries?
    • What are the deals, revenue, and value review by market types and uses?
    • What are the transactions, revenue and value review by business areas?

    About Us

    Credible Markets is a new era market research company with a firm grip on the pulse of global markets. Credible Markets has become a trusted source for business market research needs in a short period of time. We’ve partnered with leading market intelligence publishers and our report pool coverage spans all key industry verticals and thousands of micro-markets. The massive repository allows our clients to choose from recently released reports from a range of publishers who also provide in-depth analysis by region and country. Moreover, pre-booked research reports are among our best offers.

    The collection of market intelligence reports is regularly updated to provide visitors with quick access to the latest market information. We provide round-the-clock support to help you reuse search parameters and benefit from a full range of reserved reports. After all, it’s about helping you make an informed, strategic decision on purchasing the right report that meets all your market research demands.

    Contact us

    Credible market analyzes
    99 Wall Street 2124 New York, NY 10005
    E-mail: [email protected]

    read more
    Medical products

    South Korea to deliver non-lethal military medical products to Ukraine

    On the 15th, the South Korean government said it would provide non-lethal military supplies to Ukraine, which is fighting the Russian incursion. “The government has agreed to deliver non-lethal military supplies to Ukraine,” Boo Seung-chan, spokesman for the Ministry of National Defense, said during a regular briefing. “As for details, including transportation and other matters, conversations are ongoing,” spokesman Boo said. A total of 20 goods will be sent to Ukraine. Military supplies include combat helmets, blankets, emergency snacks and military folding beds, which total 12 items. Medical supplies are among the other items. The total amount of supplies provided to Ukraine is estimated at around 1 billion won.

    Military supplies should be shipped by air. From this week or next week at least, the supplies will be sent to Ukraine. Meanwhile, the Ministry of National Defense announced on the 15th that a direct communication channel with the Russian Navy and Air Force would be opened. Spokesman Boo said: “We were informed earlier this year that the Russian communication network has been installed. The official opening is expected to take place after a test call between the two countries.

    Summary of news:

    • South Korea to deliver non-lethal military medical products to Ukraine
    • Check out all the news and articles from the latest global news updates.
    Disclaimer: If you need to update/edit this article, please visit our Help Center. For the latest updates, follow us on gohohgIand News
    read more
    Prescription drugs

    Most Commonly Misused Prescription Drugs in the United States

    Cloth

    Most Commonly Misused Prescription Drugs in the United States

    The Substance Abuse and Mental Health Services Administration, or SAMHSA, reported that among people who abused prescription painkillers in 2020, nearly 65% ​​said their main reason for doing so was to relieve physical pain. The percentage of people reporting drug abuse as a reason for getting high was 11.3%.

    Abuse is defined as patients who take prescription drugs in a manner other than that recommended by their doctor. It may be like taking someone else’s prescription or taking their own in larger or more frequent doses, or for a longer period of time.

    Citing data from SAMHSA, Zinnia Health identified the most commonly used prescription medications in the United States, all of which are opioid pain relievers or opioid pain relievers. This class of drugs acts on the central nervous system by blocking pain signals to the brain. In addition to relieving pain, these drugs also intensely trigger the brain’s reward centers, releasing endorphins and creating positive feelings commonly referred to as euphoria. This is what makes prescription opioids – and all opioids, for that matter – so dangerously addictive.

    Prolonged use of opioids may increase a patient’s tolerance to a particular drug. With higher tolerance, the drug becomes less effective and patients do not experience the same level of pain relief and feelings of euphoria, which often leads people to seek out stronger opioids. This could explain why such a large percentage of people reported misusing prescription opioids for pain relief. For example, someone who has abused and developed a tolerance to morphine may seek something stronger like oxycodone or hydromorphone, whose effects kick in faster and more intensely.

    SAMHSA also found that nearly half of people who abused painkillers (47.2%) said they got the drugs from a friend or relative, either by stealing them, buying them, or getting them for free. . About 44% of people said they got prescriptions from a health care provider. Drug diversion—or the disruption of a prescription drug along its legal, intended journey from manufacturer to physician to patient—is a contributing factor to drug abuse. Diversion occurs, among other things, through doctor purchases, theft and tampering.

    The United States is in its third wave of the opioid crisis, but it is important to note that this current wave is characterized by illicitly produced synthetic opioids. Overdose deaths from commonly prescribed opioids have declined in recent years. However, knowing the uses and risks associated with these drugs can save lives. Read on to learn about the most commonly used prescription drugs in the United States.



    MedStock Photos // Shutterstock

    #8. Morphine

    – Abuse in the past year (former users): 8.9%
    – Misuse in the past year (general population): 0.2%

    Known by its brand names Avinza or Kadian, morphine is an opioid used to treat acute and chronic pain. Although morphine can be given intravenously, it is most often taken as tablets or capsules. Morphine is closely related to other painkillers like hydrocodone and oxycodone. The potency of other opioids is often determined or compared against the potency of morphine.



    chatuphot // Shutterstock

    #7. Tramadol

    – Abuse in the past year (former users): 9.0%
    – Misuse in the past year (general population): 0.5%

    Tramadol, commonly referred to by its brand name Ultram, is a synthetic opioid used to treat moderate to severe pain, usually after surgery. The drug is commonly prescribed in the form of extended-release tablets to relieve severe chronic pain caused by conditions such as fibromyalgia. In 2019, approximately 5.5 million people were prescribed Tramadol, totaling almost 20 million prescriptions. It was the 35th most prescribed drug in the United States



    Joe Mamer // Shutterstock

    #6. Codeine

    – Misuse in the past year (former users): 12.2%
    – Misuse in the past year (general population): 0.9%

    Codeine is an opioid used to treat mild to moderate pain and is most commonly prescribed as a cough suppressant. It can also be used to treat gastrointestinal issues like diarrhea. Because codeine is milder than other opioids, users with misuse intentions increase doses to achieve a higher high. Codeine abuse can lead to more intense opioid abuse.



    Cloth

    #5. Hydrocodone

    – Misuse in the past year (former users): 12.6%
    – Misuse in the past year (general population): 1.7%

    Hydrocodone is the most frequently prescribed opioid in the United States In 2020, 4.7 million people misused hydrocodone products, making it the most commonly used type of prescription pain reliever this that year. Hydrocodone, also known by its brand name Vicodin, is given to patients with moderate to severe pain, usually after surgery or injury, or to relieve pain associated with medical conditions such as cancer. In combination with homatropine, hydrocodone can also be used as an antitussive. Unlike other opioids, hydrocodone is not often illicitly manufactured and the vast majority of diverted hydrocodone is pharmaceutical.



    Cloth

    #4. Oxycodone

    – Abuse in past year (former users): 14.5%
    – Misuse in the past year (general population): 1.1%

    Oxycodone is an opioid prescribed to treat persistent severe pain. OxyContin and Percocet are two of the most recognizable brands, the former being a pure form of oxycodone and the latter a combination of oxycodone and aspirin. About 3.2 million people abused oxycodone products in 2020, making it the second most misused painkiller behind hydrocodone. Oxycodone abuse is prevalent across the spectrum of geographic, demographic, and socioeconomic conditions.



    PureRadiancePhoto // Shutterstock

    #3. Fentanyl

    – Misuse in the past year (former users): 14.8%
    – Misuse in the past year (general population): 0.1%

    The pharmaceutical fentanyl, which this data refers to, can be up to 100 times more potent than morphine and is most commonly used to treat pain associated with advanced cancer. Legally produced fentanyl is usually given in the form of patches or lozenges. According to the Drug Enforcement Administration, misuse of these products may include ingesting the gel inside the patches or freezing the patches, cutting them into pieces, and placing them inside the cheek to absorb the contents. . Because a percentage of fentanyl remains in used patches even after three days of use, used patches are also targeted for misuse. Illegally manufactured, non-pharmaceutical fentanyl is at the heart of the third and current wave of the opioid epidemic in the United States.



    Cloth

    #2. Hydromorphone

    – Misuse in the past year (former users): 16.6%
    – Misuse in the past year (general population): 0.1%

    Hydromorphone, commonly referred to by the brand names Dilaudid or Exalgo, is an opioid prescribed to treat severe pain in patients resistant to less potent opioids. It is about eight times stronger than morphine and the effects of a 1-2 mg dose can be felt in as little as 15 minutes. Hydromorphone carries a high risk of addiction and is only prescribed in certain medical circumstances, such as cancer pain management or cancer-related treatment. According to the Drug Enforcement Administration, hydromorphone was once the most commonly misused or misused drug, now supplanted by oxycodone and hydrocodone.



    PureRadiancePhoto // Shutterstock

    #1. Buprenorphine

    – Abuse in the past year (former users): 26.5%
    – Misuse in the past year (general population): 0.2%

    Buprenorphine is an opioid used in the drug treatment of opioid use disorder, or OUD, specifically to reduce intense withdrawal symptoms that can lead to relapse. It works by stimulating the brain in the same way as heroin or methadone, but to a lesser degree, creating a limit to its effects. It can produce euphoria without the risk of suppressing breathing, which is the true cause of death in opioid overdose. Since prolonged use of opioids inhibits the brain’s ability to produce dopamine on its own, the right dosage of buprenorphine and a comprehensive treatment plan allow patients with OUD to feel “normal” or equilibrium.

    This story originally appeared on Zinnia Health
    and was produced and distributed in partnership with Stacker Studio.


    read more
    Medical supplies

    Medical supplies made from fish skin sent from Iceland to Ukraine

    Thanks to the initiative of Anastiasiya Shyshlova, medical supplies from the Icelandic biotechnology company Kerecis have arrived in Ukraine, where they will be used to treat injuries resulting from burns, bombs and gunshots, Morgunblaðið reports. The products are made from cod skin in Ísafjörður in the Westfjords and are used worldwide for the treatment of wounds.

    Anastasiya, one of Kerecis’ 200 employees, was born in Ukraine and raised in Canada. She lives in Iceland with her husband, originally from Belgium.

    She has been following the situation in Ukraine closely for weeks and after experiencing anxiety and despair, she decided to take matters into her own hands.

    “The terrible situation in Ukraine, due to the invasion of Putin’s government, and the uncertainty about the future of the family, especially that of my grandfather, upset me,” she says. I was constantly looking for news and checking to see if the city I was born in was still doing well. I had no idea how to be helpful.

    The invasion began on February 24 and soon after she heard about a Ukrainian doctor working in Belgium, Dr Ihor Vitenko. Hoping to help Ukrainians in the war against Russia, he had recently bought a van, which he loads with medical supplies and drives to Ukraine, where he works in hospitals in the combat zone and teaches doctors. locals the latest Western methods of wound treatment. With the help of her mother-in-law, Anastasiya was able to get in touch with the doctor.

    “I told him that we shared this feeling of injustice and asked him if he had ever heard of or used medical products made from cod skin,” she said. “He said he didn’t, but seemed very interested.”

    On Sunday, February 27, Anastasiya got the all-clear from Kerecis to get supplies to Belgium, and the next morning she boarded a plane for Amsterdam. From there, she drove a rental car to Belgium, where she delivered the medical supplies herself. She says she was received with gratitude and the doctor appreciated having the supplies delivered to her in person.

    “Dr. Vitenko and I had a great conversation,” she notes, “and the phone kept ringing the whole time I was there. offer help.While I was talking to him, he was offered three ambulances to accompany him across the border into Ukraine.

    The doctor left Belgium with the medical supplies the first week of March, heading for Poland. From there, he crossed the Ukrainian border, where Anastasiya hopes the supplies will prove useful.

    Related News:

    read more
    Medical products

    The Definitive Guide 2021 – Second Sight Medical Products LLC, Nano Retina Ltd., Nidek Co. Ltd., MetaModal LLC, Bionic Vision Technologies, Biomedical Technologies SL – The Bollywood Post

    The Global bionic eye market report focused on the comprehensive analysis of the current and future outlook of the Bionic Eye industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics and forecasts for various segments and sub-segments considering macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements of the Bionic Eye market has been performed to calculate the growth rates of each segment and sub-segments.

    The influence of the latest government directives is also analyzed in detail in the report. It studies the Bionic Eyes market’s trajectory between forecast periods. The cost analysis of the Global Bionic Eyes Market has been done while considering manufacturing expense, labor cost, and raw materials along with their market concentration rate, suppliers, and price trend.

    Sample Free Report + All Related Charts & Graphs @ https://www.adroitmarketresearch.com/contacts/request-sample/1651?utm_source=PT14

    Major Bionic Eyes Market Players Including:

    Second Sight Medical Products LLC, Nano Retina Ltd., Nidek Co. Ltd., MetaModal LLC, Bionic Vision Technologies, Biomedical Technologies SL, Monash Vision Group and Pixium Vision

    This report in this research study provides the current economic state of the Bionic Eye industry in both local and . The market study is a valuable source of information for market players including policy makers, professionals, R&D experts, academics, suppliers, manufacturers and all market players interested in the Eye Care market bionic. The strongest single-level segments of the Bionic Eye market are highlighted in the report, representing their market share, market size, annual sales, revenue in terms of Million US$ and future scope of these markets.

    In addition, new technologies incorporated into these segments to increase productivity and efficiency are studied in detail. Different standard methodologies are applied to collect the data and measure the current status and development of the Eye Bionics Market. The specific objective of data collection is to analyze the most innovative and productive sectors of the Bionic Eye market. The research is supplemented with data from various surveys and industry associations. The report presents all important market information such as business scenarios, cost structure, cost benchmarking, top performing application and product segments and those about to experience growth quick. The report estimates the revenue generated by these products and their contribution to market output.

    The report discusses the segments and its products or services that are dominating the market and have immense growth potential in the market. Also, the production cost, competition, and which companies are investing significant funds to make the product or service more attractive are detailed in the report. Data and product or service distribution and market response are included in the report. Price patterns, target markets for the same product and reasons for price fluctuations for the same product or service in different markets are discussed in the report.

    Bionic Eyes Market Segment By Type:

    By technology (electronic, mechanical) Type (external eye, implanted eye) End use (hospitals, eye clinics, other)

    Bionic Eyes Market Segment By Application:

    N / A

    Why B2B companies around the world rely on us to grow and maintain revenue:

    • Obtain a clear understanding of the Bionic Eye market, how it works and the different stages of the value chain.
    • Understand the current market situation and future growth potential of the Eye Bionics Market throughout the forecast period.
    • Develop marketing strategies, market entry, market expansion and other business plans by understanding the factors influencing market growth and buyer purchasing decisions.
    • Understand your competitors’ business structures, strategies and prospects and react accordingly.
    • Make more informed business decisions using insightful primary and secondary research sources.

    This report provides:

    A detailed overview of the global Bionic Eye Market.
    Assessment of global industry trends, historical data from 2011, projections for the coming years and anticipation of compound annual growth rates (CAGR) by the end of the forecast period.
    Discoveries of new market insights and targeted marketing methodologies for Global Bionic Eye
    Discussion on R&D and demand for new product launches and applications.
    Varied company profiles of major industry players.
    The composition of the market, in terms of dynamic molecule types and targets, highlighting the key industry resources and players.
    The growth of patient epidemiology and market revenue for the global market and among key players and market segments.
    Study the market in terms of generic and premium product revenues.
    Determine business opportunities in the market sales scenario by analyzing trends in licensing and co-development agreements.

    Contents:

    1 Scope of the report
    1.1 Market Overview
    1.2 Research objectives
    1.3 Years considered
    1.4 Market research methodology
    1.5 Economic indicators
    1.6 Currency considered
    2 Executive Summary
    3 Global Bionic Eye by Players
    4 Bionic Eye by Regions
    4.1 Bionic Eyes Market Size by Regions
    4.2 Americas Bionic Eyes Market Size Growth
    4.3 APAC Bionic Eyes Market Size Growth
    4.4 Europe Bionic Eyes Market Size Growth
    4.5 Middle East & Africa Bionic Eyes Market Size Growth
    5 Americas
    6 APACs
    7Europe
    8 Middle East and Africa
    9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
    9.1.1 Growing Demand from Key Regions
    9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market trends
    10 Global Bionic Eyes Market Forecast
    Analysis of the 11 key players
    12 Research findings and conclusion

    Do you have a specific question or requirement? Ask our industry expert @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1651?utm_source=PT14

    ABOUT US:

    Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of businesses, manufacturing companies, product/technology development institutions and industry associations who need to understand market size, key trends, participants and future prospects of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help them create opportunities that increase their revenue. We follow a code – Explore, learn and transform. At our core, we are curious people who enjoy identifying and understanding industry patterns, creating insightful study around our findings, and crafting lucrative roadmaps.

    CONTACT US:

    ryan johnson
    Global Account Manager
    3131 McKinney Ave Ste 600, Dallas,
    TX 75204, USA
    Phone number: USA: +1.210.667.2421/ +91 9665341414

    read more
    Generic drugs

    Doctors will only prescribe generic drugs from April

    General pediatricians in Georgia will only be able to prescribe generic drugs to their patients, without specifying a drug brand, starting next month, Georgian Health Minister Zurab Azarashvili said on Sunday.

    In an interview with the Imedi TV channel, Azarashvili said the decision was aimed at providing citizens with freedom of choice when it comes to medicines and was part of an effort to create a “well-regulated and transparent pharmaceutical market” in the world. country.

    He also stressed the importance of not prescribing “biased or excessive amounts” of drugs, saying the ministry had drawn up an action plan to do so.

    The news about generic drugs comes after the country imported drugs from Turkey-based producers, which led to a reduction in the prices of the drugs most in demand. A digital prescription system has also been operating since March 1, Azarashvili noting that it would facilitate “better regulation” of the market.

    Georgian Prime Minister Irakli Garibashvili announced last week that general drug prices in the local Georgian market had been reduced by 60-80% following the import of drugs from Turkey, adding that products such as cardiovascular drugs had decreased from 220 GEL (around $68/€61) to 48 GEL (around $14/€13).

    Garibashvili announced his team’s initiative to ensure a reduction in general pharmaceutical prices for citizens at the end of last year, citing the huge discrepancy between the cost of drugs produced under good manufacturing practices on the Turkish market and in Georgia.

    read more
    Prescription drugs

    Global Prescription Drugs Market – Applications in various verticals will emerge in favor of market growth to increase sales revenue

    Global Prescription Drugs Market Report Highlights Latest Market Advancements Amid COVID-19 Pandemic

    Market research store has released the latest report on the Global Prescription Drugs Market. The report provides all the valuable data based on the fundamental fragmentation of the market into different sectors. In this research report, different vital elements including competitive landscape, geographical spread, market dynamics, market share, and other market growth attributes. The report on the prescription drug market also covers market breakdown and size through detailed study of regional and company profiles. The report entails all the information about the Global Prescription Drugs Market, breakdown, competitive players, applications, and more. decoded. The study also innately determines the market status, barrier analysis, sales breakdown, risks, growth drivers, and opportunities to guide through the in-depth market analysis.

    Get Free Sample Report + All Related Charts & Graphs (with COVID 19 Impact Analysis): https://www.marketresearchstore.com/sample/prescription-drugs-market-813432

    Prescription Drugs Market Size, Status and Forecast 2028

    1 Market Overview
    2 manufacturer profiles
    3 Global Prescription Drugs Sales, Revenue, Market Share and Competition by Manufacturer
    4 Global Prescription Drugs Market Analysis by Regions
    5 Prescription Drugs in North America by Country
    6 Europe Prescription Drugs by Countries
    7 Asia-Pacific Prescription Drugs by Countries
    8 South America Prescription Drugs by Countries
    9 Middle East and Africa Prescription Drugs by Countries
    10 Global Prescription Drugs Market Segment by Type
    11 Global Prescription Drugs Market Segment by Application
    12 Prescription Drugs Market Forecast
    13 Sales channel, distributors, traders and resellers
    14 Research findings and conclusion
    15 Appendix

    In addition, key market players mentioned in the report include Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche AG, Allergan PLC, AstraZeneca PLC, Johnson & Johnson, Eli Lilly and Company, Shire PLC, Novartis International AG, Novo . The company profile provides comprehensive market revenue, future development, industry policies, strategies, and demand analysis with the help of comprehensive market analysis. The study also details the market status, regional distribution, latest innovations, and government policies pertaining to the prescription drugs market. The regional segmentation United States, Canada, and Mexico into North America, Peru, Brazil, Argentina, and Rest of South America as part of South America, Germany, Italy, United Kingdom, France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia- The Pacific (APAC), South Africa, Saudi Arabia, United Arab Emirates, Kuwait, Israel, Egypt, the rest of the Middle East and Africa (MEA) offers the understanding, reach and application of this market. A valuable source of relevant data can be obtained from the report through the competitive and strategic analysis.

    Read the full report @ https://www.marketresearchstore.com/market-insights/prescription-drugs-market-813432

    The report also covers the details such as economic, environmental, social, technological, and political status of the Prescription Drugs market after observing and studying various factors. Regional profiling of market revenue, size and volume will provide insight into the growth rate of the market over the forecast period. The comprehensive summary of Prescription Drugs Market will provide readers with a clear overview of the investment potential in the market. The market research report provides a clear picture to fight competition in the market. All macroscopic and microscopic imprints of the market are well explained in the Prescription Drugs Market report.

    Segmentation:

    By product : Brand name drugs, Generic drug

    By app : Hospital, Clinic, Other

    Here are the questions answered by the market report:

    What are the objectives of the report?

    This market report shows the projected market size for the prescription drugs market by the end of the forecast period. The report also examines historical and current market sizes.

    Based on various indicators, the charts present the year-on-year growth (%) and the compound annual growth rate (CAGR) for the given forecast period.

    The report includes market overview, geographic scope, segmentation, and financial performance of key players.

    The report examines the current state of the industry and potential growth opportunities in North America, Asia-Pacific, Europe, Latin America, Middle East and Africa.

    The research report includes various factors contributing to the growth of the market.

    The report analyzes the growth rate, market size and market valuation over the forecast period.

    For an additional revised list of market players in 2021, request a sample report: https://www.marketresearchstore.com/sample/prescription-drugs-market-813432

    What factors are taken into consideration while evaluating the major market players?

    The report analyzes companies around the world in detail.

    The report provides an overview of the major market vendors including key players.

    The reports include information about each manufacturer, such as profiles, revenue, product prices, and other relevant information about the products produced.

    This report includes a comparison of market competitors and a discussion of key player perspectives.

    Market reports provide information on recent developments, mergers and acquisitions involving key players.

    Get more information before buying@ https://www.marketresearchstore.com/inquiry/prescription-drugs-market-813432

    What are the main conclusions of the report?

    This report provides comprehensive information about the factors that are expected to influence market growth and market share in the future.

    The report presents the current market status and future prospects for various geographical regions.

    This report provides qualitative and quantitative insights into the competitive landscape of the market.

    Combined with Porter’s five forces analysis, it serves as a SWOT analysis and competitive landscape analysis.

    It provides an in-depth analysis of the market, highlighting its growth rates and growth opportunities.

    read more
    Medical supplies

    Volunteers pack medical supplies and military equipment donated to Ukraine – Metro Philadelphia

    Sign up for our Daily Email newsletter to stay up to date with the latest local news across Philadelphia.

    By Barbara Goldberg

    In a corner of a cavernous warehouse, a woman in a yellow Tweety Bird sweatshirt separated catheters from blood-stopping gauzes. Another volunteer sealed a box of energy bars and gloves, while a ponytailed man sorted through batteries and diapers.

    “I am a Ukrainian – every Ukrainian should do something,” said Roman Pylypiv, 27, who had driven from his home in Philadelphia to the New Jersey warehouse to help prepare donations for Ukrainians.

    “There are men my age fighting there,” said Pylypiv, who moved to the United States eight years ago from the western Ukrainian town of Ivano-Frankivsk. where his family lives. “It’s nothing like what they do.”

    Hundreds of volunteers descended on the warehouse run by Meest-America Inc, a shipping company specializing in deliveries to Eastern Europe, to sort and pack medical supplies, clothing, military equipment and equipment. other goods destined for Ukraine.

    REUTERS/Eduardo Munoz

    Its warehouse spans 92,000 square feet — bigger than an American football field — just 14 miles from Newark Liberty International Airport.

    Inside are 35 long rows of orange-painted racks, each three shelves high and overflowing with bundles of toys, household items and other goods – typical shipments that have been put on hold since the invasion. of Ukraine by Russia.

    Over the past two weeks, nearly all of Meest-America’s work has shifted to organizing humanitarian aid deliveries donated by churches, charities and individuals, operations director Natalia Brandafi said in an interview.

    The company, whose name means bridge in Ukrainian, charges a reduced rate of 30% for the humanitarian goods it manages, funded by monetary donations, she said. He was able to obtain export permits for sensitive items such as body armor and helmets.

    In the past week alone, the Meest, New Jersey warehouse shipped more than 260,000 pounds (120,000 kg) of humanitarian aid, almost all first aid kits, medical supplies and food non-perishable, Brandafi said.

    The demand for medical supplies and military equipment replaced an earlier call for warm clothes and baby items.

    More than 2 million Ukrainians fled the country, many with only what they had on their backs. Almost all of them are women and children, as the men have been asked to stay and fight, and the government has provided them with weapons to strengthen the defense of the Ukrainian Armed Forces.

    For donation requests, Meest consults with the Ukrainian Embassy in Washington, the Ukrainian Consulate in New York and the delivery company’s headquarters in the western Ukrainian city of Lviv, said Brandafi.

    In a corner of the warehouse, Valentyna Goloborodko, a native of Odessa and an intern at Montefiore Medical Center in New York, rolled up the sleeves of her Tweety Bird sweatshirt on her third day of volunteering.

    She separated donated “medical goods” from more urgent “tactical drugs”, such as haemostatic gauze from the first aid kit to bandage a wound and stop bleeding.

    “These are simple things that could save someone’s life on the battlefield,” Goloborodko said.

    Reuters

    read more
    Medical products

    Hot Extrusion Medical Products Market Trends by 2026 with Major Key Players – BASF Pharma, Formex, Omipa, Biogrund, AbbVie and Lubrizol

    This global Hot Extrusion Medical Products Market is an attempt to analyze the global opportunities in the field of the global industry, its current capabilities and the potential of selected countries and regions in the market. The report to businesses and companies provides a better understanding of their ability to invest in the market. The report provides the most business-critical issues of the leading organizations in the Global Hot Melt Extrusion Medical Devices Market globally. The report aims to explain to market players the business outlook, key developments and drivers of the global hot melt extrusion medical products market.

    The challenges and opportunities of the Hot Melt Extrusion Medical Products market are presented in the report. The report highlights critical value chain destinations of the global hot extrusion medical products market. The report also highlights issues and concerns of local and foreign market players and provides recommendations for policy makers and actions for industrials to grow in the global Medical Hot Melt Extrusion Products market. The report makes projections based on the current global economic scenario. The uncertainties and difficulties faced by the Hot Extrusion Medical Devices market players are included.

    Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6239962?utm_source=Sgir

    Major Players of Global Hot Extrusion Medical Products Market:

    AbbVie
    Formex
    BASF Pharmaceuticals
    omipa
    Biogrund
    Lubrizol

    Points covered in the Hot Melt Extrusion Medical Products Market report:

    • Overview of the global hot melt extrusion medical products market by studying different segments.
    • The employment contribution of the global hot melt extrusion medical products market to economies around the world.
    • The economic contribution of the global hot melt extrusion medical products market to economies around the world.
    • Key players’ marketing approaches to attract foreign markets for hot extrusion medical products.
    • Domestic and global regulatory constraints faced by the Hot Extrusion Medical Products market players.
    • Global and/or regional trends in the medical hot melt extrusion industry in selected countries.
    • Financial information and capital market information of hot melt extrusion medical products are provided in the report.

    Type of hot extrusion medical products industry includes:

    Movies
    Taste masking
    Drug eluting devices
    Others

    Hot extrusion medical products industry applications consist of:

    Research Laboratory
    Contract manufacturing organization
    Pharmaceutical companies

    This report analyzes the recent Hot Melt Extrusion Medical Devices industry trends along with the production chain, consumption patterns, regional and international level business activities and other industry related fields. The report emphasizes the potential of the global hot extrusion medical products market in developed countries. The data used to study all the factors of the global hot extrusion medical products market uses data from 2010 to 2020 also considering the latest year for performing the analysis. The report compares the growth rates of the strongest segments and consumption and production patterns. The report provides a detailed study of the performance of major Hot Melt Extrusion Medical Products market on the domestic and global fronts. Additionally, the report highlights the countries with the greatest potential for future growth.

    Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6239962?utm_source=Sgir

    Why Buy This Hot Melt Extrusion Medical Products Market Report?

    • This report helps the Hot Melt Extrusion Medical Products market players to strengthen their market position, improve their business, reach markets and gain competitive advantages.
    • The Hot Melt Extrusion Medical Products report focuses on the strategies implemented by manufacturers in their operations, purchasing, and supply chain management.
    • The report leverages the capabilities of Hot Melt Extrusion Medical Devices market players to seize new opportunities.
    • The report offers supply chain visibility to enable improvisation for Hot Melt Extrusion Medical Devices market players who wish to expand their business into new international markets.
    • The Hot Melt Extrusion Medical Products report compares the growth rates of the strongest segments and consumption and production patterns.
    • The supply chain visibility provided in this report aids in understanding the drivers of the Global Hot Melt Extrusion Medical Devices Market and helps them maintain their leading position in the Global Hot Melt Extrusion Medical Devices Market over the course of years of forecasting.

    About Us:

    Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

    Contact us:

    Hector Costello
    Senior Manager – Client Engagements
    Central Highway 4144N,
    Suite 600, Dallas,
    Texas – 75204, USA
    Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
    Email ID: [email protected]

    Buy the full report at: https://www.orbisresearch.com/contact/purchase-single-user/6239962?utm_source=Sgir

    read more
    Medical supplies

    Port Coquitlam medical supplies head to Ukraine

    A massive response is underway to support the people of Ukraine, including the efforts of a Port Coquitlam veteran who gathered medical equipment and supplies from the city of Port Coquitlam for frontline soldiers and evacuated refugees.

    Port Coquitlam and Kiev, Ukraine are thousands of miles apart, but the ties are strong.

    Whether it’s watching television coverage or trying to find ways to help refugees fleeing the war-torn country or supporting those resisting invasion, many Tri-City residents are keenly interested in the events in this Eastern European country.

    But a man, whose wife is of Ukrainian descent, has decided to step in to help – and the city of Port Coquitlam is answering the call as well.

    Andrew Richards, an 18-year-old Canadian Army veteran who served as a peacekeeper in Bosnia, just delivered several boxes of supplies, including blankets, stretchers, bandages, gauze pads, bandages and first aid kits, to a warehouse in Burnaby for shipment to Ukraine.

    They were all donated by the PoCo Fire and Emergency Service and are destined for Lviv in western Ukraine for use by sick and injured soldiers and refugees.

    Richards said these critical medical supplies are much needed and he is grateful the City of Port Coquitlam was able to help.

    Richards said he learned via a Global TV Storey on the efforts of a Vancouver real estate agent, Olga Zarudina, to gather supplies for her former country. He contacted her to see what he could do to help her.

    The Canadian border guard who lives with his wife – a global domestic producer – and their two young children in PoCo, said his years in the military taught him what was needed in Ukraine, where homes are being bombed , creating the largest number of European refugees. movement since World War II.

    MEDICAL SUPPLIES AND TRAUMA KITS FOR DELIVERY TO UKRAINE

    Already, the first shipment of 200 kilograms of military and medical supplies has been sent to Ukraine via Vienna and Richards said the contributions from Port Coquitlam will be delivered in a later shipment.

    He said he contacted the city’s mayor, Brad West, and made sure the city would help.

    “The next day I got a phone call from the fire chief (Robert Kipps), and they said ‘we’re preparing stuff. We’ll let you know when to pick it up. So yeah, it all happened pretty quickly.”

    For Richards, the tragedy unfolding in Ukraine is hard to watch, but he and his wife keep abreast of what is happening.

    “It’s like a lot of people, I think, you know, it hits close to home,” said Richards, who said his wife still has family in Ukraine.

    Mayor Brad West said the donations are a small gesture of support for the people of Ukraine.

    IMAGES OF WAR IN UKRAINE ARE ‘DEVASTATING’, SAYS MAYOR

    “It’s the least we can do. The images of devastated cities, destroyed children’s and maternity hospitals and hundreds of Ukrainians killed are heartbreaking,” West told the newspaper. Tri-City News.

    “At the same time, it was inspiring to see the bravery and courage of Ukrainians fighting to save their country from a completely unwarranted invasion.”

    The community has a large Ukrainian population, he noted, which further strengthens ties between Canada and Ukraine.

    Richards, meanwhile, plans to use his contacts to gather more supplies and help volunteers at the South Burnaby warehouse sort through items.

    For him, the war in Ukraine is unprecedented in modern times and it is something he feels he must do.

    “That doesn’t usually happen in Europe. Does it?” said Richards. “It’s kind of the scale of it… There are a lot of vulnerable people who will need a lot of help.”

    read more
    Prescription drugs

    5 charged with attempted smuggling of prescription drugs into Michigan

    GRAND RAPIDS, Mich. (WILX) – Five defendants have been charged with conspiring to smuggle prescription drugs into the United States, for distribution in the Western District of Michigan and elsewhere.

    On Friday, US Attorney Andrew Birdge announced that five men had been charged in connection with the investigation. They have been identified as Joshua Ford of Troy, Michigan; James Funaro of Atlanta, Georgia; Jeremy Walenty of Tampa, Florida; Taylor McLaren of Colorado Springs, Colorado; and Brendon Gagne of Fountain, Colorado.

    Related: Michigan Prescription Drug Task Force Recommendations Announced

    Two of the defendants, Gagné and Funaro, are also charged with money laundering conspiracy. Funaro alone is charged with one count of money laundering.

    According to court documents, the defendants operated two websites that sold prescription drugs and certain controlled substances. These sites were ExpressPCT.com and ExpressPEDS.ws.

    The United States has shut down two websites suspected of illegally selling prescription drugs.(WILX)

    Birge said in a statement that ExpressPEDS.ws also sells anabolic androgenic steroids.

    The US government is now arguing that the drugs sold on these sites were largely, if not entirely, manufactured outside the United States and smuggled into the country to be sold to people in the United States. According to the indictment, the sites did not ask for prescriptions from customers even though the drugs being sold require a person to be under the supervision of a licensed practitioner.

    Related: Michigan governor signs bills to cut prescription drug costs

    ExpressPCT.com accepted Bitcoin as well as other forms of payment, including payments sent through digital payment networks such as Zelle and Cash App.

    The indictment says that if customers chose to pay using alternative payment methods other than cryptocurrency, the co-conspirators directed payments through accounts linked to Funaro. It alleges that Funaro then converted proceeds from the scheme into cryptocurrency before it was transferred to accounts held by a group of co-conspirators.

    Birge alleges that this group of co-conspirators included foreign nationals residing abroad.

    Investigators say they have traced at least $12 million in revenue to the drug trafficking program. If convicted of conspiracy to smuggle drugs into the United States, the defendants face a legal maximum of five years in prison and a fine of up to $250,000. If Gagne and Funaro are convicted separately of the money laundering conspiracy charge, they face a legal maximum of twenty years in prison and a fine of up to $500,000 or double the value of the funds laundered. , whichever is greater.

    Criminality: ‘I’ve been advocating for this day for a long time’ – Man who saved sister from heinous attack sees bipartisan public safety bills signed

    Copyright 2022 WILX. All rights reserved.

    Subscribe to our News newsletter 10 and get the latest local news and weather straight to your email every morning.

    read more
    Prescription drugs

    Amazon Pharmacy will provide low-cost prescription drugs

    Amazon Pharmacy provides lower cost prescription drugs in five states through a new partnership with Blue Cross Blue Shield.

    The Verge reports that the retail giant’s pharmacy wing is offering a prescription drug discount card to Blue Cross Blue Shield customers in New Jersey, Nebraska, Alabama, Florida and Kansas. The partnership will allow customers to get discounts through a MedsYourWay card when using Amazon Pharmacy. Also, the cost of medications will still count towards insurance deductibles.

    “They can be free to choose which is cheaper and not have to worry about what applies to their maximum disbursement or deductible, because both apply,” Nworah AyoguAmazon Pharmacy’s chief medical officer, said at a health technology conference this week.

    While most prescription discount cards work in a pharmacy network, customers will be able to use the MedsYourWay card at Amazon pharmacies. MedsYourWay is offered by pharmacy benefit manager Prime Therapeutics, owned by more than a dozen BlueCross Blue Shield health plans.

    Amazon Pharmacy debuted in 2020, two years after buying drug delivery startup Pillpack, offering discounted costs on common prescription drugs and drugs based on their manufacturing cost.

    Others are getting into the prescription drug game, including Dallas Mavericks owner and Shark Tank investor Marc Cubanwhich launched its online pharmacy The Cost Plus Drug Co. in January.

    “I want to be above the break-even point while maximizing the number of people who can afford their drugs,” Cuban told TechCrunch. “Shoot. I would be happy if we could earn a little, but bring down the prices of generics sold elsewhere considerably.”

    According to BioSpace, prescription drugs have seen their prices increase by 3.3% in 2021 and 5.8% in 2020. This year, Pfizer, Purdue Pharma and Gilead have all increased the prices of drugs for HIV, cancer breast cancer, cardiovascular problems and opioids. .

    read more
    Generic drugs

    Global generic drug market to reach $507.8 billion by 2026

    • Global competitiveness and percentage market shares of main competitors
    • Market presence in multiple geographies – Strong/Active/Niche/Trivial
    • Peer-to-peer collaborative online interactive updates
    • Access to our digital archives and the MarketGlass research platform
    • Free updates for one year

    Editing: 7; Published: February 2022
    Executive Pool: 1974
    Companies: 42 – Players covered include Abbott Laboratories; Apotex Inc.; ASKA Pharmaceutical Co., Ltd. ; Aspen Pharmacare Holdings Limited; AstraZeneca Plc; Baxter International Inc.; Dr. Reddy’s Laboratories Limited; Eli Lilly and company; Endo International plc; Fresenius Kabi; GlaxoSmithKline Plc. ; H.Lundbeck A/S; Hospira; Lupine Pharmaceuticals, Inc.; Mylan NV; Novartis International SA; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Sandoz International GmbH; Sanofi-Aventis US LLC; STADA Arzneimittel AG; Sun Pharma; Teva Pharmaceutical Industries Ltd. and others.
    Blanket: All major geographies and key segments
    segments: Type (small molecule generics, biosimilars); Therapeutic application (cardiovascular, central nervous system (CNS), dermatology, oncology, respiratory, other therapeutic applications)
    Geographies: World; United States; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia Pacific; Australia; India; South Korea; Rest of Asia Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UNITED ARAB EMIRATES; Rest of Middle East; Africa.

    Free Project Preview – This is an ongoing global program. Preview our research program before making a purchasing decision. We provide free access to qualified executives in strategy, business development, sales and marketing, and product management roles at featured companies. Insights provide insider access to business trends; competing brands; profiles of experts in the field; and market data models and much more. You can also create your own bespoke report using our MarketGlass™ platform which offers thousands of bytes of data with no obligation to purchase our report. Registry overview

    ABSTRACT-

    Global generic drugs market to reach $507.8 billion by 2026
    Generic drugs are described as the bioequivalent versions of brand name drugs in terms of safety, quality, stability, impact, strength, dosage form, and route of administration. Over the years, generic drugs have become safe and effective alternatives to brand name formulations. Generic variants differ from brand names in certain characteristics such as color, flavor and shape, although these factors have no impact on the safety and effectiveness of the drugs compared to the original version. Generic drugs are drugs that are made with the same active ingredient found in brand name drugs and also have the same therapeutic impact as their brand name counterparts. Medications are also prescribed in the same quantity as brand name medications. The method of consumption (route of administration) is also similar to brand name drugs. Generic drugs can only be marketed after the brand name drug patents have expired. The drugs are offered at much lower prices even though they are manufactured under the same strict manufacturing and safety procedures and maintain equivalent quality. A key advantage for generic drug manufacturers is that they do not need to invest time and money in drug R&D and marketing efforts, as generic drug prices are significantly lower compared to their branded counterparts.

    Amid COVID-19 Crisis, Global Generic Drugs Market Estimated at US$402.9 billion in 2022, is expected to reach a revised size of US$507.8 billion by 2026, growing at a CAGR of 5.6% over the analysis period. Generic small molecules, one of the segments analyzed in the report, is expected to grow at a CAGR of 5.2% to reach US$325.7 billion at the end of the analysis period. After a thorough analysis of the business implications of the pandemic and the induced economic crisis, the growth of the biosimilars segment is readjusted to a revised CAGR of 6.3% for the next 7-year period. This segment currently accounts for a 37.7% share of the global generic drug market. With several factors encouraging growth contributing to wider adoption, biosimilars are poised to increase their share of the global generic drug market in the coming years. The rise of biosimilars has notably reduced overall drug spending in recent years, a trend that is expected to continue for the foreseeable future. The emergence of biosimilars in the market leads to increased competition, the next generation of biologics under development aims to improve safety, efficacy and cost factors compared to the drugs of the previous generation, which further adds to the competitive heat in the market.

    The US market is estimated at $121.8 billion in 2022, when China is expected to reach $91.2 billion by 2026
    The generic drug market in the United States is estimated at US$121.8 billion in 2022. The country currently accounts for a 30.46% share of the global market. Chinaworld’s second largest economy, is expected to reach an estimated market size of US$91.2 billion in 2026 with a CAGR of 7.2% over the analysis period. Other notable geographic markets include Japan and Canada, each predicting growth of 3.8% and 5% respectively over the analysis period. In Europe, Germany is expected to grow at around 4.3% CAGR while the rest of the European market (as defined in the study) will reach US$97.6 billion at the end of the analysis period.

    The market is expected to be driven by the ever increasing risk of various chronic diseases such as hypertension, obesity and diabetes. Although pharmaceutical companies continue to develop branded drugs due to the shortage of new blockbuster drugs coming to market, generic drugs are expected to continue to meet the majority of these therapeutic needs of the population, especially the elderly population. in expansion. With the high cost of brand name drugs becoming a financial burden on people, efforts have intensified to develop cost-effective generic variants. Many branded drugs are unable to extend their exclusivity, resulting in the loss of patents and making way for affordable generics to be manufactured. The major application areas of generic drugs include cardiology, anti-infection, anti-arthritis, CNS, anti-cancer, and respiratory, among others. Generic drugs for cardiovascular diseases currently represent the dominant segment, accounting for the majority share of the overall market. Cardiovascular diseases such as heart failure, high blood pressure, circulatory disorders, dyslipidemia, cholesterol, arrhythmias, strokes and angina pectoris are the leading causes of death worldwide. The cardiovascular segment is expected to cover a larger portion of the global generic drugs market due to several patent expirations of these drugs. Generic drugs for infectious diseases would gain popularity over the next few years, mainly due to the increasing number of cases around the world. The COVID-19 pandemic has emerged as a significant growth driver for the generic drug market over the past year. As nations’ economies collapsed due to rising unemployment, the demand for cheaper substitutes for brand name drugs grew. Continued

    MarketGlass™ Platform
    Our MarketGlass™ platform is a free comprehensive knowledge center that can be custom configured to meet the intelligence needs of today’s busy business executives! This interactive, influencer-focused research platform is at the heart of our core research engagements and draws on the unique perspectives of participating executives from around the world. Features include – enterprise-wide peer-to-peer collaborations; overviews of research programs relevant to your business; 3.4 million profiles of experts in the field; profiles of competitive companies; interactive research modules; custom report generation; follow market trends; competing brands; create and publish blogs and podcasts using our primary and secondary content; follow domain events around the world; and much more. Client companies will have privileged access to the project’s data stacks. Currently used by over 67,000 domain experts worldwide.

    Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our mobile application which has just been released on iOS Where android

    About Global Industry Analysts, Inc. and StrategyR™
    Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher, the only influencer-focused market research company in the world. Proudly serving over 42,000 clients in 36 countries, GIA has been recognized for its accurate forecasting of markets and industries for over 33 years.

    CONTACTS:
    Zak Ali
    Director, Corporate Communications
    Global Industry Analysts, Inc.
    Phone: 1-408-528-9966
    www.StrategyR.com
    E-mail: [email protected]

    CONNECTIONS
    Join our group of experts
    https://www.strategyr.com/Panelist.asp

    Connect with us on LinkedIn
    https://www.linkedin.com/company/global-industry-analysts-inc./

    Follow us on twitter
    https://twitter.com/marketbytes

    Journalists and media
    [email protected]

    SOURCE Global Industry Analysts, Inc.

    read more
    Medical supplies

    How to help Scarborough’s ‘Knight in Red Armor’ transport medical supplies to Ukraine

    Derek Bratton plans to sell his bike to help fund travel

    Derek, 59, became a well-known face around Scarborough during the first lockdown, going out of his way to deliver groceries, prescriptions and other essentials to those too vulnerable to leave home.

    Read more

    Read more

    A knight in red armor

    Working with the newly created volunteer group Van-Aid, a coordinated effort of drivers across the UK, Derek will travel to Ukraine on March 29.

    Register to our daily newsletter The Scarborough News Today

    The newsletter mute the noise

    Derek’s motorbike and red van

    He said: “If I can raise enough, I’ll go as often as I can. I’ve put my 2015 Honda Repsol motorbike up for sale to raise money so I can go as many times as I need.

    “I’m going to drive from Scarborough to Southampton and fill up. Then, cover 4,000 miles in five days in a convoy. There are nine people traveling in my party.

    “We bring medical supplies directly to the Ukrainian border. AA said they would pick up anyone in our convoy free of charge in the event of a breakdown.

    “You have to fund the trip yourself. Each trip costs around £1,500 to cover the cost of fuel, food and the ferry.

    Derek regularly enjoys track days

    Friend Vicki Oliver said the trip is not without danger, she said: ‘I personally think he is crazy but he insists on going.

    “Two people going to get shot, I told him to stay away from everyone!

    “Derek just wants to help anyone and everyone the best he can.

    “It’s just a horrible situation for the people out there, so we’re asking people to help in any way they can and businesses to help sponsor and pay for Derek’s fuel.”

    A knight in shining red armor

    To help Derek raise money for his travels, his friend Ronald Wilkey started a GoFundMe page which you can find by clicking here.Ron said: ‘During both lockdowns Dez had no trouble helping anyone with access to shopping, medicine etc, especially nhs staff, even though he was collecting a sandwich for the nurses.

    “Nothing was too difficult, so now he has to join a group of drivers to deliver humanitarian goods to help the people of Ukraine.

    “Even if you see his van, put a dozen under the windshield wipers… go ahead, you know you want to!”

    read more
    Generic drugs

    Generic Medicines Forum 2022: The Current State of Generic Medicines – 04/26/2022


    Date:
    April 26 – 27, 2022
    Day 1 :


    HEY
    Day 2:


    HEY


    Visit CDER’s Small Business and Industry Support Page

    Agenda

    Sign up for industry updates

    KEY STAKEHOLDERS

    Sally Choe, Ph.D.
    Director
    Generic Medicines Office (OGD) | CDER | FDA

    Michael Kopcha, Ph.D., R.Ph.

    Michael Kopcha, Ph.D., R.Ph.
    Director
    Pharmaceutical Quality Office (OPQ) | CDER | FDA

    ABOUT THIS EVENT

    The Generic Drugs Forum (GDF) is an annual two-day virtual event that provides attendees the opportunity to hear from FDA subject matter experts from every part of the generic drug review program. The purpose of the forum is to provide information to help potential and current applicants by offering practical advice, presenting case studies, and delving deeper into the Abbreviated New Drug Application (ANDA) review process.

    This year’s theme is The current state of generic drugs and presentations will cover hot topics such as the pre-ANDA program, generic drug metrics, post-market safety, pre-approval inspections, and global generic drug affairs.

    TOPICS COVERED

    • Data integrity
    • Facility Assessment
    • FDA Pre-ANDA Program
    • Global generic drugs
    • Knowledge-Assisted Assessment and Structured Application (KASA)
    • Overview of ANDA program statistics
    • Pharmaceutical quality systems
    • Safety and post-market surveillance of generic drugs
    • Product Specific Guidelines for Generic Drug Development
    • Technical Considerations for Life Cycle Management of Pharmaceuticals

    TARGETED AUDIENCE

    The generic drug industry, consultants, regulatory affairs professionals or contractors, with an emphasis on those who:

    • are planning to submit an ANDA, are in the process of submitting an ANDA or have submitted an ANDA
    • involved in the development of generic drugs
    • work on generic drug bioequivalence, facility evaluation, stability, dissolution and impurity testing

    FDA RESOURCES

    1. Product Specific Guidelines for Generic Drug Development
    2. Pharmaceutical Grade Resources
    3. Industry Resources
    4. Generic Drug Guidelines (under Subjects, choose “Generic Drugs”)
    5. Federal Generic Drug Registry Notices
    6. Generic Drug User Fee (GDUFA) Changes Science and Research

    CONTINUOUS TRAINING

    Real-time attendance is required for the certificate of attendance which can be used in support of ECs for the following professional organizations. Certificates are only available for two weeks following the event.

    This course was:

    • pre-approved by RAPS as eligible for up to 12 credits for a two-day event (appropriate for real-time participation) toward a participant’s RAC recertification upon completion.
    • pre-approved by SOCRA which accepts documentation of the candidate’s participation in continuing education programs for recertification if the program is applicable to the regulations, operations or management of clinical research, or the therapeutic area of ​​clinical research of the candidate
    • pre-approved by the SQA as eligible for 1 non-GCP or non-GLP unit for each hour of instructional time toward a participant’s QPIP re-enrollment.
    • accredited by the ACRP for continuing education in clinical research. ACRP will provide 1 hour of ACRP contact for every 45-60 minutes of qualified material.

    TECHNICAL INFORMATIONS

    • To optimize your webinar experience, use Chrome when viewing Adobe Connect in a browser.
    • Please contact [email protected] for any technical questions.
    • If you experience any technical issues before or during the event, please contact Technical Support.
    • Test your PC for use with Adobe Connect before the day of the event. Adobe, the Adobe logo, Acrobat, and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
    read more
    Prescription drugs

    Free Prescription Drugs, Joining the National Power Grid, and the Future of Southfork Ranch

    After my story reviewing pharmacy discount cards, I heard about “the first free pharmacy serving the general public in Texas”. The association is looking for a promotion. I gladly comply here.

    On another subject, I have to tell you that between my last Atmos gas bill and the skyrocketing increase in home insurance, I’m at my wit’s end. I need to smell the salts.

    Also, can anyone help solve the mystery of the future status of the legendary Southfork Ranch?

    Let’s start this collection of great Watchdog shorts with the discount pharmacy.

    Carlos Irula is the head pharmacist at St. Vincent de Paul Pharmacy. He tells me about free prescription drugs available primarily for chronic health conditions such as diabetes, hypertension, high cholesterol, and mental health.

    To qualify, a person must have no health insurance, a household income at or below 300% of the federal poverty level ($83,250 in a four-person household), and be a Texas resident with a valid prescription. . You don’t need to go to the pharmacy because they deliver.

    Find out if you or someone else you know may qualify by calling 469-232-9902 or visiting www.svdpdallas.org/pharmacy.

    Increase in home insurance

    I wondered why my home insurance had jumped 36% in one year. I made no complaints.

    The culprit was the cost of replacing the house, which jumped $100,000 in one year, I was told. wow.

    My initial guess was that it was the result of the February frost. Someone has to pay for all those broken water pipes in so many Texas homes. But Ben Gonzalez of the Texas Department of Insurance tells me my guess is wrong.

    “Industry sources indicate that wood and other building materials are more expensive,” he said. He also cited labor shortages and natural disasters. “If it costs more to build a house, it will cost more to insure it,” he said.

    Richard Johnson of the Texas Insurance Board told The Watchdog, “Your 35% increase seems like an outlier. …The national average is about 11.4%. We see closer to 7% to 10% in Texas. »

    His advice for me? Shop!

    Sale of Southfork Ranch?

    I’ve been told that the future of Southfork Ranch, legendary home of the Ewing family of television, is in jeopardy.

    I called there half a dozen times, but no one called me back. Finding out who shot JR was easier than finding out about this world famous tourist attraction from Parker.

    Realtor Sarah Hamilton of 1845 Realty in Frisco checked it out for me. She learns that the ranch is under a sales contract. But the future of the tourist attraction is unknown.

    Banking News

    After I told you how several big banks were eliminating NSF fees and ending overdraft protection fees, another big one jumped into the pool. Citigroup has announced that it is ending all overdraft fees and insufficient funds fees.

    The Center for Responsible Lending says Citi is the biggest bank to do so.

    Join the grids

    Isn’t it ridiculous that Texas leaders don’t want to join the two national power grids? I mean, come on, if Putin has taught us anything in the last few weeks, it’s that we need reinforcements.

    I disagree with former Governor Rick Perry, who explained that “Texans would be without power for more than three days to keep the feds out of their business.”

    But as University of Texas energy professor Michael E. Webber points out, Texas already deals with federal regulations when it exports natural gas, gasoline, liquefied natural gas and crude oil.

    Why not electricity too? He estimates that by joining the large grids, Texas could sell $10 billion worth of excess energy each year. And in the event of a disaster, we could buy back some of it.

    Note that Pat Wood, a former chairman of the Utilities (Public) Commission, told the Texas Tribune last month that Texas could join without losing control of its system. But for politicians, it sounds better to say we don’t want the federal government in our business.

    Post office changes

    I will never forget that 16 years ago I reported a story to my editor about the US Postal Service, but he didn’t believe it could be true.

    The USPS had raised the price of a stamp by two cents and charged more for priority, express, and certified mail. Most people thought it was because the post office was failing. But in fact, that year, the post office had a surplus.

    While attending a postal conference, I learned that the money was used to pre-fund future pension benefits for postal workers, not postal operations themselves. My boss didn’t believe it.

    Now, all these years later, Congress has voted to end the practice of pre-funding retirees on postage.

    A postal overhaul bill awaiting President Biden’s signature also locks down six-day-a-week delivery and — my favorite part — imposes special postage rates for local newspapers to promote local news, The Wall Street Journal reported.

    AT&T Tip of the Day

    Finally, I pass on this common-sense advice from Arlington’s Mark Schnyder:

    “Whenever I have a billing issue with AT&T, at the very end of the call, when they ask if there’s anything else they can do for me, I say, ‘Hey, since this issue has was caused by AT&T and I had to spend x-amount of time dealing with it, how about a $25 loyalty credit?”

    “I get it almost every time,” he says. “The thing is, they will if you ask. I’d like to think that if we all did this when AT&T had to correct its own mistakes, maybe the company would start to feel enough pain, it would make fewer mistakes. A guy can dream.

    Become a citizen of Watchdog Nation.

    Join Dave Lieber and learn how to be a super consumer.

    Surveillance bulletin: Sign up for The Watchdog’s FREE weekly newsletter to keep up to date: click here.

    Watch this free training video from Dave: https://youtu.be/uhUEUCNKGjc

    Subscribe: PLEASE support The Watchdog’s brand of simple journalism designed to save you time, money and aggravation. Treat yourself to a digital subscription (and make it look good!) using the special Watchdog code: https://www.dallasnews.com/subscribe/watchdog-1

    Watchdog home page: You can’t afford to miss The Watchdog’s two reports every week. Follow our latest reports always on The Watchdog home page which presents all the recent headings.

    Facebook: Connect with The Watchdog on our Facebook group. Search for “Dallas News Watchdog Posse”.

    The Dallas Morning News Watchdog column is the 2019 winner of the National Society of Newspaper Columnists’ top column writing award. The contest judge called his winning works “models of suspenseful storytelling and public service.”

    Read his winning columns:

    * Assist the widow of Officer JD Tippit, the Dallas police officer killed by Lee Harvey Oswald, to be buried next to her late husband

    * Help a waitress injured by an unscrupulous used car dealer

    read more
    Medical products

    This week’s big story: Stop banning medical product exports, report says

    A new report from the National Academies of Sciences, Engineering and Medicine in the United States calls for an international treaty to prevent countries from banning exports of medical products, in a bid to prevent supply shortages.

    The paper, called Strengthen the resilience of the country’s medical product supply chains, cites the restrictions that a number of countries have imposed on the export of medical products during the pandemic. Many of these still remain, as according to the World Trade Organization (WTO), 45 countries still had more than 70 restrictions in place in 2021, many of which applied to medical products.

    The authors of the article go on to warn that export restrictions “can be dangerously counterproductive. What makes sense in an isolated emergency can be seriously detrimental in a global crisis.”

    Globalization and the pharmaceutical industry

    The pandemic has highlighted how dependent countries have become on imports to ensure they can meet domestic drug demand. China produces most of the active pharmaceutical ingredients (APIs) needed to manufacture common drugs such as penicillin and acetaminophen. India, in turn, relies heavily on imports from China to manufacture drugs for the US market, where it is the largest supplier of generic drugs.

    The Russian invasion of Ukraine also raises fears that global supply chains could be disrupted. Russia signed an executive order this week banning exports of medical products from a list of countries it has deemed “unfriendly”, including the UK, EU, Canada, New Zealand, US States, Switzerland and Japan. This ban will apply to products stored in warehouses in Russia, or which pass through customs controls.

    The need for collaboration

    In the paper, the authors urge the US federal government to consider a multilateral agreement with major exporters of medical products that would be overseen by the World Trade Organization (WTO). They also suggest that the WTO could impose sanctions on countries that have not joined the agreement.

    The 336-page document calls for greater international cooperation to prevent supply chain disruptions. It also contains detailed recommendations to prevent national shortages, such as pharmacy teams working with hospitals to inform them of a potential shortage and suggest alternative forms of treatment.

    Earlier this year, the US Food and Drug Administration (FDA) made permanent its guidance to prevent supply shortages in the wake of the Covid-19 pandemic. This included requiring manufacturers to submit a notification at least six months before a product is permanently discontinued.

    Also in the news:

    google launched a new campaign featuring women entrepreneurs in Africa, including the story of Vivian Nwakah who launched Medsaf, a pharmaceutical supply chain solution to help Nigerians access quality pharmaceutical healthcare.
    Pharmaceutical Logistics IQ has launched a new survey with SkyCell to get your perspective on the issues facing pharmaceutical supply chains today and the role hybrid container solutions could play. Share your thoughts with us and enter our draw to win a $100 Amazon gift card.

    Get exclusive access to articles, reports, videos, interviews, webinars and other members-only premium content from industry experts and thought leaders by signing up for Pharma Logistics IQ here.

    read more
    Medical supplies

    Chicago nurse helps collect donations for more than 150 suitcases of medical supplies destined for Ukraine

    CHICAGO — A Chicago nurse helped collect donations for 167 suitcases full of medical supplies to send to Ukraine.

    The luggage was filled with medical and surgical supplies to help civilians and soldiers.

    Jessica Szostak collected donations all week with the help of her family and friends. What started as a small collection has grown into thousands of medical supplies.

    “Kind of, what we really wanted to do was make suitcase first aid kits, so in a lot of them they have a bit of everything,” Szostak said.

    For Szostak, the actions were more than just a good deed — it’s personal to her. Szostak’s mother grew up in Poland and his aunt is still there, witnessing the refugee crisis firsthand.

    “Just because you’re halfway around the world doesn’t mean we’re not united,” Szostak said. “We always do our part, they are always our neighbors from the Polish point of view. We are doing what no one ever did for us in World War II. We have to do our part.

    Once Szostak, who is an intensive care nurse on the South Side, spread the word – the donations kept pouring in.

    The supplies were packed at her home and dropped off at O’Hare on Wednesday. The luggage will accompany a group of doctors with Med Global to survey the war zone and determine other means of providing medical assistance.

    “It’s just a small piece of the puzzle in the bigger picture, but even if it’s just this small piece, it’s a piece that can save someone’s life,” Szostak said. .

    The intention is to continue sending medical supplies with groups of doctors heading to Poland and Ukraine.

    read more
    Prescription drugs

    10 prescription drugs that cost Medicare the most


    “You certainly envision a significant impact on Medicare Part D spending, both on the program and on beneficiaries,” says Leigh Purvis, AARP’s director of healthcare cost and access. “It’s indicative of the larger problem where we’ve left pharma companies free to continue to engage in the kind of pricing behavior that has been problematic for so long.” New data from AARP shows that in January 2022, the average list price increase for the top 75 brand name drugs was 5.2%. Price increases ranged from 2% to 7.9%, and the prices of more than half (42 of 75) increased by 5% or more.As

    AARP’s Fair Rx Prices Now campaign has worked to convince lawmakers to allow Medicare to negotiate prices with pharmaceutical manufacturers, impose tax penalties on drug manufacturers who raise prices more than the inflation and to cap Part D disbursements.

    Here’s a look at the 10 drugs Medicare spent the most money on in 2020 and whose prices rose in January 2022.

    1. Equip

    • Use: A blood thinner for people with atrial fibrillation (A-fib)
    • Health insurance expenditure in 2020: $9.9 billion
    • Number of beneficiaries: 2,641,941
    • January 2022 price increase: 6 percent

    2. Revlimid

    • Use: To treat cancer
    • Health insurance expenditure in 2020: $5.4 billion
    • Number of beneficiaries: 43,747
    • January 2022 price increase: 4.5%

    3. Xarelto

    • Use: A blood thinner for people with atrial fibrillation (A-fib)
    • Health insurance expenditure in 2020: $4.7 billion
    • Number of beneficiaries: 1,184,718
    • January 2022 price increase: 4.9%

    4. Januvia

    • Use: To treat diabetes
    • Health insurance expenditure in 2020: $3.9 billion
    • Number of beneficiaries: 934 686
    • January 2022 price increase: 5 percent

    5. Truth

    • Use: To treat diabetes
    • Health insurance expenditure in 2020: $3.3 billion
    • Number of beneficiaries: 497 327
    • January 2022 price increase: 5 percent

    6. Imbruvic

    • Use: To treat cancer
    • Health insurance expenditure in 2020: $3 billion
    • Number of beneficiaries: 26,847
    • January 2022 price increase: 7.4%

    7. Gardening

    • Use: To treat diabetes
    • Health insurance expenditure in 2020: $2.4 billion
    • Number of beneficiaries: 594 859
    • January 2022 price increase: 4 percent

    8. Humira Pen (Cf)

    • Use: To treat rheumatoid arthritis, plaque psoriasis
    • Health insurance expenditure in 2020: $2.2 billion
    • Number of beneficiaries: 42,406
    • January 2022 price increase: 7.4%

    9. Ibrance

    • Use: To treat cancer
    • Health insurance expenditure in 2020: $2.1 billion
    • Number of beneficiaries: 21,394
    • January 2022 price increase: 6.9%

    10. Symbicort

    • Use: To treat asthma
    • Health insurance expenditure in 2020: $2 billion
    • Number of beneficiaries: 1,017,530
    • January 2022 price increase: 2 percent

    Dena Bunis covers Medicare, health care, health policy and Congress. She also writes the “Medicare Made Easy” column for the AARP Newsletter. An award-winning journalist, Bunis has spent decades working for metropolitan dailies, including as Washington bureau chief for the Orange County Register and as a health and workplace policy maker for press day.

    read more
    Medical products

    “Shortage” of medical products in Ukraine – WHO

    There is a “shortage” of essential medical supplies in Ukraine, health officials have warned in condemning at least 16 attacks on health services in the country.

    The World Health Organization (WHO) said there had been 16 attacks on health services, including damage to facilities and hospitals, as well as the commandeering of ambulances and the hijacking of ambulances from ’emergency.

    These attacks left nine dead and 16 injured, according to the WHO.

    The European branch of the global health body also said there was a shortage of essential supplies in Ukraine, including oxygen, insulin, surgical supplies and blood.

    (PA graphics)

    (PA graphics)

    Experts have also warned that Covid deaths will rise due to a lack of oxygen supply in the region – with 731 deaths reported last week.

    Meanwhile, health officials have raised concerns about cases of hypothermia – where a person’s body temperature becomes dangerously low – among refugees in cold weather.

    They also highlighted fears over maternity care for pregnant Ukrainian women, with around 80,000 women expected to give birth in the country in the next three months.

    During a press briefing on the humanitarian crisis that resulted from the conflict, Dr Hans Henri Kluge, WHO Regional Director for Europe, said: “It is now 13 days since the military offensive began in Ukraine, and today in the country, we see a healthcare system under great pressure, and beyond its borders, the fastest growing refugee crisis in Europe for more than 75 years.

    “Life-saving essential medicines, such as oxygen and insulin, personal protective equipment, surgical supplies, anesthetics and safe blood products, are in short supply.”

    He said 76 tons of trauma and emergency health supplies are in transit in Ukraine, with more on the way.

    WHO is also working to ensure that refugees crossing the border have access to health care and that those who remain in the country also receive support.

    Dr Kluge added: “It should not be necessary to say that health workers, hospitals and other medical establishments should never be a target at any time, including during crises and conflicts. To date, we have 16 confirmed reports of health incidents in Ukraine, with more being verified.



    We know from previous conflicts that when more doors close, health diplomacy becomes key

    Dr Hans Henri Kluge, WHO Regional Director for Europe

    “WHO strongly condemns these attacks on health services.”

    Dr Catherine Smallwood, WHO Europe Incident Manager for Covid-19, said: “We have documented or verified 16 attacks with varying levels of certainty.

    “These have, to our knowledge, caused at least nine deaths and 16 injuries, and they have occurred in various major cities and around conflict zones.

    “This includes direct attacks on health facilities or hospitals that have been damaged.

    “It also includes the appropriation of health infrastructure such as ambulances, it includes the diversion of ambulances and their use for purposes not directly related to the provision of health care.”

    Dr Kluge praised Ukrainian health officials for continuing to monitor the spread of Covid-19, but added that “731 Covid-19 deaths were reported to WHO from Ukraine last week, and unfortunately, that number will increase as oxygen shortages continue.”

    He said: “Older people will be disproportionately affected because their access to healthcare is disrupted and because only a third of those over 60 are fully protected with a full course of vaccines.”

    Asked about the humanitarian corridors, Dr Kluge said: “Time is running out, so in that sense, willy-nilly, we need to get whatever we can to the affected areas.

    (PA graphics)

    (PA graphics)

    “We know from previous conflicts that when more doors close, health diplomacy becomes key.

    “Our principle is health for all and our top priority is to get life-saving humanitarian medical supplies to people in need.”

    On maternity care, Dr Isabel Yordi Aguirre, WHO Europe Technical Officer for Gender and Human Rights, said: “The estimate from UNFPA (United Nations Population Fund ) that 80,000 women will give birth in the next three months in Ukraine means that these women may have gone from a life-changing experience to a life-threatening experience.

    “The UNHCR (UN Refugee Agency) predicts that by July this year we will have four million refugees, which will mean around 1,000 births per week that will be anticipated.

    “That’s why we must ensure that sexual and reproductive health services are at the heart of our assistance to women – refugees crossing borders and women left behind.”

    Tarik Jasarevic, WHO Field Representative in Ukraine, said at the briefing: “It is heartbreaking to see hundreds, if not thousands, of people on the border between Ukraine and Poland – mainly women and children seeking treatment and seeking safety.



    Health facilities need supplies, they need electricity, they need water

    Tarik Jasarevic, WHO representative in Ukraine

    He added: “In the east, hundreds of health facilities are either areas that have changed control or are along the battle lines or within 10 kilometers of them.

    “Health facilities need supplies, they need electricity, they need water.

    “I have just spoken to a doctor who is in contact with his colleagues in the most affected areas in the East and she was telling me that people cannot access health centers and hospitals because of security and the structural damage.

    “And this is not just the case for patients but also for health workers who risk their lives to get to their place of work.”

    read more
    Medical supplies

    Two women from Mass. travel to the Ukrainian border to deliver medical supplies

    BOSTON, MASS. (WLNE)- Two Massachusetts women of Ukrainian descent make a special delivery in war-torn Ukraine.

    Ulana Nosal and Terry Reid have hopped on a plane to Poland and plan to deliver six duffel bags full of medical supplies to help refugees, on behalf of the Sunflower of Peace organization.

    Natives of North Attleboro and Walpole say this is a personal mission for them.

    Nosal came to the United States from Ukraine when she was 12 years old, and Reids’ grandmother is from Ukraine.

    “I’m preparing for this, it’s what I was taught to do, I don’t know how to do anything but fight in a certain way,” Reid says.

    Once in Poland, the two women will drive for hours and deliver supplies directly to the border.

    “Surrounding countries are running out of their product and some fear they may even be running out,” says Nosal.

    Thanks to generous donations, they then plan to pick up families at the border, feed them and help them find accommodation.

    Nosal and Reid said they had to take action to help Ukrainians and are grateful to everyone who helped.

    “The money just started coming in,” Nosal said. “Our Venmos are exploding and people really want to help.”

    If you would like to donate to help with housing, you can donate to the Ukrainian American Youth Association Boston through Venmo @CYM-Boston.

    read more
    Prescription drugs

    Reduce prescription drug costs

    The cost of prescription drugs is too high in this country. We know Ohioans are concerned about the cost of living right now, and one of the worst inflations we see, year after year, is drug prices. And often the culprit is price hikes by big pharma.

    That is why I introduced the Affordable Medicines Act. It would penalize drug companies that raise the price of their drugs without justification, and it would finally allow Medicare to negotiate lower drug prices for American seniors.

    My entire career I’ve pushed for allowing Medicare to negotiate directly with drug companies for lower prices. Currently, the Secretary of Health and Human Services is prohibited from negotiating better prices for Americans on Medicare like VAs or private companies do.

    It is not a mistake that the law protects the profits of big pharmaceutical companies, to the direct detriment of patients. The pharmaceutical companies were there when this law was drafted. And it’s something I’ve been fighting to fix ever since. And with the cost of living hitting American retirees on fixed incomes particularly hard, now is the time to do so.

    We also know that some companies increase the price of drugs year after year, even though the drug costs the same to produce. Many of these companies do not create new drugs or invest in innovation – they simply buy the rights to existing drugs from other companies; dismiss workers; multiply prices by eight, nine or ten; and then expecting patients, hospitals and taxpayers to foot the bill.

    If drug companies raise prices at twice the rate of inflation for no other reason than to increase their bottom line at the expense of sick Americans, then that’s a price hike, and they should pay the price.

    AARP recently released a study showing that between 2019 and 2020, the price of more than 250 brand name prescription drugs widely used by older Americans rose more than twice as fast as overall inflation.

    We have to control these prices.

    We know high drug costs are a problem. We know how to fix it: we let Medicare negotiate, we penalize companies that price-gouging, and we cap out-of-pocket expenses.

    The purpose of prescription drugs is to help Ohioans live longer, healthier lives, not to line the pockets of Big Pharma executives.

    President Biden has made it clear in the State of the Union that this is a priority, and I will work to make it happen.

    Brown-062609-18446-0008

    Sherrod Brown is the senior US senator from Ohio.

    read more
    Generic drugs

    Generic Drugs Market 2022 Size, Manufactures, Types, Applications, Opportunities, Challenges and Forecast 2027

    Absolute Reports Pvt Ltd

    Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical, Pfizer, Sanofi, Lupin

    Pune, March 07, 2022 (GLOBE NEWSWIRE) — Generic drugs market The 2022 Research Report gives experts an analysis of the current global market size estimation, market scenario, structure, products, major industry players, segmentation by types, applications . The Generic Drugs market report covers the dynamics which are having a strong impact on the Generic Drugs market and may also impact its future development. Growth-driving dynamics, market restraints, and recent growths have also been analyzed in the report to provide in-depth industry data.

    A generic drug is a pharmaceutical drug that is equivalent to a brand name product in terms of dosage, strength, route of administration, quality, performance, and intended use. The term can also refer to any drug marketed under its chemical name without advertising, or the chemical composition of a drug rather than the brand name under which the drug is sold.

    Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the industry leaders with approximately 19% market share.

    Get a sample copy of the report at – https://www.absolutereports.com/enquiry/request-sample/19859268

    North America is the largest consumer location, with a market share of almost 44%. After North America, Europe is the second place of consumption with a market share of 18%.

    The global generic drugs market size is expected to reach USD 505790 million by 2027, from USD 281010 million in 2020, at a CAGR of 8.3% during the period 2021-2027.

    With industry-standard analytical accuracy and high data integrity, the report brilliantly attempts to unveil major opportunities available in the global Generic Drugs market to help players gain a strong position in the market. Buyers of the report can access verified and reliable market forecasts including those regarding the overall size of the global generic drugs market in terms of revenue.

    Market segmentation : –

    The Generic Drugs Market report provides an analysis of key trends in each sub-segment of the global Generic Drugs report, with estimates for development at global, regional and country levels and categorized the market based on product type and apps.

    Segment by type

    • Order

    • Medicines without a prescription

    Segment by application

    Inquire or share your questions, if any, before purchasing this report: https://www.absolutereports.com/enquiry/pre-order-enquiry/19859268

    The leading companies in the market mainly focus on new ideas associated with the invention and supply of generic drugs. These policies will allow major players to expand their trading boundaries and increase their market position. Here are some of the major players in the Generic Drugs market:

    By company

    By region

    • North America

    • we

    • Canada

    • Europe

    • Germany

    • France

    • UK

    • Italy

    • Russia

    • Nordic

    • The rest of Europe

    • Asia Pacific

    • China

    • Japan

    • South Korea

    • South East Asia

    To understand how the impact of Covid-19 is covered in this report: https://www.absolutereports.com/enquiry/request-covid19/19859268

    TOC of Global Generic Drugs Market Size, Status and Forecast 2022

    1 Presentation of the report

    1.1 Scope of the study

    1.2 Market Analysis by Type

    1.2.1 Global Generic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

    1.2.2 Type 1

    1.2.3 Type 2

    1.3 Market by Application

    1.3.1 Global Generic Drugs Market Share by Application: 2016 VS 2021 VS 2027

    1.3.2 Request 1

    1.3.3 Request 2

    1.4 Objectives of the study

    1.5 years considered

    2 Global Growth Trends

    2.1 Global Generic Drugs Market Outlook (2016-2027)

    2.2 Generic Drugs Growth Trends by Regions

    2.2.1 Generic Drugs Market Size by Regions: 2016 VS 2021 VS 2027

    2.2.2 Generic Drugs Historic Market Share by Regions (2016-2021)

    2.2.3 Generic Drugs Forecasted Market Size by Regions (2022-2027)

    2.3 Dynamics of the generic drugs sector

    2.3.1 Generic Drug Market Trends

    2.3.2 Generic Drugs Market Drivers

    2.3.3 Generic Drugs Market Challenges

    2.3.4 Generic Drugs Market Constraints

    3 Competition Landscape by Key Players

    3.1 Global Top Generic Drugs Players by Revenue

    3.1.1 Global Top Generic Drugs Players by Revenue (2016-2021)

    3.1.2 Global Generic Drug Revenue Market Share by Players (2016-2021)

    3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    3.3 Players covered: classification by revenue of generic drugs

    3.4 Global Generic Drugs Market Concentration Ratio

    3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)

    3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2020

    3.5 Generic Drugs Key Players Head office and Area Served

    3.6 Key Players Generic Drug Product Solution and Service

    3.7 Date of Entry into the Generic Drugs Market

    3.8 Mergers and acquisitions, expansion plans

    Generic Drugs Market Research Report Questions Answered:

    • What is the size of the generic drugs market?

    • What are the market driving factors behind the Generic Drugs market?

    • What are the market trends and forecasts for the global Generic Drugs market?

    • What are the trends and forecasts based on market research and analysis of generic drugs market segmentation by type, application, geography?

    • What are the world’s leading generic drug companies?

    • What is the CAGR and revenue expected in the future?

    Buy this report (Price 3900 USD for single user license) – https://www.absolutereports.com/checkout/19859268

    About absolute ratios:

    Absolute Reports is a premium platform to help key business personnel strategize and make visionary decisions based on facts and figures from in-depth market research. We are one of the best report resellers in the market, dedicated to bringing you an ingenious concoction of data metrics.

    CONTACT: Contact Us: Absolute Reports Phone : US +1 424 253 0807 UK +44 203 239 8187 Email : [email protected] Web : https://www.absolutereports.com
    read more
    Medical supplies

    You can donate medical supplies from Amazon with the charity UnitedWithUkraine

    As the Conflict between Ukraine and Russia continues, charities across the UK are raising funds to donate to those in need.

    Whether it’s for displaced families, financial support or medical supplies, all kinds of charities are making sure that this aid reaches those in need.

    But when you donate items, how do you know what is really needed?

    Charitable organisation, UnitedWithUkraine turned into an international aid organization almost overnight.

    It allows people to buy items that have been selected by medical teams across the UK and Ukraine, so you can donate what’s really needed.

    You place the order through Amazon where a list is updated daily, and your donated item will be routed to those in need across Ukraine.

    Orders are delivered to UnitedWithUkraine headquarters, where items are then sorted, categorized, and boxed to ensure they are accessible when they reach their destination.

    Items requested include treatments for type 1 diabetes, as many people in Ukraine do not have access to insulin, blood sugar monitoring or any other treatment.

    Charlie Cawsey, co-founder of the association, explained in a YouTube video that it was a personal connection with type 1 diabetes that inspired this organization.

    When his fiancée, Emma, ​​suffered a bout of hypoglycemia (low blood sugar) in the middle of the night, he had to get sugary foods to help stabilize his blood sugar.

    The ease with which he was able to do this made him think of diabetics in Ukraine who may not have the supplies to treat this.

    It inspired the idea. Cawsey made a simple social media post, and she immediately “went crazy.”

    Starting in a small storage space in Kent, in the coming days the charity will be based at Manson Airport, allowing them to dispatch even more aid to those in need.

    Cash donations can also be made on the the charity’s website. Financial donations go to hard-to-find items which are listed on the site like insulin and other drugs.

    The supply list is updated daily. You can place your order on the Amazon site here.

    read more
    Prescription drugs

    Rising cost of prescription drugs is a concern | News

    WASHINGTON, DC – Although current prices have recently skyrocketed due to inflation and global issues, they pale in comparison to the rise in prescription drugs.

    “For years, increases in prescription drug prices have eclipsed even the highest rates of inflation,” said Holly Holtzer, director of Ohio AARP.

    “To give you an example, if consumer prices had risen as fast as drug prices over the past 15 years, gasoline would now cost $12.20 a gallon and milk $13 a gallon,” he said. she added.

    Holtzer said last month that major drugmakers had hiked prices on 800 prescription drugs.

    “They’ve imposed similar increases for decades with no effective way to stop them from raising prices for American seniors,” Holtzer said.

    She said her organization frequently hears of older Americans in Ohio having to choose whether to pay for medicine or for food and heat.

    In an attempt to alleviate the problem, U.S. Senator Sherrod Brown, D-Ohio, introduced the Affordable Medicines Act, which would penalize drug companies that raise the price of their drugs without justification and also end the restriction that prevents Medicare to negotiate lower prices. prizes for beneficiaries.

    “It is no mistake that current law protects the profits of Big Pharma, to the direct detriment of patients, by prohibiting the government from negotiating better prices for the American people,” Brown said. “The pharmaceutical companies were in the room when this law was written.”

    Holtzer said giving Medicare the ability to negotiate would lower prices.

    Brown also supports other efforts to reduce the cost of health care for workers in Ohio by capping the cost of insulin at $35 per month, imposing penalties on drugmakers who raise prices at above inflation and capping out-of-pocket expenses for Medicare beneficiaries at $2,000 per month. year.

    “The point of prescription drugs is to allow (people) to live longer, healthier lives, not to make a bunch of drug company executives in New Jersey and elsewhere much richer,” Brown said.

    “Congress has promised for years to lower the price of prescription drugs,” Holtzer said. “For any member of Congress concerned about inflation, lowering drug prices should be high on the to-do list.”

    On Wednesday, Ohio AARP presented members of Congress with a petition signed by 182,000 Ohioans calling on lawmakers to act on prescription drug prices.

    read more
    Medical supplies

    Medical supplies head to Ukraine from Rochester – Reuters

    ROCHESTER — The first of what will likely be many trucks of medical supplies from the Rochester Medical and Relief Mission Group to Ukraine departed Friday afternoon.

    Roman Kowalchuk, originally from Ukraine, searched the Mission’s warehouse for items specifically requested by the Ukrainian Ministry of Defense and Ukrainian hospitals.

    Kowalchuk has family in Ukraine who are unhurt on Friday but determined to stay in the country, he said.

    With heavy fighting and mounting civilian casualties across Ukraine since Russia invaded the country on February 24, it would be easy to assume that anything and everything would help.

    Kowalchuk said that’s not necessarily the case.

    “We don’t want to inundate them with things they already have,” he said.

    The lists ask for surgical kits, hemostats, which are drugs that help with bleeding, and anything that helps stop bleeding. Oxygen is another important need, he added.

    A volunteer helping pack the pallets heard Kowalchuk’s list and showed him an oxygen concentrator. Kowalchuk plugged the machine into a wall outlet to confirm it was working and got it ready for a truck arriving Friday afternoon to ship the supplies to Chicago.

    Roman Kowalchuk tests an oxygen concentrator in the Rochester Medical and Relief Mission Group medical supply warehouse. The machine was one of the pieces of medical equipment that Kowalchuk and other volunteers needed to be shipped to Chicago. From there, the Ukrainian Medical Association of North America will help distribute the supplies to where they are needed.

    John Molseed / Post Bulletin

    From there, the Ukrainian Medical Association of North America will distribute the supplies directly to Ukrainian hospitals and the Ministry of Health.

    The Rochester Medical and Relief Mission Group was founded over 42 years ago. Leon Wagner, co-founder, is 95 but was eager for a quick tour of the Mission’s medical supply warehouse.

    About 95% of the supplies are donated by the Mayo Clinic. The group sends supplies around the world to where they are needed as well as to local groups that help people in need of medical supplies, said Diane Wagner, who coordinates the group.

    Kowalchuk, who is a radiation oncology resident at the Mayo Clinic, said he heard about the group from a colleague who helped bring medical supplies to Ghana.

    The shipment that left the warehouse on Friday will likely be the first in a long line. People interested in helping with the effort can contact Rochester Medical and Relief Mission Group at (507) 282-3634 or email Diage Wagner at [email protected]

    read more
    Medical supplies

    From Dublin with love as four guys bring in drones and medical supplies

    Tight rows of cots stretch across Medyka’s huge gym. Against a wall, there are mattresses on the floor. A blanket, pillow and clean towels are on each bed.

    oys throw soccer balls at the basketball hoops hanging on the wall. In the furthest corner, Polish volunteers run a crèche to entertain the little ones and babies for a while.

    read more
    Medical products

    Stereotactic Biopsy Table Market Size 2022-2029

    New Jersey, United States,-Global Stereotactic Biopsy Table Market Size, Status and Forecast 2022-2028. This research report covers key aspects of the Stereotactic Biopsy Table market including drivers, limitations, past and current trends, regulatory scenarios, and technological developments. An in-depth study of industry’s role in the COVID-19 outbreak. A comprehensive risk assessment and industry recommendations have been made for market research reports and industry analysis over a specific period of time. The report compares the market before Corona 19 and after Corona 19. The impact of COVID-19 on the local economy is also considered in the study.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=448109

    The term Based Stereotactic Biopsy Table market study provides helpful insights such as studying the effects on significant aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights features which limit demand growth, adequately predict Stereotactic Biopsy Table Market quantities, and have long term effects over the predicted period.

    The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

    Major Players Covered in Stereotactic Biopsy Tables Markets:

    • MPI Medical
    • Devicor medical products
    • Siemens
    • Aurora imaging technology
    • Hological
    • Planmeca
    • Metaltronics

    Stereotactic Biopsy Tables Market Split By Type:

    • Mechanically operated stereotactic biopsy table
    • Electronically controlled stereotactic biopsy table

    Stereotactic Biopsy Tables Market Split By Applications:

    • Hospital
    • diagnostic center
    • Others

    The Stereotactic Biopsy Table market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Stereotactic Biopsy Tables Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Stereotactic Biopsy Tables market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=448109

    Scope of the Stereotactic Biopsy Tables Market Report

    Report attribute Details
    Market size available for years 2022 – 2029
    Base year considered 2022
    Historical data 2019 – 2021
    Forecast period 2022 – 2029
    Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Market Analysis Stereotaxic Biopsy Chart can be represented as follows:

    Each regional Stereotaxic Biopsy Table sector is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global stereotaxic biopsy table market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-stereotactic-biopsy-table-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US Toll Free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Non-prescription Drug Consumption Market Size 2022-2029

    New Jersey, United States,-Global Non-prescription Drug Consumption Market Size, Status and Forecast 2022-2028. This research report covers key aspects of the Non-Prescription Drug Consumption market, including drivers, limitations, past and current trends, regulatory scenarios, and technological developments. An in-depth study of industry’s role in the COVID-19 outbreak. A comprehensive risk assessment and industry recommendations have been made for market research reports and industry analysis over a specific period of time. The report compares the market before Corona 19 and after Corona 19. The impact of COVID-19 on the local economy is also considered in the study.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=419998

    The term based Non Prescription Drug Consumption market research provides useful insights such as the study of the effects on important aspects, alternatives, and restraints. Graphical analysis of the Emotion Detection and Recognition demand forecasts for the predicted periods can demonstrate the financial requirements of the global Emotion Detection and Recognition industry. Likewise, the study highlights the features which limit the demand growth, adequately predict the OTC Drug Consumption market quantities and have long term effects over the predicted period.

    The impact of the Corona 19 outbreak on the global Emotion Sensing and Awareness industry, growth rates, correct supply chain analysis, scale in various scenarios, and responses Corporate critiques of the outbreak are all examined in research on emotion sensing and sensitization. The research focuses on emotion detection and recognition in global markets, particularly in North America, Europe and the Asia-Pacific region, as well as South America, the Middle East and Africa. The study divides the market into four parts: manufacturer, region, type and application.

    Major Players Covered in Non-prescription Drug Consumption Markets:

    • Pfizer
    • rock
    • Sanofi
    • Johnson & Johnson
    • Merck & Co. (MSD)
    • Novartis
    • AbbVie
    • Gilead Sciences
    • GlaxoSmithKline (GSK)
    • Amgen
    • Astra Zeneca
    • Bristol Myers Squibb
    • Eli Lily
    • Suits you
    • Bayer
    • Novo Nordisk
    • Allergan
    • County
    • Boehringer Ingelheim
    • Takeda

    Non-Prescription Drug Consumption Market Breakdown by Type:

    Non-prescription Drug Consumption Market Split By Application:

    The Non-Prescription Drug Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Non-Prescription Drug Consumption Market in the coming years. This segmental analysis will surely prove a useful tool for readers, stakeholders, and market players to get a complete picture of the global Non-Prescription Drug Consumption market and its growth potential in the coming years. .

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=419998

    Scope of Non-Prescription Drug Consumption Market Report

    Report attribute Details
    Market size available for years 2022 – 2029
    Reference year considered 2022
    Historical data 2019 – 2021
    Forecast period 2022 – 2029
    Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Market Analysis OTC Drug Consumption can be represented as follows:

    Each regional Non-Prescription Drug Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global non-prescription drug consumption market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-non-prescription-drugs-consumption-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical products

    Dale Medical Products, Inc. Becomes 100% Employee-Owned

    John Brezak commented on Dale’s story; “Since our founding in 1961 and as Chairman since 1997, my philosophy has been to empower our people to make our products and to work with our suppliers and customers as if they were direct Dale stakeholders. I am extremely pleased that my vision has become fully realized. Our employees can now have an added level of confidence that Dale is here to meet the needs of its customers over a much longer horizon. I am thrilled to sell the business to our employees themselves, so they can continue our Dale brand, our vision and our unity as a unique company and culture.”

    Bob SimpsonDale’s new President and CEO comments “As an employee-owned company, we will uphold Dale’s heritage of providing highly reliable medical products to help caregivers and patients around the world. Our employees have always been extremely proud of the positive impact we have on patient care, and now they can benefit even more as stakeholders in our business.”

    Dale Medical Products, Inc. was founded in 1961, in Sharon, MA. From humble beginnings, the company has become an industry leader in the market niches it serves around the world. Today, Dale is headquartered in Franklin, Mass. where their headquarters and manufacturing facilities are located. Dale Medical Products, Inc. is an ISO 13485 registered company.

    For more information, please see www.dalemed.com or call 800-343-3980.

    SOURCEDale Medical Products, Inc.

    read more
    Generic drugs

    Savings on Generic Drugs Continue to Grow, Says Canadian Pharmacy Intermediary SaveRxCanada.to

    VANCOUVER, BC, March 3, 2022 /PRNewswire/ — SaveRxCanada.to, a Leading Canadian Pharma Intermediary Since 2002, Continues to See an Uptrend Among Americans buy generic drugs. Generic drugs contain the same active ingredients with the same strength and purity as their brand name counterparts, but at a fraction of the cost.

    the Rx Select The SaveRxCanada program was one of the first programs of its kind launched in 2004 to provide access to generic drugs. By adding several international pharmacies to their network, patients were able to find many generic and branded drugs not available in Canada.

    The RxSelect program offers free shipping and 5% in rewards points that can be redeemed on future orders.

    In United States76 million patients consult at least one prescription drug in 2020.

    the 2021 U.S. Generic and Biosimilar Drug Savings Report highlighted the increased cost savings on generic drugs. Some key research findings:

    • $338 billion: US healthcare system savings
    • 90%: Portion of U.S. prescriptions filled with generic drugs
    • $6.61: The average generic share
    • $7.9 billion: savings on biosimilars
    • $109.6 billion: Medicare savings

    The savings of individual consumers and the health care system as a whole continue to grow, reaching $338 billion in 2020. Tens of millions of Americans trust their health to generics and biosimilars. These savings are the main component of an often overlooked success story in public health.

    About SaveRxCanada.to

    SaveRxCanada.to has been a reliable, affordable and reliable Canadian pharmaceutical intermediary for over 18 years.

    The company is committed to providing affordable prescription drugs to patients around the world through its network of licensed Canadian pharmacies and international pharmacies.

    Visit SaveRxCanada.to to learn more about the company.

    Customer service

    Toll free: 1-866-799-3435 – Use reference #100048
    Monday Friday 9:00 a.m. to 5:00 p.m. (EST)

    All orders required a valid prescription from a licensed physician or physician.

    This press release was published via 24-7PressRelease.com. For more information, visit http://www.24-7pressrelease.com.

    SOURCESaveRxCanada.com

    read more
    Medical supplies

    Drugmakers and device makers say sanctions could hamper medical supply in Russia

    March 3 (Reuters) – Western drugmakers and medical device companies are warning that their plans to continue selling products to Russia could be complicated by economic sanctions targeting the country and its major banks as punishment over Moscow’s invasion of Ukraine.

    Sanctions imposed by the United States, Britain, Europe and Canada against Russia do not apply to medicines and medical equipment, and the industry has a responsibility under international humanitarian law to to continue supplying these products, said industry trade groups, policy experts and business officials.

    International aid groups are pushing for essential medicines to keep flowing into Ukraine, where Russian troops are seeking to take control of major cities, prompting more than 870,000 Ukrainians to flee their country and millions to shelter from airstrikes. Already, pharmacies are reporting shortages of medical supplies. Read more .

    Join now for FREE unlimited access to Reuters.com

    Register

    Many Western companies have said they will stop selling everything from cars to movies in Russia. Transactions related to drugs and medical devices, as well as food, were permitted despite US and EU sanctions.

    But the sanctions that have cut off Russian banks from the international financial system, as well as decisions by major shipping companies to suspend services to the country, could also hamper the delivery of medical supplies.

    The withdrawal of seven Russian banks from the SWIFT international payment system – as well as the ongoing assault on Ukraine – could cause disruptions, said MedTechEurope, the European lobby group for medical device companies. Without access to this payment system, it becomes more difficult to transact with Russia. Read more

    “The freezing of bank transfers could indeed have an impact on the export of medical devices from the EU to Russia, and we are actively examining the extent of this and will see how the situation develops,” the spokesperson said. of MedTechEurope.

    In a statement, the European Federation of Pharmaceutical Industries and Associations called for the safe passage of medicines and vaccines to people in need in Ukraine, neighboring EU member states and Russia.

    US pharmaceutical industry group PhRMA said it supported maintaining exemption from all sanctions for drugs and the materials needed to make them.

    Under international humanitarian law, everyone has the right to access essential medical services and supplies, including medicines and vaccines, said Lawrence Gostin, a public health law expert at Georgetown University.

    “In times of conflict, this right to uninterrupted access to essential medical supplies has often been violated,” Gostin said. “Governments imposing sanctions are also supposed to make an exception for medical supplies. Yet sanctions often disrupt medical services and supply chains.”

    The United States, in a general license issued last week, authorized transactions related to the export or re-export of drugs and medical devices with Russia. It also issued exclusions for energy-related payments and international organizations, among others.

    The US Treasury Department declined to comment on the matter.

    The EU supplied Russia with 6.5 billion euros ($7.23 billion) worth of pharmaceuticals in 2020, around 8.4% of the region’s total exports to Russia, according to data from Eurostat. It sent around 1.6 billion euros worth of medical equipment to the country in the 12 months ending in September 2021, according to MedTech Europe.

    US government data shows that in 2021, pharmaceuticals and medical equipment accounted for about 8% of all US goods exported to Russia. It sent $355 million in medicine and $157 million in medical equipment to the country.

    Reuters Charts

    Leading shipping group AP Moller-Maersk (MAERSKb.CO) warned on Wednesday that shipments to Russia, including medical supplies, risk being damaged or spoiled due to significant delays at ports and customs. Read more

    Drugmakers including Switzerland’s Novartis (NOVN.S), Denmark’s Novo Nordisk (NOVOb.CO) and Lundbeck, Britain’s GlaxoSmithKline (GSK.L) and America’s Eli Lilly, said they were working guarantee patients continuous access to their medicines.

    Novo Nordisk, the world’s largest maker of diabetes drugs, said it would do “everything we can to maintain supply in Ukraine and Russia”, but it expects sanctions will make that more difficult. He has had problems delivering medicine to Ukraine before.

    “The supply of medicines may be indirectly affected by sanctions in other areas, and we will do everything possible to ensure that Russian citizens receive their life-saving medicines,” Novo Nordisk said in an emailed statement.

    Lundbeck, which specializes in treatments for depression, said it will continue to serve patients who need medication in Russia.

    “As long as we can get medicine to patients in Russia under the current sanctions, we will,” Chief Commercial Officer Jacob Tolstrup said in a written comment.

    Join now for FREE unlimited access to Reuters.com

    Register

    Reporting by Francesco Guarascio in Brussels, Michael Erman in New Jersey and Stine Jacobsen in Copenhagen; Additional reporting by Jennifer Rigby in London, Jason Lange and Daphne Psaledakis in Washington, Julie Steenhuysen in Chicago and Dan Burns in New York; Editing by Caroline Humer and Bill Berkrot

    Our standards: The Thomson Reuters Trust Principles.

    read more
    Prescription drugs

    Manchin presents a Democratic bill he can support: taxes, prescription drugs, climate cash

    “If you do that, the revenue producing [measures] would be taxes and drugs. Spending will be climate-related,” Manchin said.

    “And social issues, we basically have to deal with them” afterwards, he added.

    Manchin, who also chairs the Senate Energy Committee, said the climate portion of any moot bill will be different now that Russia is invading Ukraine. He calls on the United States to ban oil imports from Russia and increase domestic energy production, including fossil fuels. He would back big investments in clean energy as part of a potential deal, he said, but wants domestic oil, gas and coal production to remain a big part of the mix.

    “Do you want to be able to defend your people, have reliable, reliable and affordable energy? You have to use “all of the above,” Manchin said, defending his support for clean energy investments. “They say ‘Manchin doesn’t care… he’s killing the environment.’ I don’t kill anything.

    Though he prefers everything in Congress to be bipartisan, Manchin said he’s “come to this conclusion” that changing the tax code so the wealthy and corporations pay their fair share can only be done with Democratic votes. On whether he thinks his party finally understands its parameters for joining the talks, he said Democrats “know where I am. They just think I’m going to change.

    To realize Manchin’s vision, Democrats would also have to negotiate with the senator. Kirsten Sinema (D-Arizona) who last year steered the party toward surtaxes and minimum corporate taxes — and away from raising personal and corporate tax rates. Manchin acknowledged that he and Sinema “might have a different take on this whole thing”, but did not see it as fatal to future negotiations.

    Asked about Manchin’s much narrower proposal, Rep. Barbara Lee (D-California) scoffed, saying that would not satisfy many frustrated Liberals in the House. She seemed more interested in trying to change Manchin’s mind about expanding the child tax credit and other national programs than agreeing to his plan.

    “I hope he reconsiders and realizes how many people are being left behind,” Lee said. “We have to keep going and try to get everything we can get.”

    But other progressives are willing to accept just about anything they can do with just 50 Senate Democrats and a slim majority in the House. After all, the midterm reviews are now eight months away; recreating the momentum to put a big bill on the floor can take months.

    “We just have to fish or cut the bait on reconciliation. Enough of that,” the senator said. Elizabeth Warren (D-Mass.). there are so many things we all agree on, that we should be able to reach a deal, bring it together and do it”

    Biden’s State of the Union address called for congressional action on some of the individual parts of the sweeping social spending measure the House passed last year, including drug pricing, childcare, and more. children, tax hikes on the rich and climate change. The momentum Democrats had garnered for their trillion-plus proposal has largely evaporated, and some lawmakers are increasingly open to slimmed-down legislation or even stand-alone bills to respond. to their political priorities.

    “I basically said as far as I’m concerned, it’ll be like found money if we find anything,” the Senate Majority Whip said. Dick Durbin. “I assume nothing with a reconciliation bill. [Expectations are] as low as they go.

    And while Manchin said no “formal” discussions were taking place with the White House, there were “informal back and forths.” He declined to say if he had spoken to Biden about it recently: “Various members of the White House contact us, and we talk from time to time.”

    Meanwhile, aggravation with the senator from West Virginia remains high in the House, where members saw no action on the multi-trillion-dollar social spending plan that required them to burn huge amounts of political capital to be adopted.

    “I think Mr. Manchin is a good, decent man who is out of step with the goals of the American public,” the rep said. Emmanuel Cleaver (D-Mo.) said, adding that he was unaware of any of Manchin’s recent pivots toward energy or deficit reduction.

    Sarah Ferris contributed to this report.

    read more
    Medical products

    Summit Medical Products, Taizhou Pinqing – business philosophy

    The updated Analgesic Infusion Pumps Market report gives an accurate analysis of the value chain assessment for the review period of 2022 to 2027. The research includes comprehensive administration assessment of major companies market and their revenue-generating business strategies adopted by to conduct sustainable business. The Services industry report further lists market gaps, stability, growth drivers, restraining factors, opportunities for the projected period.

    Get a sample report with the latest industry trend analysis:

    https://www.a2zmarketresearch.com/sample-request/313749

    Leading companies in this report include: Summit Medical Products, Taizhou Pinqing, B. Braun, KD Scientific, Smiths Medical, Medtronic, Woo Young Medical, Hospira, Terumo, CareFusion (BD), Baxter, Fresenius Kabi.

    The global analgesic infusion pump market is expected to register a notable expansion in the market of XX% during the considered period due to the highest market value in 2022. The market research provides measure of product effectiveness, real-time Analgesic Infusion Pumps market scenario, along with customized facility . The study further offers market analysis, strategies and planning, R&D landscape, target audience management, market potential, due diligence and competitive landscape.

    Report Scope:

    An in-depth statistical analysis of current and emerging trends offers insights into the Analgesic Infusion Pump market dynamics. The report includes Porter’s five forces to analyze the importance of various characteristics such as understanding suppliers and customers, risks posed by various agents, strength of competition and promising emerging businessmen to understand a resource precious. Additionally, the report covers research data on Analgesic Infusion Pumps of various companies, benefits, gross margin, strategic decision of the global market, and more through tables, graphs, and infographics.

    The Analgesic Infusion Pumps report highlights an all-encompassing assessment of the revenue generated from different segments across different regions for the forecast period, 2022 to 2027. To leverage business owners gain an in-depth understanding of the In its current momentum, analgesic infusion pump research is harnessing hard-to-find data on aspects such as, but not limited to, demand and supply, distribution channel, and technology upgrades. Primarily, the determination of stringent government policies and regulations and government initiatives enhancing the growth of the Analgesic Infusion Pump market offers knowledge of what awaits business owners in the coming years.

    Global Analgesic Infusion Pumps Market Segmentation:

    Market Segmentation: By Type

    Self-controlled analgesic pumps, uncontrolled analgesic pumps

    Market Segmentation: By Application

    Hospitals, Clinics, Others

    Get an exclusive discount on this report:

    https://www.a2zmarketresearch.com/discount/313749

    COVID-19 Impact Analysis

    The COVID-19 pandemic has emerged in lockdown across regions, line limitations and collapsing transport organizations. Furthermore, the financial vulnerability of the Analgesic Infusion Pumps market is much higher than past outbreaks like Extreme Severe Respiratory Disease (SARS), Bird Flu, Swine Flu, Avian Influenza, and Ebola, inferred from the increasing number of individuals infected and vulnerability to the end of the crisis. With the rapid increase in cases, the global analgesic infusion pump refresh market is influenced from multiple perspectives.

    Labor accessibility is evidently disrupting the inventory network of the global Analgesic Infusion Pump Drinks market as lockdown and spread of infection pushes individuals to stay indoors. Analgesic Infusion Pump manufacturers overview and product transportation are related. If the assembly movement is stopped, the transport and, likewise, the store network additionally stop. Stacking and dumping of elements, i.e. raw materials and results (fasteners), which require a ton of labor, are also heavily affected by the pandemic. From the entrance of the assembly plant to the warehouse or distribution center to the end customers, that is, the application companies, the entire network of inventory of analgesic infusion pumps is seriously compromised because of the episode.

    The research provides answers to the following key questions:

    • What is the projected size of the analgesic infusion pump market by 2027?
    • What will be the normal share of the whole industry for the coming years?
    • What is the prominent development driving the components and restraints of the Global Analgesic Infusion Pump Market across different geographies?
    • Who are the top sellers expected to lead the market for the assessment period 2022 to 2027?
    • What are the moving and emerging advancements expected to influence the advancement of the Global Analgesic Infusion Pumps Market?

    What are the development techniques received by the important sellers of the market to stay on the lookout?

    Buy an exclusive report on:

    https://www.a2zmarketresearch.com/checkout

    If you have any special requirements, please let us know and we will offer you the report you want. you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

    About A2Z Market Research:

    The A2Z Market Research Library provides market research syndication reports from around the world. Buy-ready syndication Market research will help you find the most relevant business intelligence.

    Our research analyst provides business insights and market research reports for large and small businesses.

    The company helps its clients to develop business policies and grow in this market. A2Z Market Research is interested not only in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F&B , media, etc., but also your company data, country profiles, trends, information. and analysis on the sector that interests you.

    Contact us:

    Roger Smith

    1887 WHITNEY MESA DR HENDERSON, NV 89014

    [email protected]

    +1 775 237 4147

    read more
    Medical products

    Medicom donates over $250,000 in medical products

    In order to support ongoing humanitarian efforts in UkraineMedicom will send $250,000 value of medical products North America and Europe. In addition, the company is launching a fundraiser among its nearly 2,000 employees and will match every dollar donated. The funds raised will be donated to Médecins Sans Frontières and used mainly to improve access to healthcare and medicines.

    “For the past few days, our thoughts have been with our colleagues from Kyiv and with the Ukrainian people. In line with our mission to protect, we have decided to help caregivers involved in humanitarian efforts and their patients,” said Guillaume LaverdureChief Operating Officer of Medicom.

    Medicom customers and partners who wish to support humanitarian medical aid operations in Ukraine can visit the Médecins Sans Frontières website at https://www.msf.org.

    About Medicom Group

    The Medicom Group is one of the world’s leading manufacturers and distributors of high quality, single-use, infection prevention and control products for the medical, dental, industrial, animal health, laboratory, retail, retail and health and wellness. Medicom was named one of from Canada Best Managed Companies for 2021 and received a Mercure Award at Mercuriades 2021.

    Medicom distributes infection control products under the Medicom, Ritmed, Kolmi, Hopen, Ocean Pacific and Hedy brands. Medicom subsidiaries include Kolmi-Hopen in FranceMedicom Asia in hong kongUnited Medical Enterprise in the United StatesKHM Engineering at Singapore and Medicom HealthPro Limited in the UK

    Medicom has extensive experience in meeting the demand for personal protective equipment in the event of a pandemic. Medicom was founded in 1988 in response to the urgent need for medical gloves for healthcare professionals during the global HIV crisis. Since then, the company has been a reliable provider of infection control solutions during multiple epidemics, including Avian Flu, SARS, H1N1 and Ebola, as well as the COVID-19 pandemic.

    For more information about Medicom and the company’s full portfolio of infection control solutions, including an extensive line of medical masks, please visit Medicom.comfollow us on Twitter @MedicomGlobal or visit our pages on Facebook Where LinkedIn.

    SOURCEAMD Medicom Inc.

    read more
    Medical supplies

    War veteran feels ‘sense of duty’ to help deliver medical supplies to Poland

    A war veteran, who says he has a “sense of duty” to “do something” for Ukraine, plans to travel to Poland to deliver medical supplies.

    Matt Simmons, 42, from Emsworth, Hampshire, set up the Ems4Afghans organization last year in response to the Taliban takeover of Afghanistan, which is now relaunched as the community benefit corporation Bridge to Unity to offer support for multiple causes.

    He told the PA news agency that he found a Facebook page for a non-governmental organization (NGO) in Poland (Zintegrowana Sluzba Ratownicza) and partnered with them to help provide medical supplies. to Ukrainians, including bandages for ambulances and eyewash stations.

    Members of Zintegrowana Służba Ratownicza help Ukrainians entering the Polish border (Zintegrowana Służba Ratownicza/AP)

    Mr Simmons has been crowdfunding to help raise money for medical supplies, and said he was ‘reaching out to absolutely everyone’ and working on ‘three hours of sleep a night’.

    So far £10,000 has been raised against the target of £12,500 set by Mr Simmons when he started fundraising on February 25 – just a day after Vladimir Putin ordered troops Russians to enter Ukraine.

    “We went to the Emsworth and surrounding community and it got bigger than us in Hampshire,” he said.

    “It got crazy. I have people sending in from New York and donating from all over the world.

    “Charlotte Crosby from Geordie Shore posted about me on her Instagram (story).”

    Charlotte Crosby’s story from March 1 that mentioned the Bridge to Unity fundraiser (@charlottegshore/PA)

    Mr Simmons added that the support he has received so far has been “overwhelming and heartwarming”.

    “I think sometimes people want to do something when you see such things in the media but don’t necessarily know how they can help,” he added.

    “(Fundraising) gives people direction on how to help. I’ve tried to tell people it doesn’t matter if you donate money, if you share a post, if you interact with a post, if you connect us with someone who might be able to help .

    “It’s about sharing, interacting and getting the message out and that’s what’s important – we’re all uniting in the face of Russian aggression and fighting back in some way.”

    Mr Simmons is due to travel to Poland from March 4-5 with five other people, including two members of the Portsmouth Baby Bank who collected essential items for mothers and their children – and Hannah Jarvis, 39, from Abergavenny, in Wales, who has worked with Mr Simmons on helping Afghan refugees in the past.

    Hannah Jarvis (Hannah Jarvis/AP)

    She said: “(It has been heartening to see) the best of humanity spring into action and respond to the worst of humanity.

    “I didn’t expect us to raise over £10,000 in such a short time and we are now at the point where we are declining offers of support which is a wonderful problem to have.

    “While I think we can see unpleasant scenes at the aid camp and no doubt be upset to hear about the experiences of Ukrainian refugees, it is certainly better to be at home feeling helpless and frustrated. “

    Conversations Mr. Simmons had with the Polish NGO, which provides medical care and practical assistance to those entering Poland from Ukraine, made the search for donations even more paramount.

    Members of Zintegrowana Służba Ratownicza (Zintegrowana Służba Ratownicza/PA)

    “They say they’re really against it. They have teams of medical personnel there 24 hours a day,” he said.

    “Supply is a huge problem. They have to make rounds of supplies all the time, which keeps people with medical experience away from the border.

    “They said in the past 24 hours there had been a difference in the type of injuries they had seen and the type of medical needs that arose.

    “They’re starting to see more traumatic injuries.”



    People will be able to follow us, follow the story and by taking it myself, it’s actually like I’m taking the supporters with me and they can see where their donations went.

    Matt Simmons

    Although there is a risk in traveling to Poland, Mr Simmons said: “I have to go. This is the most important thing.

    “That’s what’s going to get people behind us, I think, because then we can be transparent with what’s given.

    “People will be able to follow us, follow the story and by taking it myself, it’s actually like I’m taking the supporters with me and they’ll be able to see where their donations have ended up.”

    read more
    Prescription drugs

    Letter to the Editor – About Prescription Drugs | Opinion

    As a Registered Nurse with decades of professional experience, I have provided health care to hundreds of rural Iowas. From treating traumatic injuries to chronic disease care to helping patients manage medications, we healthcare providers gain valuable insight into the inner workings of one of the largest sectors of the economy. And sometimes that hands-on experience and training in healthcare can be incredibly frustrating.

    The high cost of life-saving drugs and prescription drugs is at the top of my list of concerns. I’m not alone. 83% of Americans say the cost of prescription drugs is unreasonable, according to an October 2021 public opinion poll conducted by the nonpartisan health care organization Kaiser Family Foundation (KFF).

    The KFF poll also shows strong, bipartisan public support – more than 80% in favor – for government actions that:

    facilitate the marketing of generic drugs

    limit the drug company’s ability to raise prices above inflation

    limit out-of-pocket spending for people on Medicare

    allow governments to negotiate with pharmaceutical companies for lower prices on Rx drugs covered by Medicare and private insurance

    Federal action to implement these grassroots policy changes has been blocked primarily by Senate Republicans and filibuster rules that Democrats seem unwilling to change.

    Fortunately, we have an opportunity here in Iowa this legislative session to make prescription drugs more affordable and accessible. House File 263 would cap the cost of insulin at $100 per month for state-regulated health care plans in Iowa. House File 262 would allow those who need insulin, Epi-Pens and inhalers to receive emergency prescriptions from their pharmacist if their doctor is unavailable for a prescription. Both bills would help tens of thousands of Iowans.

    Both of these bills passed the Iowa House of Representatives last year 91-0 and 89-2. Unfortunately, the state senate took no action. Sen. Jeff Edler (R, State Center), who chairs the Senate Human Resources Committee, declined to schedule votes on these incredibly popular and important bills.

    Senator Edler is certainly aware of his role in this process. For example, regular Iowans who rely on insulin to manage their diabetes have called and met with Senator Edler to implore him to allow a yes or no vote on these issues. Senator Edler needs to stop playing political games with people’s lives. After all, over 10% of adults in Iowa have diabetes, with diabetes rates over 20% for Iowans earning less than $25,000 a year.

    If Senator Edler isn’t supporting Iowans with diabetes, who is he protecting? U.S. Senator Charles Grassley (R-IA), who was a key leader of Edler’s party for half a century, led an investigation into how drug companies measured insulin prices in 2019 when Grassley was Chairman of the Senate Finance Committee. The Grassley Committee report found that pharmaceutical companies Eli Lilly, Sanofi and Novo Nordisk have dramatically increased the prices of long- and short-acting insulins over the past decade, in some cases by more than 70% by only 5 years old.

    It’s not a complicated question. To refuse to provide basic cost controls for life-saving prescription drugs is simply cruel and cynical policy. Pharmaceutical companies are among the most profitable companies in the world. Our political leaders, both in Washington DC and here at the Des Moines Statehouse, have allowed corporate power to block grassroots reform for too long. Now is the time to act, and it starts with Senator Edler scheduling a vote on House Items 262 and 263 before it’s too late during this year’s legislative session.

    Barb Kalbach is a 4th generation family farmer, registered nurse, and board member of Iowa Citizens for Community Improvement. Barb can be reached at [email protected]

    read more
    Medical products

    Metal Fiduciary Marks Market Analysis by 2030

    New Jersey, United States,-The Metal Fiduciary Marks Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

    Metal Fiduciary Marks Market Overview:

    The research report on global “Metal Fiduciary Marks Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Metal Fiduciary Marks market study provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

    This Metal Fiduciary Marks Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=245961

    The report includes a detailed segmentation study of the global Metal Fiduciary Brands market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Metal Fiduciary Marks Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Metal Fiduciary Marks Market.

    Key Players Covered in Metal Fiduciary Marks Markets:

    • CIVCO Radiotherapy
    • IZI medical products
    • Naslund Medical AB
    • IBA
    • Boston Scientific Society
    • Medtronic

    Metal Fiduciary Marks Market Split By Type:

    • pure gold
    • Gold alloys
    • Other metal-based markers

    Metal Fiduciary Marks Market Split By Application:

    • Hospitals and outpatient facilities
    • Independent radiotherapy centers
    • Cancer research centers

    The Metal Fiduciary Marks Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Metal Fiduciary Brands Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Metal Fiduciary Marks market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=245961

    Scope of the Metal Fiduciary Marks Market Report

    Report attribute Details
    Market size available for years 2022 – 2029
    Reference year considered 2022
    Historical data 2019 – 2021
    Forecast period 2022 – 2029
    Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Metal Fiducial Marks Market analysis can be represented as follows:

    Each regional Metal Fiduciary Brands industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global metal fiat brands market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-metal-fiducial-marks-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical supplies

    NPMC Acquires GNG Medical Supplies, Another Milestone By NPMC Spokesperson Khaniya Gupta

    Dr. Gautam Arora

    Dr. Gautam Arora

    Dr. Gautam Arora

    Dr. Gautam Arora

    Dr. Gautam Arora

    This would further improve patient care by NPMC Dr Gautam Arora

    This would improve patient outcomes and reduce the cost of healthcare”

    —Dr. Gautam Arora

    MONROE, NJ, USA, February 28, 2022 /EINPresswire.com/ — NPMC, a diversified company founded by Dr. Gautam Arora focused on synergistic acquisitions in critical, fast-growing sectors, acquired a majority stake in medical supplies company GNG. GNG’s primary revenue drivers focus on providing globally sourced heavy duty consumable medical supplies. These include hygiene products, syringes, dressings and sterilization equipment.

    Among other elements, the acquisition of GNG brings immediate revenues to NPMC, a high level of operational profitability and an order book of 1.8 Cr for 2021. The company is also engaged in other sales of personal care products. related healthcare and in the development of products that could bear considerable fruit in future quarters.

    GNG Medical supply is currently on track to generate revenue of 2.7 Cr in 2022 and is targeting revenue of 3.6 Cr in 2023. In comparison, in 2020 the company generated revenue of 86 Lakhs with an EBITDA of 32.8 Lakhs. Dr. Gautam Arora, MD, CEO, of NPMC commented, “The acquisition of GNG’s medical supply business further strengthens our revenue estimate of Cr3.6 for FY2023. The acquisition provides NPMC a channel to leverage its existing relationships in the medical supply chain to increase GNG’s medical revenue. and global supply chain footprint.”

    GNG Medical Supply Background:
    Mr. Gavin Kumar founded GNG Medical Supply in 2017 as a sole proprietorship before incorporating in 2019. The company provides the market with globally sourced medical supply products. In addition, it is a financial partner at all stages of enterprise and post-enterprise, private and public – partnership in the sector of biotechnology and sustainable medical equipment.

    About NPMC
    NPMC started as a clinical practice and is now a diversified company focusing on acquisitions in the following sectors: Healthcare and real estate. NPMC is an acquisition-driven company. The company’s strategy is to acquire majority stakes in undervalued companies and play an active role in improving their performance – accelerating their growth by providing them with both access to capital and management expertise. .

    Gautam Arora
    NPMC Neurology and Pain Management Clinic
    +91 85951 68656
    write to us here

    read more
    Generic drugs

    Global Multi-Cancer Generic Drugs Market 2021 Manufacturer Landscape, Revenue and Volume Analysis to 2027 – Business Ethics

    The research report MarketQuest.bizto Global market for generic drugs for several cancers reviews important industry and market trends, as well as historical and anticipated market data. The research has implications for the stock market as well as other terms and definitions. Analytics promotes its products by application, sort and location in terms of volume and value.

    The market accurately reflected the total sales and marketing volume, maximum production and consumption costs, profit margins, import and export, cost structure analysis, in-depth price analysis , vendor landscapes, and other critical market variables. The research helps identify new marketing opportunities and offers a complete picture of the existing global market for generic drugs for multiple cancers.

    DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/45315

    The study is significant for organizations or individuals looking to enter the Generic Drugs for Multiple Cancers industry as it provides detailed qualitative and quantitative insights. It also examines how changing patterns, COVID-19, and inflation are affecting market growth. Additionally, supply chain analysis, profit margin analysis, and price research are all covered in depth to help businesses and give them an estimate of how much money they will need to join this market.

    Market segmentation based on region:

    • North America (United States, Canada and Mexico)
    • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
    • South America (Brazil, Argentina, Colombia and rest of South America)
    • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)

    Player Market Segmentation:

    • Pfizer
    • GlaxoSmithKline
    • Novartis
    • Merck
    • Celgene
    • Teva pharmaceutical
    • Mylan
    • Aurobindo Pharmacy
    • Hikma Pharmaceuticals
    • rock
    • Redsenol

    Segment the market by product type:

    • Cytotoxic drug
    • Non-cytotoxic drugs

    Market segmentation based on application

    • Hospital pharmacy
    • Retail pharmacies
    • Online pharmacies

    ACCESS FULL REPORT: https://www.marketquest.biz/report/45315/global-generic-drugs-for-multiple-cancers-market-2021-by-key-countries-companies-type-and-application

    In addition, a framework of study has been created to emphasize future events and possibilities in the global Generic Multiple Cancer Drugs industry in recent years. According to the research study, the market will face a variety of drivers and restraints, opportunities and challenges throughout the forecast period. The report also examines the geographical characteristics of the market, which will impact its growth from 2021 to 2027.

    Report customization:

    This report can be customized to meet customer requirements. Please contact our sales team ([email protected]), who will ensure that you get a report tailored to your needs. You can also get in touch with our executives at +1-201-465-4211 to share your research needs.

    Contact us
    mark the stone
    Business Development Manager
    Call: +1-201-465-4211
    E-mail: [email protected]

    read more
    Prescription drugs

    REUTHER: Prescription Drugs: America’s Scam | Opinion

    By DAVID REUTHER

    The continued rise in prescription drug prices remains a long-term hardship for many American families. Overall, US residents spend significantly more on prescription drugs than residents of other comparable developed countries.

    Soaring drug prices, coupled with an aging population in dire need, have led many congressional lawmakers and public groups to tackle the current pricing system with increasing urgency.

    It is a harsh reality that many people have to choose between food, shelter and medicine. According to an AARP report, applying the drug price increase rate to everyday items would mean a gallon of milk would cost $13, a loaf of bread $4.21, and a gallon of gasoline $12.20.

    When President Biden visited Culpeper on Feb. 10, Rep. Abigail Spanberger (D-Va.) introduced him to Shannon Davis and her 12-year-old son Joshua, who, like his father, has diabetes from type 1 and whose insulin is expensive. the family about $1,000 a month. It’s not an optional expense, it’s vital to preserve their lives.

    People also read…

    To shed some light on the problem, Rep. Spanberger, along with five bipartisan colleagues, introduced the Public Disclosure of Drug Rebates Act, which would require that rebates, rebates, and price concessions negotiated by intermediaries be made public on a website through the Department. health and social services. The bill originally passed the House unanimously in 2019 and now sits in the divided Senate, where it languishes in committee.

    The Elijah Cummings Reduce Drug Costs Now Act of 2021 was also originally passed by the House in 2019; all Democrats voted for the measure and all but two Republicans voted against. The Republican-controlled Senate never picked it up. This would have allowed Medicare to negotiate drug prices like Veterans Affairs and Medicaid do with drug companies.

    The Congressional Budget Office estimated the Cummings bill would save $345 billion in federal spending over seven years, and the Centers for Medicare & Medicaid Services found it could reduce out-of-pocket costs by $158 billion. dollars over a decade. It was reintroduced in 2021 and was later included in the President’s Build Back Better bill, which passed the House along party lines in November 2021. Facing unanimous Republican opposition, the bill died in the Senate.

    The Build Back Better Act would have included a $2,000 annual cap on out-of-pocket expenses for people enrolled in Medicare Part D drug plans and a $35 co-pay cap on certain insulins. It also reportedly allowed Medicare to begin negotiating the price of certain prescription drugs. From 2025, 10 drugs in addition to insulin would have been traded, with this number increasing to 20 drugs in 2028 and beyond.

    Out of control drug prices, so difficult for so many Americans, translate into out of control profits for pharmaceutical companies, a problem unheard of in most other developed countries.

    In a democratic republic, the people choose representatives to act for them and for the good of the country. Today, there appears to be a major disconnect between citizens and Congress, as well as hyper-partisanship within and between the two chambers.

    The BBB is just one indicator of this unsatisfactory inaction, and the drug companies will happily continue to make obscene profits. If we don’t demand that our representatives meet the challenges we face, nothing will happen.

    David Reuther, a retired US foreign service officer, is a former chairman of the Culpeper Democratic committee.

    read more
    Medical supplies

    Medical supplies for Ukraine stuck in warehouse in Tempe | Arizona News

    TEMPE, AZ (3TV/CBS 5) – Thousands of dollars worth of medical supplies for Ukraine sit in a warehouse in Tempe, unable to be delivered amid escalating conflict.

    “It’s heartbreaking for us to know that what’s sitting here could save lives out there right now,” said Charles Irion, with Project CURE “They’re going to be needed more now because of all the injuries and suffering that is So the sooner we can hopefully get this container out, the better.

    Project CURE is a non-profit organization that collects donations of medical supplies and equipment from hospitals in Arizona and ships them to 138 different countries that may not have access to these items.

    “I’ve been seeing this equipment for two weeks, and I myself have wondered why it’s sitting here? And yesterday it got even sadder and heartbreaking that it’s not going where it’s supposed to go to help people. people…mothers, children, the elderly, the Ukrainian community. They can’t get their supplies,” said Ruth Sanchez, executive director of Project CURE in Arizona.

    Sanchez says between $250,000 and $1 million goes into 40-foot shipping containers.

    “It’s all medical. We don’t do pharmaceuticals. We do equipment, biomedical, x-rays, ultrasound, and then PPE – the gowns, the gloves, the masks, the syringes, that’s there too,” Sanchez explained. “We have wheelchairs, we have baby warmers. Everything you see in the boxes you see for Ukraine is what you and I easily have at any facility here in the United States. United.” This shipment was due to leave the warehouse for Ukraine yesterday. “We actually planned two weeks, and we finally got confirmation two days ago that it would be here, and overnight it changed, and the freight forwarder said we weren’t there. comfortable sending anything to this area.”

    Sanchez says Project CURE is working with government officials to find a safe way to get supplies to Ukraine. They plan to ship the container to Poland or Germany. “We’re working really hard to fix this and another two weeks, and we’re talking about saving lives here,” Sanchez said.

    The CURE project now has a donation campaign to help Ukraine. If you would like to donate, click here.


    Copyright 2022 Gray Media Group, Inc.

    read more
    Medical products

    Tongue Depressor Market Forecast 2022 by 2029

    New Jersey, United States,-The Tongue Depressor Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

    Overview of the Tongue Depressor market:

    The research report on “Global Tongue Depressor Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Tongue Depressor market study provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

    This Tongue Depressor Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=208333

    The report includes a detailed segmentation study of the global Tongue Depressor market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Tongue Depressor Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Tongue Depressor Market.

    Major Players Covered in Tongue Depressor Market:

    • Puritan Medical Products
    • Agaplastic
    • medical dtr
    • Fazzini
    • Fl Medical
    • FASA Group
    • Francois Mensch
    • Parburch Medical Developments
    • Plasti Lab
    • Dental Shufa
    • timesco
    • We Ophthalmic
    • A. Algeo
    • Dental Asa

    Tongue Depressor Market Split By Type:

    • wooden tongue depressor
    • Metal tongue depressor
    • plastic tongue depressor

    Tongue Depressor Market Split By Application:

    • Hospitals
    • Clinics
    • Academic research institutes

    The Tongue Depressor Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Tongue Depressor Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Tongue Depressor market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=208333

    Scope of the Tongue Depressor Market Report

    Report attribute Details
    Market size available for years 2022 – 2029
    Base year considered 2022
    Historical data 2019 – 2021
    Forecast period 2022 – 2029
    Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Tongue Depressor Market Analysis can be represented as follows:

    Each regional Tongue Depressor industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global Tongue Depressor market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/%ef%bb%bftongue-depressors-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Generic drugs

    Generic Drugs Market Continues to Grow Due to Rising Incidence of Chronic Diseases Worldwide | Teva Pharmaceutical Industries, Mylan NV, Novartis International AG, Pfizer, Inc.

    Market Overview:

    Generic drugs are those that have the same active chemical substance as a brand name drug. Before generics became available, generic drugs were made using identical active ingredients, the only difference being the chemical makeup or dosage. Generic drugs can be sold without any authorization from the Food and Drug Administration. Generic drugs can also be manufactured and approved at the same time as the patented drug if the company that holds the patent for the drug can meet the necessary requirements. Once these requirements are met, a generic drug can be marketed. Generic drugs, however, are not available without a doctor’s prescription because generic drugs lack the safety offered by brand name drugs.

    Request a PDF brochure here @ https://www.coherentmarketinsights.com/insight/request-pdf/1132

    Key Market Drivers:

    Rising cases of chronic diseases across the world is the major factor that is expected to drive the growth of the global generic drugs market. For example, according to the World Health Organization, approximately 422 million people worldwide have diabetes and approximately 1.6 million deaths are directly related to diabetes each year. Generic drugs are manufactured using the same facilities and methods as brand name drugs. In fact, it is usually the same product created with the same quality and consistency. However, generic drugs are manufactured to meet or exceed the safety and efficacy requirements of the United States Food and Drug Administration. Generic drugs can be sold without the need for an expensive marketing campaign because generic drugs can be manufactured at lower prices than brand name drugs. Increase in product launches by major market players is estimated to propel the growth of the global generic drugs market.

    Covid-19 impact analysis:

    The rising incidence of COVID-positive cases globally has significantly affected the growth of the global generic drugs market. For example, according to Springer, in April 2020, the number of individuals infected with SARS-CoV-2 was approximately 0.9 million with a fatality rate of approximately 1.38%. Additionally, increasing transportation restrictions and lockdown restrictions in several countries has also affected the market growth.

    Key points to remember:

    • The global generic drugs market size was valued at around US$263 billion in 2020 and at a CAGR of 6.58%, it is estimated to reach around US$385 billion in 2026, owing to the increase in chronic diseases worldwide. For example, according to the International Agency for Research on Cancer, in 2020 the global cancer burden was approximately 19.3 million.
    • North America is expected to hold a major share of the global generic drug market, owing to the growing prevalence of drug manufacturers in the region. For example, according to Pharmapproach, in 2019 the United States generated approximately US$490 billion in revenue.
    • Asia-Pacific is expected to experience high growth in the global generic drug market, owing to the growing prevalence of pharmaceutical companies in developing regions. For example, according to India Briefing, there are over 3,000 pharmaceutical companies in India, along with 10,500 manufacturing units.

    Buy this report directly with a fixed discount of 2000 USD @ https://www.coherentmarketinsights.com/promo/buynow/1132

    Reasons to Buy this Generic Drugs Market Report

    ➡ Save time conducting entry-level research by identifying the size, growth and key players in the emerging Generic Drugs market

    ➡Use five forces analysis to determine the competitive intensity and hence the attractiveness of the emerging generic drugs market

    ➡Key Company Profiles Reveals Details of Major Generic Drugs Market Players Emerging from Five Transactions and Financial Performance

    ➡Add weight to presentations and presentations by understanding the future growth prospects of the emerging Generic Drugs market with five-year historical forecasts

    ➡Compares data from North America, South America, Asia-Pacific, Europe and the Middle East, as well as individual chapters on each region.

    Contents

    Chapter 1 Industry Overview
    1.1 Definition
    1.2 Assumptions
    1.3 Scope of research
    1.4 Market Analysis by Regions
    1.5 Generic Drugs Market Size Analysis from 2021 to 2028
    11.6 COVID-19 Outbreak: Impact on Generic Drugs Industry

    Chapter 2 Global Generic Drug Competition by Types, Applications and Top Regions and Countries
    2.1 Global Generic Drugs (Volume and Value) by Type
    2.3 Global Generic Drugs (Volume and Value) by Regions

    chapter 3 Generation market analysis
    3.1 Global Production Market Analysis
    3.2 Regional Production Market Analysis

    Chapter 4 Global Generic Drug Sales, Consumption, Export, Import by Regions (2016-2021)
    Chapter 5 North America Generic drugs market To analyse
    Chapter 6 Analysis of the generic drugs market in East Asia
    Chapter 7 Analysis of the generic drugs market in Europe
    Chapter 8 South Asia Generic Drugs Market Analysis
    Chapter 9 Southeast Asia Generic Drugs Market Analysis
    Chapter 10 Analysis of the generic drugs market in the Middle East
    Chapter 11 Analysis of the generic drugs market in Africa
    Chapter 12 Analysis of the Generic Medicines Market in Oceania
    Chapter 13 Analysis of the generic drugs market in South America
    Chapter 14 Company profiles and key figures of the generic drugs sector
    Chapter 15 Global Generic Drugs Market Forecast (2021-2027)
    Chapter 16 conclusion
    Research Methodology

    Get Sample PDF Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/1132

    About Us:

    Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

    Contact:

    Consistent market information
    1001 4th Ave, #3200 Seattle, WA 98154, USA
    Email: [email protected]
    United States of America: +1-206-701-6702
    UK: +44-020-8133-4027
    Japan: +050-5539-1737
    India: +91-848-285-0837

    read more
    Medical supplies

    Ukraine Assistance: Vienna sends trucks with medical supplies to Kyiv and Odessa – Vindobona.org

    The man is in uniform with his wife and daughter in front of their burning house. Here, the soldier could no longer protect his family. The Red Cross became the main relief association and in 1917 received the only Nobel Peace Prize during the war years. / Photo: © Wikimedia Commons / Eybl, Plakatmuseum Wien/Wikimedia Commons / CC BY-SA 4.0

    The fact that the aid material donated by Vienna consists mainly of medical products such as FFP2 masks as well as protective equipment for hospital staff is somewhat reminiscent of the 5,000 helmets that the world’s fourth largest economy, Germany, wanted give to the Ukrainians. .

    According to information from the city government, three trucks carrying relief supplies are already on their way to the war zone.

    When loading, Mayor Michael Ludwig stressed that Vienna stands for cohesion and unity.

    “The images reaching us today from Ukraine are deeply moving. It is a sad and deeply depressing day. Our thoughts are first and foremost with the innocent civilians who are the main victims. Austria is perhaps neutral in international law, but we are not neutral when it comes to our values. That is why Vienna is also ready to help people in need.”

    “Especially in the current situation, it is important that we show solidarity,” continued Ludwig. “Let us reflect on the humanitarian traditions of our history and bring solidarity aid!”

    He also highlighted the close urban network between Vienna and Ukraine. “Especially in an international crisis like the one we are currently experiencing, Vienna is there to help people.”

    “Vienna has been involved in Ukraine for a long time, even independently” of the current crisis,” Ludwig explained.

    Among other things, associations and organizations such as Caritas and Volkshilfe have been helping for years in the fields of education and health care, as well as in the treatment of drinking water in eastern Ukraine.

    “We will continue to expand these aid programs in the future,” Ludwig said. He also said the city has already ordered more aid trucks. In the coming weeks, seven more trucks are expected to travel to Ukraine.

    Vienna City Hall – Magistrate of the Stadt Wien

    read more
    Generic drugs

    FDA OGD Releases Guidance Documents to Accelerate Generic Market Entry | Morgan Lewis – As Prescribed

    As the Biden administration and the US Congress continue to debate ways to address perceived concerns about prescription drug prices, the Food and Drug Administration (FDA) is taking action. Under its Drug Competition Action Plan (DCAP), administered by the Office of Generic Drugs (OGD), the FDA has issued approximately 24 guidance documents since 2017, directing industry stakeholders on how to develop, prepare and submit abbreviated new drug applications (ANDAs), so generic drugs can gain timely FDA approval and reach the market faster. In January 2022, the FDA released three more guidance documents in the DCAP series.

    By helping to make additional generic drugs available at lower prices, the FDA believes this can impact the overall drug price burden. For example, according to the latest Congressional Budget Office (CBO) Reportt, the average net price of a prescription drug in the Medicare Part D and Medicaid programs fell from 2009 to 2018, and this decline “reflects the increased use of cheaper generic drugs.” In the words of the FDADCAP “helps break down barriers to generic drug development and market entry with the goal of driving competition so consumers can get the drugs they need at affordable prices.”

    When we asked other departments about the importance of the last three guidelines, Maryll Toufanian, Director of the Office of Generic Drug Policy, replied:

    As stated in the DCAP, the FDA understands that it is essential to provide as much transparency as possible in our regulatory expectations. This allows for maximum efficiency for claimants submitting generic drug claims and for our assessment of those claims. Guidance like the one recently released is a key tool in our toolbox to achieve this.

    Below is a list of recently released DCAP guidance documents and a brief description of each. Although much of the information has already been provided to industry stakeholders in various forms, it is important for every company considering submitting an ANDA (or has an ANDA pending) to carefully review these published versions of the guidance from the FDA and update their regulatory procedures. Therefore.

    REQUESTS FOR INFORMATION AND DISCIPLINE REVIEW LETTERS UNDER GDUFA, GUIDANCE FOR INDUSTRY

    Updating a 2017 draft, these final guidelines detail how the DMO will provide ANDA applicants with “preliminary thoughts on possible gaps” after the DMO’s initial assessment for ANDAs submitted between 2018 and 2022 in the under the 2017 Generic Drug User Fee Amendments (GDUFA II). Although future “GDUFA III” legislation will likely change some details, this guidance is also instructive for planning purposes for ANDAs to be filed in 2023 and later.

    The guidelines explain that midway through the FDA’s evaluation of an ANDA’s first evaluation cycle (the mid-cycle date), the DMO will issue a Discipline Review Letter (DRL) to ANDA’s applicant to share their preliminary thoughts on a possible application. deficiencies. Alternatively, a Request for Information (RI) can be sent to request additional information or clarification needed to conduct a discipline assessment (eg bioequivalence, labeling or quality). However, these letters will not be sent when the discipline considers that it can act on the ANDA with the information contained in the request.

    The use of these letters is intended to provide applicants with the FDA’s thoughts as soon as possible so that they can modify the ANDAs and continue the evaluation process. The FDA hopes that this mid-cycle communication will minimize the number of review cycles needed for approval. Candidates’ responses will not be categorized as a major or minor change to the ANDA and, therefore, will not delay the assessment clock (formerly, the “Exam Clock”), unless the response does not contain information not requested by the FDA or information that requires further evaluation. The letters do not guarantee that a Complete Response Letter (CRL) will not be issued, as the letters reflect feedback from the assessment team, but not feedback from all levels of supervision within other departments.

    ANDA SUBMISSION GOOD PRACTICES, INDUSTRY TIPS

    In this guide, the OGD highlights common ANDA shortcomings and provides detailed recommendations, so that ANDA applicants can file compliant submissions under GDUFA II and avoid CRLs, data cycles multiple reviews and long approval times. The information is an update of an OGD guide published in 2018 and details the OGD program improvements developed under GDUFA II. By outlining common errors, OGD intends to foster the development of high quality submissions and promote the prompt correction of ANDA deficiencies.

    The guidelines cover almost all types of information required in an ANDA, such as patent certifications and exclusivity requirements, labeling, drug substance and drug product descriptions, impurities and intermediates, product quality and manufacturing processes, as well as bioequivalence and dissolution data. Other departments have specific submission and formatting requirements for each eCTD module in all of these areas, so the gap descriptions are helpful and may answer questions that have plagued regulatory affairs staff.

    The guide also provides useful information for keeping ANDAs pending, since the initial filing of an ANDA is only the first step to obtaining ANDA approval. During the evaluation cycle, applicants must continually update the information in the ANDA related to many topics, including patent litigation in paragraph IV, orange book changes, manufacturing changes , batch validation and stability data, risk assessment and implementation of mitigation strategy and commercial launch plans. Avoiding submission gaps when submitting updates to a pending ANDA is just as critical as the initial ANDA submission.

    ANDA LABELING REVISION FOLLOWING RLD LABELING REVISION, INDUSTRY GUIDANCE PROJECT

    These draft guidelines update information that the DMO had previously published in April 2000 via a directive of the same name. Twenty-two years later, FDA reminds ANDA holders of their continued obligation to ensure product labeling is accurate, not false or misleading, and “the same” as the labeling of the corresponding reference medicinal product (RLD). For these reasons, once the FDA approves relevant RLD labeling changes, an ANDA holder should update their labeling “as soon as possible.” To learn about RLD labeling changes, ANDA applicants and ANDA holders should proactively monitor public information, such as the [email protected] web page and the CDER New ListServ.

    The DMO also explains that ANDA labeling changes must be organized according to eCTD modules and submitted in electronic format via the electronic submission gateway. An annotated side-by-side comparison of the proposed ANDA labeling and the approved RLD labeling continues to be required.

    read more
    Prescription drugs

    Making prescription drugs more affordable

    The rising cost of prescription drugs is a growing concern, especially for those who depend on their medications to stay healthy. Spending on prescription drugs is only expected to risehttps://payorsolutions.cvshealth.com/updates/consultant-briefing-december-2021 with the specialty drug market expected to reach $373 billion in 2025. As more therapies come to market, they provide new options for patients who may previously have had no treatment available for their condition or who have not found the right medication for them – this has been true for conditions such as migraines and weight loss. However, new treatments on the market can also increase the overall cost of drugs, which increases the pressure on consumers. For example, autoimmune diseases were the main contributor to specialty growth, accounting for 54% of all specialty utilization trend.

    Reduce the cost of prescription drugs

    That’s why we’re committed to working with employers and health insurance plans to make prescription drugs more affordable. From ensuring appropriate use of treatment to negotiating with drug manufacturers for the lowest prices, we use every tool possible to increase member affordability – and our Trends Report in medicine proves that we can deliver. In fact, we delivered an overall drug trend of 2.4% for our customers.

    Through our clinical-first approach, innovative new programs, and digital tools, we’ve kept out-of-pocket expenses low, consistently reduced member cost share, and passed millions in savings on to members. We’re proud of the work we do — and invite you to dig deeper into how CVS Health partners with employers and health plans to reduce costs and make prescription drugs more accessible and affordable for members.

    read more
    Medical supplies

    Jacksonville medical supply store offers eco-friendly medical supplies and rental options

    Many people want to live in a more environmentally friendly way, but this can be difficult for those who regularly use medical products. Medco Inc makes it easy with its selection of rental equipment and eco-friendly medical supplies for Jacksonville customers.

    Concerns about single-use plastic and disposable items containing environmentally harmful chemicals have led some First Coast residents to adopt greener shopping habits. However, many medical items pose challenges for such a purpose because they must be sterilized before or after use, often requiring the use of harsh chemicals or disposable plastic that accumulates in landfills.

    Medco Inc., a local medical supply store, offers green options for customers looking to reduce their waste. Their inventory includes a diverse line of products suitable for many different health needs, from CPAP devices to bath safety products. Customers are encouraged to ask their staff about the reuse and recyclability of their products to find an item that meets their needs and eco-friendly lifestyle goals.

    Medco Inc. helps its customers reduce their waste generation through its medical equipment rental service. Rather than buying an item that is destined for a landfill when it’s no longer needed, customers can rent mobility aids, hospital beds and more for temporary use. Also, renting instead of buying is often much cheaper. Short and long term rentals are welcome. Their team also offers free local delivery for rentals for added convenience.

    Call (904) 264-8154 to learn more about green medical supplies and rental options available from Medco Inc. Information about their various medical products and services is also available at their website. Their store is located in Orange Park, Florida and serves customers from across the community, as well as Jacksonville, Fleming Island, Middleburg and surrounding areas.

    Media Contact
    Company Name: Medco inc.
    Contact: Shane Olson
    E-mail: Send an email
    Call: (904) 834-0764
    Address:653 Kingsley Ave.
    Town: Orange Park
    State: Florida
    The country: United States
    Website: http://medicalsupplies-jacksonville.com/

    read more
    Generic drugs

    FDA OGD Releases Guidance Documents to Accelerate Generic Market Entry

    As the Biden administration and the US Congress continue to debate ways to address perceived concerns about prescription drug prices, the Food and Drug Administration (FDA) is taking action. Under its Drug Competition Action Plan (DCAP), administered by the Office of Generic Drugs (OGD), the FDA has issued approximately 24 guidance documents since 2017, directing industry stakeholders on how to develop, prepare and submit abbreviated new drug applications (ANDAs), so generic drugs can gain timely FDA approval and reach the market faster. In January 2022, the FDA released three more guidance documents in the DCAP series.

    By helping to make additional generic drugs available at lower prices, the FDA believes this can impact the overall drug price burden. For example, according to the latest report from the Congressional Budget Office (CBO), the average net price of a prescription drug in the Medicare Part D and Medicaid programs fell from 2009 to 2018, and this drop “reflects the increased use of lower cost generic drugs. drugs.” In the words of the FDA, DCAP “helps remove barriers to generic drug development and market entry with the goal of stimulating competition so consumers can have access to the drugs they need. need at affordable prices”.

    When we asked other departments about the importance of the last three guidelines, Maryll Toufanian, Director of the Office of Generic Drug Policy, replied:

    As stated in the DCAP, the FDA understands that it is essential to provide as much transparency as possible in our regulatory expectations. This allows for maximum efficiency for claimants submitting generic drug claims and for our assessment of those claims. Guidance like the one recently released is a key tool in our toolbox to achieve this.

    Below is a list of recently released DCAP guidance documents and a brief description of each. Although much of the information has already been provided to industry stakeholders in various forms, it is important for every company considering submitting an ANDA (or has an ANDA pending) to carefully review these published versions of the guidance from the FDA and update their regulatory procedures. Therefore.

    REQUESTS FOR INFORMATION AND DISCIPLINE REVIEW LETTERS UNDER GDUFA, GUIDANCE FOR INDUSTRY

    Updating a 2017 draft, these final guidelines detail how the DMO will provide ANDA applicants with “preliminary thoughts on possible gaps” after the DMO’s initial assessment for ANDAs submitted between 2018 and 2022 in the under the 2017 Generic Drug User Fee Amendments (GDUFA II). Although future “GDUFA III” legislation will likely change some details, this guidance is also instructive for planning purposes for ANDAs to be filed in 2023 and later.

    The guidelines explain that midway through the FDA’s evaluation of an ANDA’s first evaluation cycle (the mid-cycle date), the DMO will issue a Discipline Review Letter (DRL) to ANDA’s applicant to share their preliminary thoughts on a possible application. deficiencies. Alternatively, a Request for Information (RI) can be sent to request additional information or clarification needed to conduct a discipline assessment (eg bioequivalence, labeling or quality). However, these letters will not be sent when the discipline considers that it can act on the ANDA with the information contained in the request.

    The use of these letters is intended to provide applicants with the FDA’s thoughts as soon as possible so that they can modify the ANDAs and continue the evaluation process. The FDA hopes that this mid-cycle communication will minimize the number of review cycles needed for approval. Candidates’ responses will not be categorized as a major or minor change to the ANDA and, therefore, will not delay the assessment clock (formerly, the “Exam Clock”), unless the response does not contain information not requested by the FDA or information that requires further evaluation. The letters do not guarantee that a Complete Response Letter (CRL) will not be issued, as the letters reflect feedback from the assessment team, but not feedback from all levels of supervision within other departments.

    ANDA SUBMISSION GOOD PRACTICES, INDUSTRY TIPS

    In this guide, the OGD highlights common ANDA shortcomings and provides detailed recommendations, so that ANDA applicants can file compliant submissions under GDUFA II and avoid CRLs, data cycles multiple reviews and long approval times. The information is an update of an OGD guide published in 2018 and details the improvements to the OGD program developed under GDUFA II. By outlining common errors, OGD intends to foster the development of high quality submissions and promote the prompt correction of ANDA deficiencies.

    The guidelines cover almost all types of information required in an ANDA, such as patent certifications and exclusivity requirements, labeling, drug substance and drug product descriptions, impurities and intermediates, product quality and manufacturing processes, as well as bioequivalence and dissolution data. Other departments have specific submission and formatting requirements for each eCTD module in all of these areas, so the gap descriptions are helpful and may answer questions that have plagued regulatory affairs staff.

    The guide also provides useful information for keeping ANDAs pending, since the initial filing of an ANDA is only the first step to obtaining ANDA approval. During the evaluation cycle, applicants must continually update the information in the ANDA related to many topics, including patent litigation in paragraph IV, orange book changes, manufacturing changes , batch validation and stability data, risk assessment and implementation of mitigation strategy and commercial launch plans. Avoiding submission gaps when submitting updates to a pending ANDA is just as critical as the initial ANDA submission.

    ANDA LABELING REVISION FOLLOWING RLD LABELING REVISION, INDUSTRY GUIDANCE PROJECT

    These draft guidelines update information that the DMO had previously published in April 2000 via a directive of the same name. Twenty-two years later, FDA reminds ANDA holders of their continued obligation to ensure product labeling is accurate, not false or misleading, and “the same” as the labeling of the corresponding reference medicinal product (RLD). For these reasons, after the FDA approves relevant labeling changes for the RLD, an ANDA holder must update their labeling “as soon as possible.” To learn about RLD labeling changes, ANDA applicants and ANDA holders should proactively monitor public information, such as the [email protected] CDER web page and new mailing list.

    The DMO also explains that ANDA labeling changes must be organized according to eCTD modules and submitted in electronic format via the electronic submission gateway. An annotated side-by-side comparison of the proposed ANDA labeling and the approved RLD labeling continues to be required.

    read more
    Medical products

    Laryngeal Stents Sales Market Outlook Forecast by 2029

    New Jersey, United States,-The Laryngeal Stents Sales Market report contains a detailed overview of the industry along with gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, the actual value, overall size, share and future development factors.

    Laryngeal Stent Sales Market Overview:

    The research report on the global “Laryngeal Stents Sales Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification . The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Laryngeal Stents Sales market research provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

    This Laryngeal Stents Sales Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=524591

    The report includes a detailed segmentation study of the global Laryngeal Stents sales market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets in the global Laryngeal Stents Sales Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Laryngeal Stents Sales market.

    Key Players Covered in Laryngeal Stents Sales Markets:

    • Boston Medical Products (bess AG)
    • Hood Laboratories
    • Stening S.r.l.

    Laryngeal Stents Sales Market Split By Type:

    • Hooded laryngeal stent
    • Laryngeal Tubular Stent Segment by Users
    • Child
    • Competitive landscape for adults: factors such as cost analysis
    • marketing strategy
    • factor analysis
    • distributors
    • sourcing strategy
    • and industrial chain

    Laryngeal Stents Sales Market Split By Application:

    The Laryngeal Stents Sales Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Laryngeal Stents Sales Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Laryngeal Stents sales market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=524591

    Scope of the Laryngeal Stents Sales Market Report

    Report attribute Details
    Market size available for years 2022 – 2029
    Reference year considered 2022
    Historical data 2019 – 2021
    Forecast period 2022 – 2029
    Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Laryngeal Stents Market Analysis Sales can be represented as follows:

    Each regional Laryngeal Stents Sales Industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global laryngeal stent sales market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/laryngeal-stents-sales-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Medical products

    Thermoplastic Orthotics Market Size 2031

    New Jersey, United States,-The Orthopedic Thermoplastics market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service delivery, value actual, overall size, share and future development factors.

    Orthopedic Thermoplastics Market Outlook:

    The research report on the global “Orthopedic Thermoplastics Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, orthopedic thermoplastics market research provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

    This Thermoplastic Orthotics Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

    Get | Download sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=520938

    The report includes a detailed segmentation study of the global orthopedic thermoplastics market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about the profitable revenue pockets of the global orthopedic thermoplastics market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global orthopedic thermoplastics market.

    Major Players Covered by Orthopedic Thermoplastics Markets:

    • Medical clarity
    • Performance Health
    • Chesapeake Medical Products
    • Orfit Industries
    • T-Tape Company
    • Allard International
    • Breg
    • North

    Orthopedic Thermoplastics Market Split By Type:

    • Minimum stretch resistance
    • Moderate resistance to stretching
    • Maximum stretch resistance

    Orthopedic Thermoplastics Market Split By Application:

    • hand and arm
    • Foot and Knee

    The Thermoplastic Orthotics Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global orthopedic thermoplastics market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Orthopedic Thermoplastics market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=520938

    Scope of the Orthopedic Thermoplastics Market Report

    Report attribute Details
    Market size available for years 2022 – 2029
    Base year considered 2022
    Historical data 2019 – 2021
    Forecast period 2022 – 2029
    Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Orthopedic Thermoplastics Market Analysis can be represented as follows:

    Each regional Orthopedic Thermoplastics industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global thermoplastic orthotics market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/orthotic-thermoplastics-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Generic drugs

    FDA OGD Releases Guidance Documents to Accelerate Generic Market Entry – As Prescribed – 02

    As the Biden-Harris administration and the US Congress continue to debate ways to address perceived concerns about prescription drug prices, the Food and Drug Administration (FDA) is taking action. Under its Drug Competition Action Plan (DCAP), administered by the Office of Generic Drugs (OGD), the FDA has issued approximately 24 guidance documents since 2017, directing industry stakeholders on how to develop, prepare and submit abbreviated new drug applications (ANDAs), so that generic drugs can gain timely FDA approval and reach the market faster. In January 2022, the FDA released three more guidance documents in the DCAP series.

    By helping to make additional low-cost generic drugs available, the FDA believes this can impact the overall drug price burden. For example, according to the latest report from the Congressional Budget Office (CBO), the average net price of a prescription drug in the Medicare Part D and Medicaid programs fell from 2009 to 2018, and this drop “reflects the increased use of lower cost generic drugs. drugs.” In the words of the FDA, DCAP “helps remove barriers to generic drug development and market entry with the goal of stimulating competition so consumers can have access to the drugs they need. need at affordable prices”.

    When we asked the OGD about the importance of the last three guidelines, Maryll Toufanian, Director of the Office of Generic Drug Policy, replied:

    As stated in the DCAP, the FDA understands that it is essential to provide as much transparency as possible in our regulatory expectations. This allows for maximum efficiency for claimants submitting generic drug claims and for our assessment of those claims. Guidance like the one recently released is a key tool in our toolbox to achieve this.

    Below is a list of recently released DCAP guidance documents and a brief description of each. Although much of the information has already been provided to industry stakeholders in various forms, it is important for every company considering submitting an ANDA (or has an ANDA pending) to carefully review these published versions of the guidance from the FDA and update their regulatory procedures. Therefore.

    Information Requests and Disciplinary Review Letters under GDUFA, Industry Guidance

    Updating a 2017 draft, these final guidelines detail how the DMO will provide ANDA applicants with “preliminary thoughts on possible gaps” after the DMO’s initial assessment for ANDAs submitted between 2018 and 2022 in the under the 2017 Generic Drug User Fee Amendments (GDUFA II). Although future “GDUFA III” legislation will likely change some details, this guidance is also instructive for planning purposes for ANDAs to be filed in 2023 and beyond.

    The guidelines explain that midway through the FDA’s evaluation of an ANDA’s first evaluation cycle (the mid-cycle date), the DMO will issue a Discipline Review Letter (DRL) to ANDA’s applicant to share their preliminary thoughts on a possible application. deficiencies. Alternatively, a Request for Information (RI) can be sent to request additional information or clarification needed to conduct a discipline assessment (eg bioequivalence, labeling or quality). However, these letters will not be sent when the discipline considers that it can act on the ANDA with the information contained in the request.

    The use of these letters is intended to provide applicants with the FDA’s thoughts as soon as possible so that they can modify the ANDAs and continue the evaluation process. The FDA hopes that this mid-cycle communication will minimize the number of review cycles needed for approval. Candidates’ responses will not be categorized as a major or minor change to the ANDA and, therefore, will not delay the assessment clock (formerly, the “Exam Clock”), unless the response does not contain information not requested by the FDA or information that requires further evaluation. The letters do not guarantee that a Complete Response Letter (CRL) will not be issued, as the letters reflect feedback from the assessment team, but not feedback from all levels of supervision within other departments.

    ANDA Submission Best Practices, Industry Tips

    In this guide, the OGD highlights common ANDA shortcomings and provides detailed recommendations, so that ANDA applicants can file compliant submissions under GDUFA II and avoid CRLs, data cycles multiple reviews and long approval times. The information is an update of an OGD guide published in 2018 and details the OGD program improvements developed under GDUFA II. By outlining common errors, OGD intends to foster the development of high quality submissions and promote the prompt correction of ANDA deficiencies.

    The guidelines cover almost all types of information required in an ANDA, such as patent certifications and exclusivity requirements, labeling, drug substance and drug product descriptions, impurities and intermediates, product quality and manufacturing processes, as well as bioequivalence and dissolution data. Other departments have specific submission and formatting requirements for each eCTD module in all of these areas, so the gap descriptions are helpful and may answer questions that have plagued regulatory affairs staff.

    The guide also provides useful information for keeping ANDAs pending, since the initial filing of an ANDA is only the first step to obtaining ANDA approval. During the evaluation cycle, applicants must continually update the information in the ANDA related to many topics, including Paragraph IV patent litigation, Orange Book changes, manufacturing changes , batch validation and stability data, risk assessment and mitigation strategy implementation, and commercial launch plans. Avoiding submission gaps when submitting updates to a pending ANDA is just as critical as the initial ANDA submission.

    ANDA labeling revision following RLD labeling revision, draft guidance for industry

    This draft guidance updates information that the DMO had previously published in April 2000 via a guidance of the same name. Twenty-two years later, FDA reminds ANDA holders of their continued obligation to ensure product labeling is accurate, not false or misleading, and “the same” as the corresponding reference medicinal product labeling (RLD). For these reasons, once the FDA approves relevant RLD labeling changes, an ANDA holder should update their labeling “as soon as possible.” To learn about RLD labeling changes, ANDA applicants and ANDA holders should proactively monitor public information, such as the [email protected] webpage and the CDER New ListServ.

    The DMO also explains that ANDA labeling changes must be organized according to eCTD modules and submitted in electronic format through the electronic submission gateway. An annotated side-by-side comparison of the proposed ANDA labeling and the approved RLD labeling continues to be required.

    read more
    Medical products

    Pneumatic Compression Devices for Lymphedema Consumption Market Size 2031

    New Jersey, United States,-Pneumatic Compression Devices for Lymphedema Consumption 2022 Industry Outlook Analysis: Pneumatic Compression Devices for Lymphedema Consumption Market 2022 is expected to be profitable. As the trends rise, investors, research methodologies, CEOs, traders, vendors, directors, presidents, research and media, and a better understanding of the Consumer Pneumatic Compression Devices market of lymphedema.

    The report specifically focuses on the Virtual Reality Cardboards in North America, Europe, Asia-Pacific, South America, Middle East and Africa, and global market. The report categorizes the market based on manufacturer, region, type and application. QYResearch market research analysts believe factors such as low cost of VR headsets to drive the market growth over the next five years. The assembly parts used to make the VR cartons are cost effective and do not require heavy machinery or huge manufacturing plants to produce these VR cartons. This low cost of VR cardboard is a prediction period for pneumatic compression devices for consumption of lymphedema. a new GIR (Global Information Research) study, of XX million US $ in 2017.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=429826

    The report includes a detailed segmentation study of the global Pneumatic Compression Devices for Lymphedema Consumption market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets of the global Pneumatic Compression Devices for Lymphedema Consumption Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Pneumatic Compression Devices for Lymphedema Consumption market.

    Key Players Covered in Pneumatic Compression Devices for Lymphedema Consumer Markets:

    • Devon Medical Products
    • Medical Touch
    • ArjoHuntleigh (Getinge AB)
    • LymphaPress?
    • Global DJO
    • Inc.
    • XIAMEN SENYANG CO.
    • LTD
    • Medline Industries
    • Inc.
    • Biocompression systems
    • Inc.
    • B?sl Medizintechnik

    Pneumatic Compression Devices for Lymphedema Consumption Market Split By Type:

    • Pneumatic compression pump
    • Pneumatic compression garments

    Pneumatic Compression Devices for Lymphedema Consumption Market Split By Application:

    The Pneumatic Compression Devices for Lymphedema Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Pneumatic Compression Devices for Lymphedema Consumption market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Pneumatic Compression Devices for Lymphedema Consumptions market and its growth potential in coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=429826

    Scope of Pneumatic Compression Devices for Lymphedema Consumption Market Report














    Report attribute Details
    Market size available for years 2021 – 2028
    Base year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    The regional analysis of Pneumatic Compression Devices for Lymphedema Consumption Market can be represented as follows:

    Each regional Pneumatic Compression Devices for Lymphedema Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global Pneumatic Compression Devices for Lymphedema Consumption market has been segmented as follows:

      • North America includes the United States, Canada and Mexico

      • Europe includes Germany, France, UK, Italy, Spain

      • South America includes Colombia, Argentina, Nigeria and Chile

      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-pneumatic-compression-devices-for-lymphedema-consumption-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US Toll Free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Sleeping Pills (Prescription Drugs) Market Share of APAC, Europe & Americas Application will grow at XX% CAGR to 2026





    Abstract:

    The latest Sleeping Pills (Prescription Drugs) Market research report offers an in-depth assessment of this business sphere and highlights the key driving factors, growth barriers and lucrative prospects influencing the earnings trajectory over the period 2021-2026.

    Request a sample copy of this report @ https://www.getnewsalert.com/request-sample/28757

    The Sleeping Pills (Prescription Drugs) industry is expected to register a CAGR of xx% over the forecast period. To arrive at such projections, the research relies on the history of the market increase as well as proven research mythologies.

    The document also includes data pertaining to the regional scope of the industry and emphasizes the factors fueling segmental development. Additionally, it provides in-depth company profiles of key players to offer a comprehensive view of this vertical’s competitive dynamics.

    Market overview:

    Regional outlook:

    • Regionally, the Sleeping Pills (Prescription Drugs) market is classified into North America, Europe, Asia-Pacific, South America, Middle East & Africa, Southeast Asia.
    • The study examines economic indicators for key geographies along with their implications for the overall expansion of the industry.
    • The market share as well as the consumption growth rate of each of the listed regional segments are also presented.

    Product Land Overview:

    • According to the report, product portfolio of Sleeping Pills (Prescription Drugs) Market is divided into Zolpidem Eszopiclone (Lunesta) Ramelteon (Rozerem) Ativan (Lorazepam) Adapin (Doxepin).
    • The document shows the consumer market share of each product segment.
    • Information on prices, sales and revenue generated by each product category is specifically covered in the study.

    Overview of scope:

    • Based on scope, the sleeping pills (prescription drugs) market is divided into hospital pharmacy and retail pharmacy.
    • The document includes forecasts of the consumption value and consumption share of each application category over the analysis period.
    • The market share captured by each application segment is also listed.

    Review of the competitive landscape:

    • The competitive atmosphere of the Sleeping Pills (Prescription Drugs) market is defined by top performers such as Sanofi Abbott Laboratories Takeda Pharmaceutical Apotex Aurobindo Pharma Actellon Pharmaceuticals Allegiant Health Cayman Chemical Ambitropin Hayao.
    • The report presents basic company information and a summary of each company.
    • Statistical data relating to sales, price structure, revenue share and gross margins are also presented.
    • The research document identifies major manufacturing bases, distribution channels and operational areas of key players.
    • Updated information on new product launches, market concentration rate, potential entrants, mergers and acquisitions, and development trends are also offered in the research document.

    Research objective:

    • Focuses on the key global Sleeping Pills (Prescription Drugs) Market manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans over the next few years.
    • Moreover, the business contributors, as business analysts of the whole value chain, have made extensive efforts to carry out this group action and the bulk of the work adds order to produce the actors keys with useful primary and secondary data regarding the global Sleeping Pills (Prescription Drugs) market
    • Analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
    • Establish a strategic profile of key players and analyze in depth their growth strategies.

    Influence of the Sleeping Pills (Prescription Drugs) Market Report:

    • Comprehensive assessment of all opportunities and risks in the Sleeping Pills (Prescription Drugs) Market.
    • Recent innovations and major happenings in the Sleeping Pills (Prescription Drugs) Market.
    • A detailed study of business strategies for growth of the Sleeping Pills (Prescription Drugs) Market-leading players.
    • Revealing study on the growth area of ​​the Sleeping Pills (Prescription Drugs) Market for the forthcoming years.
    • In-depth understanding of Sleeping Pills (Prescription Drugs) market drivers, restraints, and major and minor markets.
    • Favorable impression amid vital technological and market latest trends striking the Sleeping Pills (Prescription Drugs) Market.

    Main points covered in the table of contents:

    • Overview of the Sleeping Pills (Prescription Drugs) Market
    • Market competition by manufacturers
    • Production market share by regions
    • Consumption by regions
    • Global Sleeping Pills (Prescription Drugs) Production, Revenue, Price Trend by Type
    • Global Sleeping Pills (Prescription Drugs) Market Analysis by Applications
    • Sleeping Pills (Prescription Drugs) Business Profiles and Key Figures
    • Manufacturing Cost Analysis of Sleeping Pills (Prescription Drugs)
    • Marketing channel, distributors and customers
    • Market dynamics
    • Global Sleeping Pills (Prescription Drugs) Market Forecast
    • Research results and conclusion
    • Methodology and data source

    Customization request on this report @ https://www.getnewsalert.com/request-for-customization/28757





    read more
    Generic drugs

    Generic Drugs Market Share, Size, Business Opportunity, Supply Chain Analysis, Companies and Forecast Report by 2026

    global generic drug market

    SHERIDAN, USA, Feb. 22, 2022 /EINPresswire.com/ — IMARC Group’s latest research report, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021- 2026”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

    The global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth during the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

    Get Free Sample Copy of Report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

    Important Attribute and Report Highlights:
    • Detailed global market share analysis
    • Market segmentation by therapeutic area, drug delivery and distribution channel.
    • Historical, current and projected market size in terms of volume and value
    • Latest industry trends and developments
    • Competitive landscape for the generic drugs market
    • Strategies of key players and product offerings

    The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

    Key Players Covered in the Generic Drugs Market Research Report:
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan SA
    • Novartis AG
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Fresenius SE & Co.
    • Lupine Limited
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma Limited
    • Aspen Pharmacare Holdings Limited

    Do you know more information, contact our analyst at– https://www.imarcgroup.com/generic-drug-manufacturing-plant

    Overview of the impact of COVID-19:

    We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

    Key Market Segmentation:

    Breakdown by therapeutic area:
    • Central nervous system
    • Cardiovascular
    • Dermatology
    • Genitourinary/Hormonal
    • Respiratory
    • Rheumatology
    • Diabetes
    • Oncology
    • Others

    Rupture by administration of drugs:
    • Oral
    • Injectables
    • Dermal/Topical
    • Inhalers

    Breakdown by distribution channel:
    • Retail pharmacies
    • Hospital pharmacies

    Breakdown by region:
    • North America (United States, Canada)
    • Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
    • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
    • Latin America (Brazil, Mexico, others)
    • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, others)

    Table of Contents of Generic Drugs Market Research Report:
    • Preface
    • Scope and methodology
    • Abstract
    • Introduction
    • Global generic drugs market
    • SWOT analysis
    • Value chain analysis
    • Price analysis
    • Competitive landscape

    Other related reports from the IMARC group:
    WiFi chipset market: https://www.imarcgroup.com/wifi-chipset-market
    Biometrics Market: https://www.imarcgroup.com/biometrics-market
    Bakery Ingredients Market: https://www.imarcgroup.com/bakery-ingredients-market
    Plant-Based Meat Market: https://www.imarcgroup.com/plant-based-meat-market
    Kidney/Renal Function Test Market: https://www.imarcgroup.com/kidney-renal-function-test-market
    Aircraft Seating Market: https://www.imarcgroup.com/aircraft-seating-market
    Cochlear implants market: https://www.imarcgroup.com/cochlear-implants-market
    Shape memory alloys market: https://www.imarcgroup.com/shape-memory-alloys-market
    Submersible pumps market: https://www.imarcgroup.com/submersible-pumps-market
    Night Vision Devices Market: https://www.imarcgroup.com/night-vision-devices-market

    Who we are:

    The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
    IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

    Elena Anderson
    IMARC Group
    +16317911145
    write to us here

    read more
    Medical products

    Smith+Nephew appoints new CEO as medical device maker navigates pandemic

    Feb 22 (Reuters) – Smith+Nephew (SN.L) on Tuesday appointed Deepak Nath of Siemens Healthineers AG (SHLG.DE) as chief executive to succeed Roland Diggelmann after the medical device maker narrowly missed the analysts’ estimate of annual profit.

    Diggelmann was recruited by Smith+Nephew after his former boss left his salary at the end of 2019, and the British company was counting on his more than 20 years of experience in the orthopedic and diagnostic sectors to accelerate the growth of its income.

    However, the pandemic hit soon after, forcing hospitals to delay surgeries and elective services to accommodate COVID-19 patients, and slumping demand for hip and knee replacement surgeries. business, while supply chain issues have also weighed it down.

    Join now for FREE unlimited access to Reuters.com

    Register

    The UK company’s revenue rose 10.3% to $5.21 billion in the 12 months to December 31 on an underlying basis, recovering steadily from 2020, while trading profit was $936 million, compared to $683 million the previous year.

    Healthcare networks around the world are once again under pressure from the novel coronavirus variant Omicron, and the company is targeting underlying revenue growth in the range of 4.0% to 5.0% for 2022.

    “(Deepak Nath) joins us at an inflection point for the business and will bring his drive, experience and expertise to lead the team as we execute on our rapid growth strategy,” said Chairman Roberto. Quarter in a press release.

    Analysts had expected a profit of $945 million in 2021 on sales of $5.22 billion at the median, a consensus provided by the company show.

    Join now for FREE unlimited access to Reuters.com

    Register

    Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu

    Our standards: The Thomson Reuters Trust Principles.

    read more
    Generic drugs

    Generic Drugs Market – EIN Presswire

    generic drugs market report

    SHERIDAN, USA, Feb. 22, 2022 /EINPresswire.com/ — IMARC Group’s latest research report, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021- 2026”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

    The global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth during the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

    Get Free Sample Copy of Report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

    Important Attribute and Report Highlights:
    • Detailed global market share analysis
    • Market segmentation by therapeutic area, drug delivery and distribution channel.
    • Historical, current and projected market size in terms of volume and value
    • Latest industry trends and developments
    • Competitive landscape for the generic drugs market
    • Strategies of key players and product offerings

    The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, the significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

    Key Players Covered in the Generic Drugs Market Research Report:
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan SA
    • Novartis AG
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Fresenius SE & Co.
    • Lupine Limited
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma Limited
    • Aspen Pharmacare Holdings Limited

    Do you know more information, contact our analyst at– https://www.imarcgroup.com/generic-drug-manufacturing-plant

    Overview of the impact of COVID-19:

    We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

    Key Market Segmentation:

    Breakdown by therapeutic area:
    • Central nervous system
    • Cardiovascular
    • Dermatology
    • Genitourinary/Hormonal
    • Respiratory
    • Rheumatology
    • Diabetes
    • Oncology
    • Others

    Rupture by administration of drugs:
    • Oral
    • Injectables
    • Dermal/Topical
    • Inhalers

    Breakdown by distribution channel:
    • Retail pharmacies
    • Hospital pharmacies

    Breakdown by region:
    • North America (United States, Canada)
    • Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
    • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
    • Latin America (Brazil, Mexico, others)
    • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, others)

    Table of Contents of Generic Drugs Market Research Report:
    • Preface
    • Scope and methodology
    • Abstract
    • Introduction
    • Global generic drugs market
    • SWOT analysis
    • Value chain analysis
    • Price analysis
    • Competitive landscape

    Other related reports from the IMARC group:
    WiFi chipset market: https://www.imarcgroup.com/wifi-chipset-market
    Biometrics Market: https://www.imarcgroup.com/biometrics-market
    Bakery Ingredients Market: https://www.imarcgroup.com/bakery-ingredients-market
    Plant-Based Meat Market: https://www.imarcgroup.com/plant-based-meat-market
    Kidney/Renal Function Test Market: https://www.imarcgroup.com/kidney-renal-function-test-market
    Aircraft Seating Market: https://www.imarcgroup.com/aircraft-seating-market
    Cochlear implants market: https://www.imarcgroup.com/cochlear-implants-market
    Shape memory alloys market: https://www.imarcgroup.com/shape-memory-alloys-market
    Submersible pumps market: https://www.imarcgroup.com/submersible-pumps-market
    Night Vision Devices Market: https://www.imarcgroup.com/night-vision-devices-market

    Who we are:

    The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
    IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

    Elena Anderson
    IMARC Group
    +1 631-791-1145
    write to us here

    read more
    Prescription drugs

    Prescription Drugs Market Global Production, Growth, Share, Demand and Application Forecast to 2027 – ZNews Africa

    Prescription Drug Market Research Overview

    Global Prescription Drugs Market exhibits comprehensive information which is a valuable source of insightful data for business strategists during the decade 2017-2027. Based on historical data, the Prescription Drugs market report provides key segments and their sub-segments, revenue and demand and supply data. Given the technological breakthroughs in the market, the prescription drug industry is likely to emerge as a laudable platform for emerging investors in the prescription drug market.

    The results of recent scientific endeavors towards the development of new prescription drug products have been studied. Nonetheless, factors affecting major industry players to adopt synthetic sourcing of market products have also been studied in this statistical survey report. The findings provided in this report are of great value to major industry players. Every organization involved in the global production of the Prescription Drugs Market products has been mentioned in this report, to study the information on cost-effective manufacturing methods, competitive landscape and new application avenues.

    This report contains an in-depth analysis of pre-pandemic and post-pandemic market scenarios. This report covers all recent developments and changes recorded during the COVID-19 outbreak.

    Get a sample report: https://www.marketresearchupdate.com/sample/355929

    Major Key Players in the Market:
    F. Hoffmann-La Roche AG, Eli Lilly and Company, Pfizer, Inc, Novo Nordisk A/S, Amgen, Inc, Merck & Co., Inc, Sanofi, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Bristol- Myers Squibb Company, AbbVie, Inc, GlaxoSmithKline PLC, Allergan PLC, Bayer AG, Celgene Corporation, Novartis International AG, Boehringer Ingelheim GmbH, Gilead Sciences, Inc, Shire PLC

    The types covered in this report are:
    brand name drugs
    General medicine

    Based on the app:
    Sold online
    Hospital
    Clinical
    Other

    With the current market norms being revealed, the Prescription Drugs market research report has also illustrated the latest strategic developments and patterns of the market players in an unbiased manner. The report serves as a presumptive business document that can help the buyers in the global market to plan their next courses towards the future position of the market.

    Check Prescription Drugs Market Report @ https://www.marketresearchupdate.com/discount/355929

    Regional Analysis of the Prescription Drugs Market

    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia and Italy)
    Asia Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia, etc.)
    The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

    Why B2B companies around the world rely on us to grow and sustain revenue:

    • Get a clear understanding of the prescription drugs market, how it works, and the different stages of the value chain.
    • To understand the current market situation and future growth potential of the Prescription Drugs Market throughout the forecast period.
    • Develop marketing strategies, market entry, market expansion and other business plans by understanding the factors that influence market growth and buyer buying decisions.
    • Understand your competitors’ business structures, strategies and prospects and react accordingly.
    • Make more informed business decisions using relevant primary and secondary research sources.

    This report provides:

    1. A detailed overview of the global prescription drugs market.
    2. Assessment of global industry trends, historical data from 2015, projections for the upcoming years and anticipation of compound annual growth rates (CAGR) by the end of the forecast period.
    3. Discoveries of new market insights and targeted marketing methodologies for Global Prescription Drugs
    4. Discussion on R&D and demand for new product launches and applications.
    5. Varied company profiles of major industry players.
    6. The composition of the market, in terms of dynamic molecule types and targets, highlighting the key industry resources and players.
    7. The growth of patient epidemiology and market revenue for the global market and among key players and market segments.
    8. Study the market in terms of generic and premium product revenues.
    9. Determine business opportunities in the market sales scenario by analyzing trends in licensing and co-development agreements.

    Get the full report @ https://www.marketresearchupdate.com/industry-growth/prescription-drugs-report-2022-2027-355929

    Ultimately, the Prescription Drugs Market report includes analysis of investments and development trends. Present and future opportunities of the fastest growing international industry segments are covered throughout this report. This report additionally presents the product specification, manufacturing method, product cost structure, and price structure.

    Contact us:
    [email protected]

    read more
    Medical products

    Disposable Pressure Transducers Market Outlook by 2030

    New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global disposable pressure transducers market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global disposable pressure sensors market, analysts have segmented the market based on applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Disposable Pressure Transducers market.

    Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the assessment of these vendors’ financial outlook, Disposable Pressure Sensors market growth strategy and expansion plan during the forecast period. All the information presented in the Global Disposable Pressure Sensors Market research report has been certified by market experts.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=403765

    The report includes a detailed segmentation study of the global Disposable Pressure Sensors market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Disposable Pressure Transducers Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Disposable Pressure Transducers market.

    Key Players Covered in Disposable Pressure Transducers Market:

    • Edwards life sciences
    • Utah Medical Products
    • Smith’s Medical
    • Elcam Medical
    • Medical intensive care
    • Argon Medical
    • Biosensors International
    • Medical Merit Systems
    • Shenzhen Antmed
    • B. Braun
    • Cook Regentec
    • PendoTECH
    • SCW Medicath
    • George Phillips
    • DeRoyal Industries
    • Lepu Medical
    • copper medical technology
    • medical ace
    • Biometrix B.V.
    • Metko Ltd.
    • Guangdong Baihe Medical
    • Tianck Medical

    Disposable Pressure Transducers Market Split By Type:

    • Single channel transducers
    • Dual channel transducers
    • Three-channel transducers

    Disposable Pressure Transducers Market Split By Application:

    The Disposable Pressure Transducers Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Disposable Pressure Transducers Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Disposable Pressure Sensors market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=403765

    Scope of the Disposable Pressure Transducers Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Base year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Disposable Pressure Transducers Market Analysis can be represented as follows:

    Each regional Disposable Pressure Sensors industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global disposable pressure sensors market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-disposable-pressure-transducers-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Anti-Obesity Prescription Drugs Market Key Vendors, Opportunities, In-Depth Analysis by Regional and Country Perspective

    the Prescription Anti-Obesity Drugs Market The report covers the whole scenario of the global market including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Prescription Anti-Obesity Drugs market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

    This Prescription Obesity Drugs Market study outlines the economic catastrophe caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=109105

    The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Prescription Anti-Obesity Drugs market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

    The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

    Major Players Covered in Anti-Obesity Prescription Drugs Markets:

  • F Hoffmann La Roche SA
  • Alizyme
  • Arena Pharmaceuticals
  • Therapeutic Ordemanden
  • Boehringer Ingelheim
  • Novo Nordisk A/s
  • Lived
  • Glaxosmithkline

    Prescription Anti-Obesity Drugs Market Split By Type:

  • Orlistat
  • Phentermine and Topiramate
  • Bupropion and Naltrexone
  • Lorcaserin
  • Liraglutide

    Anti-Obesity Prescription Drugs Market Split By Application:

  • Pediatric
  • Adult

    The Prescription Anti-Obesity Drugs Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=109105

    Scope of Anti-Obesity Prescription Drugs Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Anti-Obesity Prescription Drugs report provides information about the market, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Aims and objectives of Anti-Obesity Prescription Drugs Market Research

    • Understanding the opportunities and advancements in Anti-Obesity Drugs determines the market strengths, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prescription Anti-Obesity Drugs market and the dynamics of the Prescription Anti-Obesity Drugs in the market.
    • Categorize the Anti-Obesity Prescription Drugs segments with increasing growth potential and assess the market for the futuristic segment.
    • To analyze the most important trends related to the various segments which help decipher and convince the Prescription Anti-Obesity Drugs market.
    • Check region-specific growth and development in the Prescription Anti-Obesity Drugs Market.
    • Understand the major stakeholders of the Prescription Anti-Obesity Drugs market and the competitive image value of the Prescription Anti-Obesity Drugs market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prescription Anti-Obesity Drugs Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Anti-obesity prescription drug historical distribution data from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=109105

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prescription Obesity Drugs Market Segmentation by Types

    4 Prescription Obesity Drugs Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Core Products of Anti-Obesity Drugs Market by Major Countries

    7 North America Anti-Obesity Drugs Landscape Analysis

    8 Europe Obesity Drugs Landscape Analysis

    9 Asia-Pacific Obesity Drugs Landscape Analysis

    10 Latin America, Middle East and Africa Obesity Drugs Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Prepackaged Medical Supplies Market Overview, High Growth Opportunities, Segmentation, Trends by 2022-2028

    the Prepackaged Medical Supplies Market The report covers the whole scenario of the global market including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Prepackaged Medical Supplies market report is the provision of guidelines and strategies followed by major market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

    This Prepackaged Medical Supplies Market study describes the economic disaster caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=134558

    The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Prepackaged Medical Supplies market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

    The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

    Major Players Covered in Prepackaged Medical Supplies Market:

  • Angiokard Medizintechnik
  • Scientific Boston
  • B Braun Melsung
  • Med-Italia Biomedica
  • Molnlycke Healthcare
  • Social
  • Teleflex Medical
  • 3M Healthcare
  • Cardinal Health
  • Covidian
  • Cypress Medical Products
  • Hogy Medical
  • Medical action industries
  • Smith and nephew

    Prepackaged Medical Supplies Market Split By Type:

  • Needle and Syringe
  • Anesthesia kit
  • Protective equipment
  • General surgery and instrument kit
  • Other

    Prepackaged Medical Supplies Market Split By Application:

  • Hospital
  • Clinical
  • Family first aid
  • Other

    The Prepackaged Medical Supplies market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=134558

    Scope of the Prepackaged Medical Supplies Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Prepackaged Medical Supplies report provides information on the market area, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Goals and Objectives of Prepackaged Medical Supplies Market Research

    • To understand the Prepackaged Medical Supplies opportunities and advancements determines the market highlights, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prepackaged Medical Supplies market and the dynamics of the Prepackaged Medical Supplies in the market.
    • Categorize the prepackaged medical supplies segments with increasing growth potential and assess the futuristic segment market.
    • To analyze the most important trends related to the different segments that help decrypt and convince the Prepackaged Medical Supplies market.
    • Check region-specific growth and development in the Prepackaged Medical Supplies Market.
    • Understand the major stakeholders in the Prepackaged Medical Supplies market and the competitive image value of the Prepackaged Medical Supplies market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prepackaged Medical Supplies Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical distribution data for prepackaged medical supplies from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=134558

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prepackaged Medical Supplies Market Segmentation by Types

    4 Prepackaged Medical Supplies Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Product Commodity Medical Devices Market by Major Countries

    7 North America Prepackaged Medical Supplies Landscape Analysis

    8 Europe Prepackaged Medical Supplies Landscape Analysis

    9 Asia Pacific Prepackaged Medical Supplies Landscape Analysis

    10 Latin America, Middle East and Africa Prepackaged Medical Supplies Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]tsglobe.com

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Med Surgical Supplies presents an easy way to buy medical supplies in the USA

    Medical and surgical supplies logo

    EDISON, NEW JERSEY, USA, February 21, 2022 /EINPresswire.com/ — Healthcare professionals face increasing challenges in their daily work, but solutions exist to help them operate effectively. Medical-surgical suppliesoften called MedsurgicalSupplies.com offers a wide range of supplies and equipment to help ensure top quality patient care. Supplies include everything from surgical instruments and patient reusable products to infection prevention tools and skin care products.

    The one-stop-shop program makes ordering supplies easy and convenient! Users can access the entire catalog, including diagnostic and surgical instruments, exam tables and more.

    Surgical equipment, plastic surgery fillers, injections, diagnostics, laboratory products, CPAP and oxygen equipment, respiratory therapy products, pharmaceuticals and vaccines all make up the more than 700,000 products available through Med Surgical Supplies.

    In-house ordering and inventory tools help nursing homes, laboratories, home health agencies, long term care facilities, nursing homes, healthcare professionals, CHWs, post care -treble with more than just control.

    Supply professionals and order nurses can easily track expenses by facility or location, enter purchase orders, approve invoices, access real-time health product information and availability through the Med Surgical Supplies website.

    Medical Surgical Supplies is a partner of Pipeline Medical, a market leader in medical technology. Their nationwide delivery network provides 48-hour next-day delivery to 95% of customers with 99.8% order accuracy and also benefits from a personal touch, with account managers assisting with backorder fulfillment.

    When you’re in the wholesale industry, you’re looking to be more than just a supplier. You want to be a partner in the success of your customers and provide them with expertise, advice and assistance so that they succeed. It’s not just about delivering their products or services; it’s about making sure they have the resources they need to start their business and keep it running smoothly.

    Anyone can sell medical supplies, but it takes an expert in the wholesale medical supplies industry to make sure everything runs smoothly, from the initial sale to any follow-up work. Med Surgical Supplies aims to keep customers healthy and prosperous by providing life-saving products such as equipment, instruments and medications. And of course, working in the regulated healthcare environment, paying attention to the smallest details.

    It’s no secret that supply chain has been a major issue in the healthcare industry for the past 18 months. Even as the pandemic itself begins to fade, supply chain issues persist.

    Hospitals and health systems are reporting supply issues, and many fear old problems could resurface. The health sector is taking steps to mitigate future disasters and learn from its mistakes, but there are always risks of further disruption.

    A recent survey of healthcare executives asked their opinion on the state of supply chain management. Many were confident about what they had learned from the pandemic, but insisted continued vigilance was needed to face future challenges.

    Med Surgical Supplies sees itself as part of the solution to providing a quick and efficient way to obtain supplies for all medical and surgical practices.

    The website provides a fast and efficient experience for physicians. The site is ideal for the medical supply chain.

    Medical-surgical supplies
    Medical surgical supplies
    write to us here

    read more
    1 2 3 4 5
    Page 2 of 5